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Chapter 1 
 
General Introduction and objective of the thesis 
 
The production of proteins needs much effort in developing a stable formulation, as proteins 
are complex molecules whose stability is governed by several thermodynamic and kinetic 
aspects. Therefore, a protein molecule would show in most cases several degradation 
pathways which almost happen simultaneously. Stability prediction is thus expected to be a 
highly complicated and tricky process and therefore mastering such a process is a valuable 
criterion in protein formulation development laboratories. An overview about protein stability 
general issues, including reported analytical and predictive scenarios in protein formulation 
development is given in chapter 1. 
 
1. Introduction: 
Biotechnologically developed medicines and vaccines offered millions of people new hope to 
cure their often life threatening diseases. More than 100 registered biopharmaceutical 
medications are already used in treating serious indications including, for example, cancer, 
hepatitis and rheumatoid arthritis. More than 30 years ago the first recombinant peptide 
hormone was successfully produced1, followed by many success stories including 
recombinant human insulin2 which was in 1982 the first approved genetically engineered 
biopharmaceutical. The process developed very fast and nowadays the number of 
biopharmaceuticals under development is extremely magnified to 633 biotechnological 
medicines in 20083. 
Therefore, the need to develop clear and reliable strategies in stabilizing proteins became 
mandatory and one of the great challenges is to prevent denaturation processes including 
protein unfolding and aggregation during the time of shelf life. However, the prediction of the 
overall protein stability is not trivial and therefore real time stability studies are conducted, 
which are very costly and time consuming. Due to the complex formation mechanisms and 
structure of protein degradation products it is quite hard to characterize and furthermore to 
quantify such species accurately with a single analytical method. In fact, many analytical 
techniques have to be involved to get reliable decisions. Moreover, predictive strategies are 
still not well evaluated with respect to real long term stability of proteins. For successful 
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prediction of protein long term stability the selected analytical method(s) should be able to 
predict the rates of main protein degradation processes.   
 
2. Protein stability:  
The term protein stability was defined by many authors4-6. Most of them refer the protein 
stability to its resistance towards chemical and physical structure modifications. It should be 
emphasized that chemical and physical stability events are not necessarily separated processes 
that take place independently, but in most cases they occur simultaneously. There are many 
published data where physical instability events were caused by chemical modification and 
vice versa. For example, human relaxin aggregates after oxidation7. The reactivity of the 
sulphydryl group in B-lactoglobulin-A is slower in native than in partially folded state8.  
 
2.1. Chemical protein stability:  
Chemical stability refers to any process involving modification via bond formation or 
cleavage. Proteins are susceptible to many chemical reactions including deamidation, 
oxidation, hydrolysis, isomerisation and proteolysis9-11. One of these reactions can dominate 
in certain proteins as for example deamidation in lysozyme and epidermal growth factor12,13  
and oxidation in parathyroid hormone14.  However, more than one chemical reaction can 
happen simultaneously in a protein such as insulin7. The location of the chemical labile amino 
acid in the protein affects its reactivity and consequently the chemical stability of the whole 
protein molecule. Therefore, the presence of such labile amino acids in a protein molecule 
might cause no chemical instability if they are buried inside the hydrophobic core of the 
protein molecule15. The dominant degradation pathway of a protein like recombinant human 
macrophage colony-stimulating factor was highly dependent on solution pH  where 
significantly different degradation products were found at different pHs16.  
 
2.2. Physical protein stability: 
Physical protein stability, which is often the main determinant of the overall protein stability, 
refers to changes in protein secondary, tertiary or quaternary structures9. In contrast to small 
molecule drugs, proteins can undergo structural physical changes independent of chemical 
modification. Native proteins occur normally in a folded form where the exposure of 
hydrophobic groups is minimized17. Many forces are involved in preserving the native protein 
confirmation, including hydrophobic interactions, electrostatic interactions, hydrogen bonding 
 2 
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and van der Waals forces18.  The loss of its natively folded structure is referred to as protein 
denaturation which is usually characterized by aggregate formation. As protein aggregates are 
usually malfunctioned or could even cause immunological problems, such denatured protein 
species are not accepted in pharmaceutical protein preparations. Protein physical stability is 
linked to two main thermodynamic aspects: conformational and colloidal stability of proteins. 
 
2.2.1. Protein conformational stability: 
Protein conformation stability is a major aspect in protein physical stability in which a protein 
undergoes irreversible structural transformation from native to denatured species through the 
reversible formation of unfolded transition state19-22. Such behaviour mainly depends on the 
protein structural thermodynamic stability23,24. Protein structure stability is affected by two 
main opposing forces. Stabilizing enthalpic and destabilizing entropic forces6,18 in which the 
later is the main force opposing protein folding processes. 
Thermodynamic stability of the native protein structure is typically quantified by the free 
energy of unfolding (ΔGunf), also called Gibbs free energy of unfolding, which represents the 
total work required to transform the native proteins to denatured species. This value is highly 
dependent on temperature and shows a parabolic profile when plotted against temperature25,26. 
ΔGunf is determined from calorimetric techniques including differential scanning 
microcalorimetry (µDSC) by direct measurement of thermodynamic parameters involved in 
the Gibbs-Helmholtz equation 27 
 
∆Gunf = ∆Hunf (1-T/Tm) - ∆Cp [(Tm-T) + T In(T/Tm)] 
 
Where, ∆Hunf is the enthalpy change during unfolding and calculated from the area under the 
apparent denaturation curve. Tm, the temperature at the mid of the unfolding peak is defined 
as the temperature at which 50% of the protein is unfolded and is well known as protein 
unfolding or melting temperature9,10,28. ∆Cp is the difference in heat capacity between folded 
and unfolded state of protein. Determination of this parameter using µDSC is possible in all 
reversible proteins where positive ∆Cp could be measured directly from the protein thermal 
denaturation curve. Most protein molecules undergo irreversible denaturation which makes 
the accurate determination of the above mentioned thermodynamic parameters impossible and 
only unfolding temperature (Tm) can be determined. However, the extraction of meaningful 
thermodynamic data from such irreversible systems was proved to be applicable29,30.  
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2.2.2. Protein colloidal stability:  
Proteins may undergo intermolecular assembly to form higher molecular weight aggregates as 
a result of protein-protein interaction. The osmotic second virial coefficient (B22) is a 
thermodynamic solution parameter that directly quantifies overall protein-protein 
interaction31. Positive B22 means more repulsive forces between protein molecules32 
indicating favored protein–solvent interaction rather than protein–protein interaction. In 
contrast a negative B22 indicates higher protein–protein interaction and more aggregation. B22 
has been used to predict solution conditions for protein assembly32,33. 
 
2.3. Factors affecting protein stability: 
Protein stability, either chemical or physical, is affected to a great extent by temperature. In 
general, the higher the temperature, the lower the stability of a protein is. High temperatures 
are reported to cause denaturation of many proteins including recombinant keratinocyte 
growth factor34, procaine growth hormone35 and recombinant consensus α-interferon36. 
Furthermore, chemical degradation of RNase A and lysozyme is accelerated by increasing the 
temperature6. However, the same protein molecule may undergo different degradation 
mechanism at different temperatures37.  
One of the most critical aspects concerning protein stability is the solution pH. Near the 
isoelectric point (pI), proteins tend to self associate and aggregation increases24,38. On the 
other hand, far away from the pI electrostatic repulsion increases and proteins tend to 
unfold18,39.  
Protein molecules are surface active and tend to adsorb on surfaces and interfaces. Such 
behaviour leads in most cases to protein denaturation and aggregation40.  
Applying mechanical stress like shaking on proteins causes air entrapment which in turn 
introduces air/water interface in the bulk solution at which proteins can be adsorbed and 
aggregate10. Aggregation caused by shaking is reported for several proteins for example, 
human growth hormone41 and haemoglobin42.  
Protein aggregation is affected to a great extent by protein concentration. Increased 
aggregation rate at high protein concentration was reported for interleukin 1B37. In contrast, 
bovine insulin at 0.1 mg/ml at pH 7.4 aggregates more readily than at 0.6 mg/ml during 
shaking. This is attributable to the more favourable formation of insulin hexamers at 0.6 
mg/ml, which are less susceptible to hydrophobic surface induced adsorption aggregation than 
insulin monomers43,44. 
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3. Analytical techniques for protein formulation development: 
Studying the stability of proteins, analytical techniques should be able to quantify 
denaturation and degradation products during long term stability studies. Registration of new 
active pharmaceutical products requires long term stability for two or more years to be 
performed. Usually such data is not available until the clinical program is in late stage. 
Therefore, additional techniques are extremely required to predict instability events early 
enough before starting the long term stability studies. The main target would be to reduce the 
risk of late stage changes in formulation, which is quite costly in term of time and material, 
and to avoid unexpected aggregation during storage45.  
Protein analytical techniques can be classified into two main categories based on their role in 
the formulation development process.  
 
3.1. Monitoring techniques:  
Monitoring techniques include techniques used to monitor a certain stability character such as 
monomer content or particle count in accelerated stress studies. These techniques, which are 
mostly applied in long term stability studies as well, include i.e. chromatographic techniques, 
particle analysis and gel electrophoresis. Such methods are fundamental in all protein 
formulation studies. Using a single technique in such predictive strategy is usually not enough 
for a decision concerning formulation stability. 
 
3.1.1. Chromatography:  
Chromatographic analysis of protein pharmaceuticals is commonly used for screening of 
impurities formed during protein purification, manufacturing and storage. These could be 
formed already due to minor chemical or major physical instability events46. Chromatographic 
separation techniques provide a sensitive and reliable method to monitor the resulting 
impurities and are consistently applied during stability studies or in quality control of the final 
product. Many chromatographic methods are now on hand which differ in the separation 
mode. 
 
3.1.1.1. Reversed phase chromatography (RPC): 
Reversed phase chromatography is the most applied technique in pharmaceutical development 
laboratories both for protein and small drug molecules. Reversed phase chromatography 
employs a non-polar stationary phase and a polar mobile phase and separation happens due to 
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the so called solvophobic theory47 where the protein (the solute) molecule is excluded from 
the polar solvent and retains on the non polar stationary phase. Reversed phase 
chromatography is used in protein formulation development mainly to observe chemical 
degradation such as oxidation and deamidation48. That was extensively published as for 
example oxidation of bovine parathyroid hormone49 and recombinant human granulocyte 
colony stimulating factor50, and disulphide bridging for Nonglycosylated interleukin – 251. 
 
3.1.1.2. Size exclusion chromatography (SEC): 
In Size exclusion or gel permeation chromatography non-interactive porous solid (mostly 
carbohydrate gels52) is used as a stationary phase whereas the mobile phase consists normally 
of a buffer system in a pH of 2-8 with addition of salts in order to increase the ionic strength. 
Separation is based on molecular shape and size. Smaller molecules are easily entrapped in 
the pores of the column and then retained for longer time whereas the lager ones diffuse faster 
out of the column and are detected first by the detector. Size exclusion chromatography is 
applied mainly in protein formulation development to monitor physical changes like 
aggregation but also fragmentation as a result of chemical degradation. The use of SEC in 
protein formulation development is extensively published where various protein stability 
aspects were studied35,53-56.  
 
3.1.1.3. Ion exchange chromatography (IEC): 
Ion exchange chromatography is based on electrostatic interactions between positively or 
negatively charged amino acids in protein and oppositely charged stationary phase molecules. 
During storage, a protein molecule is susceptible to chemical changes leading to the formation 
of isoforms. These isoforms are approximately similar in molecular weight and therefore 
difficult to be separated using SEC. However, the resulting small differences in charge 
properties could be determined using IEC57,58. 
 
3.1.2. Particle analysis: 
A major concern during protein formulation development is the formation of either visible or 
invisible particles which may be introduced in the formulation during manufacturing 
procedures and/or storage. Such particles may devastate the safety of the final formulation 
since they not only may affect capillaries59 but also could induce immunogenicity60,61.  
Therefore, particle count in the final protein formulation is essential for product release. The 
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United state pharmacopeia has set requirements for the particle contents in parenterals62 and 
has specified the method of light obscuration as the preferred one.  
 
3.1.3. Gel electrophoresis: 
The principle known as electrophoresis is very commonly applied to study the structural 
changes of proteins. High resolution discontinuous electrophoresis was first developed by 
Ornstein63 and Davis64. There are many types of gel electrophoresis depending on the 
separation mode.  
 
3.1.3.1. Native gel electrophoresis:  
In native electrophoresis, where no denaturant is used, separation takes place according to  the 
protein net charge and its Stokes’ radius and therefore the basis of separation is the difference 
in mass–to–charge ratio65. 
 
3.1.3.2. Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE): 
SDS-PAGE is the most common gel electrophoresis technique in protein formulation 
development. Sodium dodecyl sulphate (SDS) molecules carry negative charge and complex 
with protein molecules to equalize their mass–to–charge ratios and consequently the 
separation is based only on the particle size65. SDS-PAGE is common in assessing protein 
purity and determining molecular weight66,67. In protein formulation development SDS-PAGE 
is used mainly in stability studies to allow the detection of proteolytic degradation events and 
covalent aggregates which was reported for many proteins such as bovine growth hormone68.  
 
3.1.3.3. Isoelectric focusing (IEF): 
Protein migration in electric field is mainly derived, as mentioned above, by its net charge 
which is dependent on the pH of the solution. At the protein isoelectric point (pI) the net 
charge is zero and no mobility in an electric field is shown. Therefore, in a pH gradient 
electric field the protein will migrate till its pI and migration will stop. Such phenomenon is 
called isoelectric focusing (IEF)69 which is used in protein formulation development mainly to 
determine modifications leading to formation of species having different pI.  
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3.1.3.4. Two dimensional(2D) gel electrophoresis:  
The combination of both SDS-PAGE and IEF in the 2D gel electrophoresis represents higher 
resolution for complex protein mixtures where the resolution provided by one dimensional 
analysis is not enough70. The samples are allowed to separate first by IEF in a thin tube which 
is laid after special treatments across a slab gel which is run as one-dimensional SDS-PAGE. 
 
3.2. Stability prediction techniques: 
Stability prediction techniques comprise techniques in which conformational changes in 
protein molecules are monitored during heat cycles. Such methods are able in short time, 
compared to classical accelerated stress studies, to obtain stability predictive parameters 
through either spectroscopic or calorimetric measurements. It is to be highlighted that 
spectroscopic predictive techniques are also used in monitoring protein structural changes 
during and after stress, i.e. in both stress and long term stability studies.  
 
3.2.1. Spectroscopy: 
Spectroscopic techniques are able to measure changes in protein secondary and/or tertiary 
structures based on different aspects. The most commonly applied techniques in protein 
formulation development are described below. 
The ultraviolet (UV) protein absorption spectra between 240 – 300 nm is composed of 
multiple overlapping spectra bands arising from the absorbance of several amino acid 
residue71. After being able to isolate the multiple components of the zero order spectra by 
derivative analysis72 the peak position of each amino acid residue is used to identify changes 
in the microenvironment around the aromatic residue and therefore conformational changes in 
tertiary structure could be monitored73. 
Circular dichroism (CD) spectroscopy is widely used to monitor both secondary and tertiary 
structures of protein molecules. The basics of CD measurements depends on the difference in 
absorption between left- and right-handed circularly polarized light exerted by asymmetric 
optically active materials74. Protein molecules are normally asymmetric and therefore their 
structure can be studied by CD where far-UV CD spectra (190-250 nm) are sensitive to 
changes in protein secondary structures and near-UV CD spectra (over 250 nm) are used for 
monitoring changes in protein tertiary structures75.  
Fluorescence spectroscopy is a highly sensitive method for protein analysis. Monitoring 
protein structural changes takes place either by intrinsic fluorescence of the naturally 
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fluorescent amino acid residues which expose during unfolding and show fluorescence, or by 
addition of various extrinsic fluorescent dyes which combine with the hydrophobic residues 
after protein unfolding increasing their fluorescence as well76,77.  
The use of infrared spectroscopy in studying protein structure was first recognized by Elliott 
and Ambrose78 in 1950. The advent and availability of Fourier transform infrared (FTIR) 
increased the sensitivity of this method. Furthermore, the advancement in computer systems 
enabled more applications in protein formulation development. FTIR is used in monitoring 
changes in protein secondary structure obtained mainly from absorbance originating from 
C=O stretching vibrations (amide I band)79. Infrared spectroscopy has the advantage of being 
suitable for a variety of sample forms including solids and powder. However, the main 
drawback is the interference of overlapping H2O bands80.  
Raman spectroscopy is an alternative vibrational spectroscopic technique where the 
overlapping H2O band is not interfering. Raman is based on the scattering of light. A sample 
will transmit light either unchanged (elastically) or, a small amount is scattered inelastically. 
This is called “Raman Effect” which causes photons to gain or lose energy and accordingly 
the Raman spectra could be recorded. Raman requires a centre of symmetry for a band to be 
seen while IR requires a dipole. The water molecule has a strong permanent dipole which is 
the reason why it is not seen by Raman81 
All the above mentioned analytical techniques are widely used in monitoring structural 
changes of proteins after applying stresses such as heat, mechanical stress or freeze thaw 
cycles having the advantage over traditional monitoring methods in obtaining fast 
information. However, advancement in spectroscopic methodology has enabled most of them 
to be used in determining the protein unfolding temperature (Tm) where the structural changes 
in protein are monitored during heating cycles. Based on spectroscopic determination of Tm 
prediction of protein stability could be achieved.  
 
3.2.2. Calorimetry:  
Calorimetry in protein formulation development incorporates two main techniques, 
Differential scanning calorimetry (DSC) and Isothermal titration calorimetry (ITC). Due to 
the low energy accompanied by biochemical reactions, high sensitivity DSC instruments lead 
to be available known as differential scanning micro- or nanocalorimetry (µDSC of NDSC). 
In the next section the use of such sensitive techniques in protein formulation development 
will be discussed in more details.  
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ITC allows thermodynamic characterization of binding processes including protein-protein 
and protein-ligand bindings and nowadays both techniques are essential in protein formulation 
laboratories82.  
Many authors have reported the use of DSC and/or ITC in many protein stability aspects83-85. 
The use of DSC in protein formulation development is mainly to predict the rank order of 
different potential formulations having the advantage of being able to achieve that without any 
need to apply extra stress protocols. The use of such techniques in monitoring changes in 
protein conformation after stress is however reported by few authors86,87. 
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4. Differential scanning microcalorimetry (µDSC): 
Differential scanning microcalorimetry (µDSC) provides direct measurement for enthalpy 
changes and therefore many thermodynamic parameters can be determined. Due to its high 
sensitivity, µDSC is able to measure changes in protein conformational structure which might 
be too weak for spectroscopic detections.  
A typical instrument is composed of two cells: a sample cell containing the protein solution 
and a reference cell containing buffer. During the experimental, a heating element is used to 
increase the temperature in both cells while the individual temperature of each cell is 
monitored continuously. Any difference in heat capacity of the sample compared to the 
reference cell will give rise to a temperature difference that triggers a feedback system to 
supply additional heat to the cell that has the lower temperature. The feedback power 
necessary to keep the temperature difference equal to zero between cells is the measured 
signal and has the unit µJ/s or µcal/s prior to any normalization by the scan rate. For a well 
matched system with the two cells containing identical buffers, the only difference being the 
protein in the sample cell, heating of the cells can be seen as an increase in temperature that 
monotonic in both cells until the protein starts to denature. Because the denaturation of a 
protein is an energy-requiring process, the feedback system will supply the heat necessary to 
keep the sample cell at the same temperature as the reference cell until all the protein has 
unfolded. Subtracting a separate scan where both cells are filled with the same buffer 
eliminates instrumental effects. 
Figure 1.182 shows the result normalized by the scan rate and by the total amount of protein 
present in the calorimetric sample cell. From such a measurement several parameters could be 
extracted. 
 
4.1. µDSC parameters: 
 
4.1.1. Protein unfolding temperature (Tm): 
Applied heat during a µDSC measurement introduces enthalpy that loosens the protein 
stabilizing forces including hydrogen bonds and hydrophobic interaction88,89. A typical 
protein denaturation transition is shown by µDSC as endothermic event where the peak 
maximum is the protein melting or unfolding temperature (Tm). Tm is defined as the 
temperature at which 50% of the protein is unfolded90,91 and is a very important parameter for 
each protein with regard to its conformational stability. Different solution conditions can 
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cause shifts in Tm84,92. Lower Tm values indicate easier unfolding and in turn lower stability. 
On the other hand, Tm shift to higher values indicates stronger native structure which resists 
denaturation16,93. Protein unfolding may catalyze many other denaturation processes including 
aggregations94-96, or chemical instabilities including deamidation97, oxidation and 
proteolysis98.  
 
 
 
 
Figure 1. 1: A typical DSC experiment showing the excess heat capacity of a protein 82 
 
 
 
 
4.1.2. Protein unfolding reversibility:  
The ability of a protein to refold after unfolding can be determined using µDSC by applying 2 
subsequent scans and the degree of reversibility is calculated from the percentage of the 
enthalpy of the second up-scan (∆H2) in relation to the first up-scan enthalpy (∆H1). Protein 
unfolding reversibility was determined for several molecules99-101.  
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4.1.3. Denaturation heat capacity: 
The heat capacity of unfolding or denaturation (∆Cp) is the difference between the heat 
capacity of the folded state and that of the unfolded or denatured state. This value is always 
positive due to the larger heat capacity of the unfolded state resulting from the high exposure 
of the hydrophobic amino acids to the solvent where in the folded native state all hydrophobic 
residues are imbedded inside the molecule102. ∆Cp is typically measured from the heat 
capacity differences between the pre and post transition base line90. Provided that ∆Cp is not 
constant and does not change with temperature103, an alternative method to determine ∆Cp is 
obtained from the slope of the linear plot between Tm and ∆H as a function of pH96,104.   
 
4.1.4. Gibbs free energy:  
Protein conformational stability is quantified in terms of free energy change of unfolding 
∆Gunf10,31. This value is calculated using the above mentioned parameters in the Gibbs-
Helmholtz Equation27,98: 
 
∆Gunf = ∆Hm (1-T/Tm) - ∆Cp [(Tm-T) + T In(T/Tm)]     (1) 
 
At a temperature where T = Tm ∆Gunf = 0, the parabolic curve obtained from the effect of 
temperature on ∆Gunf suggests that there is lower temperature where ∆Gunf would be equal to 
zero which is called cold denaturation temperature25.  
 
4.2. Applications of µDSC in protein formulation development: 
Once the eligibility of a new active pharmaceutical protein is proved, a formulator would be 
responsible to introduce such candidate in a suitable formulation to be used in the early 
clinical phases. During preclinical formulation development, time is very critical and the 
formulator should be able, in stiff timelines, to answer a very important question: what 
excipients and solution conditions offer the best stabilization? Microcalorimetry can, in a 
short time, screen excipients to find the best stabilizer for the native protein state. Moreover, it 
is well suited and already established to access how different solution conditions perturb 
protein unfolding. The main objective is to maintain the protein molecule in its native state in 
the desired dosage form. 
At early phases of protein liquid formulation development the optimum pH where the protein 
will best maintain its native structure is to be determined. By examining the behavior of Tm 
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the optimum pH was determined for recombinant human macrophage colony stimulating 
factor 16. The optimum Tm in this case correlated well with the pH value in which aggregation 
was minimized. The destabilizing effect of pH on protein was estimated by determining Tm of 
several proteins such as myoglobin105, rhDNase84, RNase A106,107 and thrombin108. The effect 
of pH and ionic strength of a variant of protein G B1 domain109 was investigated using Tm. 
Determining the unfolding reversibility (if possible) within the region of optimum pH was a 
successful approach in the development of a stable formulation of Flt3L110 
Once the optimum pH is determined further augmentation of Tm by screening different buffer 
and stabilizing excipients is possible. Generally, most excipients behave as protein stabilizers 
by being preferentially excluded from the vicinity of protein molecules, thus making the 
denatured state more thermodynamically unfavorable than the native state. These excipient 
shift the equilibrium to the native conformation and exhibit high melting temperature98 
Screening several excipients, NaCl showed to increase the Tm of Interleukin 1 receptor (IL-
1R) to its highest level93. Additionally, investigating the effect of excipients on the degree of 
unfolding reversibility was of some benefit for the stabilization of recombinant human 
megakaryocyte growth and development factor111. A variety of osmolytes and salts were 
screened to find the best stabilizer for of the recombinant human keratinocyte growth factor 
where NaCl, sodium phosphate, ammonium sulfate and sodium citrate were highly effective 
in increasing Tm112. However, quite a lot of data were reported about excipient screening for 
proteins based on Tm measured from µDSC113-118 
The use of preservatives in a protein formulation might be needed if the formulated dosage 
form is to be a multidose presentation. The choice of the suitable excipient that does not affect 
the protein stability can be achieved based on Tm. The effect of preservatives on the sterility 
of IL-1R was investigated using Tm93. Protein unfolding as a function of preservative 
concentration generally shifts the Tm to lower temperature119. 
It is important to remember that the use of Tm as a stability marker is based on the notion that 
higher Tm represents greater resistance of protein to unfold and that this behavior holds at 
lower temperatures where protein is to be stored. Many of the previously mentioned 
examples16,110,112 proved a correlation between the optimum conditioned determined by Tm 
and that in which aggregation was minimized. On the other hand, few studies showed 
unsuccessful Tm prediction. A typical example for such behavior is the negative effect of 
polysorbate 20 on Tm of recombinant growth hormone although the aggregation formation 
after agitation was reduced41. 
 
 
General Introduction and objective of the thesis 
_________________________________________________________________________________________________________________ 
5. Objectives of the thesis: 
In theory, long term stability studies are the best strategy to find the best formulation. 
However, applying such an experimental plan for all stabilizing factors would be very costly 
and time consuming. Therefore, accelerated stability studies are applied to obtain preliminary 
information about formulation factors (such as pH, ionic strength, buffer and stabilizers). In 
such studies different formulations are subjected to different stresses such as elevated 
temperatures, mechanical stress and freeze-thaw cycles. However, how the resulting data can 
be correlated with the real time stability is debated. Although stabilization of protein 
formulations at elevated temperatures was extensively investigated35,110,120, none of these 
studies has proved reliable prediction of the real time stability. Furthermore, the work load for 
a broad accelerated stability study is still considerably high. Therefore, predictive stability 
studies are extremely valuable in biopharmaceutical industry. µDSC represents a predictive 
tool which is believed to be successful in such issues depending on measured Tms but till now 
systematic data from real time studies correlated with Tm determined by µDSC have not been 
published before. 
Therefore, the main objective of this thesis is to find out how far a formulator can rely on Tm 
as a marker for protein stability. Systematic studies to correlate µDSC data with long term 
stability as well as short term stress studies are performed and the quality of the obtained 
prediction is evaluated. 
The following topics are covered: 
 
1. Microcalorimetry as a predictive tool for physical stability of granulocyte colony 
stimulating factor (GCSF) in solution at different pH values. 
 
2. A Critical evaluation of µDSC as a predictive tool for long term stability of liquid 
protein formulations (GCSF, Monoclonal antibody and Pegylated Interferon) 
 
 
3. Other predictive strategies for the prediction of long term stability of GCSF liquid 
formulations. 
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Chapter 2 
 
Microcalorimetry as a predictive tool for physical stability of granulocyte 
colony stimulating factor (GCSF) in solution at different pH values 
 
1. Introduction: 
Differential scanning microcalorimetry (µDSC), one of the main techniques in protein 
stability predictive studies, permits an accurate measurement of the overall thermodynamic 
parameters and facilitates the study of energetics of biomolecular processes. Many parameters 
can be measured using µDSC including unfolding temperature (Tm), also called denaturation 
or melting temperature, heat of reaction, denaturation heat capacity and free energy change 
between native and unfolded states. Tm is widely used nowadays in predicting the physical 
stability of protein formulations1-3, where formulations showing higher Tm values are 
considered more stable. Many studies were performed in order to prove the predictive power 
of Tm3-7 mainly by comparing the Tm of selected protein formulations with the results of 
traditional accelerated stress stability studies.  
The degree of unfolding reversibility is a very important parameter that can be determined 
using µDSC simply by considering the enthalpies of two subsequent µDSC scans and can be 
calculated using the equation: % reversibility = (∆H2/∆H1) x 100. So far, little attention was 
given to the use of unfolding reversibility in predicting protein formulations stability. 
However, the importance of the degree of unfolding reversibility in predicting the optimum 
pH of Flt3 Ligand formulations has been investigated8. In that study the prediction was based 
primarily on Tm in the whole pH range until the optimum Tm was reached. At a pH between 
6.1 and 9.1 Tm didn’t show any significant difference and the degree of unfolding reversibility 
declined over that pH range. It was found that using the degree of unfolding reversibility in 
the area where Tm is stable (Tm plateau) has improved the predictive power of µDSC. The 
author has studied the predictive power of the unfolding reversibility only at the area of Tm 
plateau and only towards thermal stress.  
In this chapter a critical evaluation of Tm and degree of unfolding reversibility in predicting 
the optimum pH value of Granulocyte colony stimulating factor (GCSF) was performed. The 
objective was not to find the optimum pH value for GCSF, but to test the predictive power in 
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a challenging set where both Tm and degree of reversibility are changing. Both Tm and degree 
of unfolding reversibility were determined for GCSF solutions in the pH range 2 – 7.  
The ranking based on each parameter was compared with the ranking based on the results of 
an isothermal accelerated stability study. Furthermore, a mechanical stress study was also 
applied and the ranking based on which was compared with that based on both Tm and 
unfolding reversibility. The predictive power of Tm and the degree of unfolding reversibility 
over the whole pH range were evaluated. 
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2. Materials and methods: 
 
2.1. Materials: 
Granulocyte Colony stimulating factor (GCSF) was obtained as a gift from Roche Diagnostics 
GmbH (D-Penzberg). All other materials and solvent were of analytical grade. Deionized 
double-distilled water was used throughout the study. 
 
2.2. Formulations: 
GCSF bulk was obtained in Phosphate buffer 20 mM at pH 4 with a concentration of 4.2 
mg/ml. The original solution was dialyzed using Slide-A-LyzerR Dialysis Cassette 2000 
MWCO, 12-30 ml capacity (Pierce, Rockford, USA), to remove the buffer salt. After dialysis 
sample concentration was examined using an Uvikon 810 UV spectrophotometer (Tegimenta, 
Rotkreutz, Switzerland.) and the final concentration was adjusted to 0.2 mg/ml. The final pH 
of the sample was adjusted using 0.1N HCL as well as 0.1N NaOH to the following pH 
values: 2, 3, 3.5, 3.6, 3.7, 3.8, 3.9, 4, 4.5, 5, 6 and 7. This was performed using a Mettler 
Toledo MP220 pH meter (Mettler-Toledo GmbH, Schwezenbach, Switzerland). After 
preparation, all formulations were filtered using low protein binding syringe filters (25 mm, 
0.2 µm, polyvinylidene Fluoride (PVDF) membrane (Pall Corporation, MI, USA). For µDSC 
measurements, a reference for each formulation was prepared by adjusting the pH of 
deionised water to the above mentioned values using 0.1N HCl and 0.1N NaOH. References 
were filtered using cellulose acetate disk filters, 0.2 µm pore size (VWR international, USA).  
The same formulations were subjected to accelerated stress stability testing as well. In both 
µDSC and stress studies, all formulations were kept at 2-8°C and the pH value was rechecked 
immediately before measurement. 
 
2.3. Thermal stability using microcalorimetry (µDSC): 
All formulations were analyzed using a VP-DSC (Microcal Inc., MA). Samples, as well as the 
corresponding references were degassed for 5 min just before injection in the µDSC cells 
using a Thermo vac pump (Microcal. Inc., MA). Both samples and references were loaded 
into cells using a gas tight Hamilton 2.5 ml glass syringe.  
Each formulation was heated from 20°C to 80-90°C (depending on the formulation Tm) using 
90K/hr heating rate. Thermal stability was determined 3 times for each formulation. The 
unfolding reversibility was investigated by temperature cycling using the upscan-upscan 
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method which employed two consecutive upscans. After the first upscan the device is 
programmed to cool the sample again and repeat the heating cycle immediately. In case of 
reversible formulations the reversibility was checked for all three heating replicates. The 
µDSC cell was pressurized to prevent boiling of the sample during heating. 
A base line run was performed before the sample run by loading both sample and reference 
cells with the corresponding reference. This base line was subtracted later form the protein 
thermal data and the excess heat capacity were normalized for protein concentration. For each 
formulation Tm and degree of reversibility were determined. The degree of unfolding 
reversibility is the percentage of the enthalpy of the second upscan (∆H2) in relation to the 
first upscan enthalpy (∆H1). Both ∆H1 and ∆H2 were the apparent calorimetric enthalpies 
calculated by the area under the unfolding endotherm. For data analysis ORIGIN DSC data 
analysis software was used. 
 
2.4. Accelerated stress stability study: 
All formulations were subjected to accelerated stress stability study in which the effects of 
mechanical and thermal stress were tested. 
 
2.4.1. Mechanical stress: 
10 ml of each formulation were filtered using 0.2 µm low protein binding syringe filter 
(PALL 0.2 µm PVDF Acrodisc LC 25 mm) into a 50 ml falcon tube. pH values were re-
adjusted exactly to the desired value. 
Figure 2.1 shows the setup for the vortex mixer (Heidoiph REXA Top) used in the stress 
experiments. The tube was placed into the clamp in a way that allowed free movement of the 
tube. The vortex speed was fixed for all formulations. 3 ml samples were withdrawn at the 
beginning, after 15 min and 1 hr and analyzed.  
 
2.4.2. Thermal stress: 
20 ml of each formulation were rechecked for pH and filled into type I 20 ml sterile glass 
vials, stoppered, capped, and crimped. All filling procedures were performed under laminar 
flow. 
All formulations were stored in a dark calibrated oven at 50°C. Samples were withdrawn at 
zero time, after one day, one week and two weeks time points. 
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Figure 2. 1: The test set up for the mechanical stress. 
 
2.5. Analytical methods: 
 
2.5.1. Size-Exclusion high performance liquid chromatography (SE-HPLC): 
Loss of GCSF monomer, due to aggregation or fragmentation, was monitored using SE-
HPLC. The separation was achieved using Thermo separation system and a TSKgel 
G3000SWXL 7.8 mm ID x 30.0 cm L column (Tosoh Bioscience). Mobile phase consisted of 
100 mM phosphate buffer pH 7. Flow rate of 0.6 ml/min was used and protein was detected at 
215 nm. All samples were centrifuged before injection in the HPLC system. Reduction in the 
recovery of the whole protein content was noticed after stress, most probably, due to the 
formation of insoluble aggregates which are excluded from the formulation by centrifugation. 
Therefore, the method was not able to determine the percentage of such aggregates and as a 
result calculating the monomer content after stress may lead to misjudgements. Consequently, 
instead of calculating the monomer content, the percentage of monomer remaining in each 
formulation was determined after stress where the reduction in the monomer peak was 
calculated.  
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2.5.2. Light obscuration: 
The insoluble aggregates (particle size > 1 µm) were determined in each formulation using 
light obscuration measurements (PAMAS SVSS-CTM (Rutesheim, Germany)), using a 
rinsing volume of 0.5 ml and a measuring volume of 0.3 ml and the number of measurements 
was set to 3 times. Before each measurement the device was rinsed with particle free water 
until less than 100 particles larger than 1 µm and no particles over 10 µm were counted. 
 
2.5.3. Sodium dodecylesulphate polyacrylamide gel electrophoresis (SDS-PAGE): 
SDS-PAGE was conducted under non-reducing conditions using XCell II mini cell system 
(Novex, Sand Diego, CA). The protein solutions were diluted in a pH 6.8 tris-buffer, 
containing 4% SDS and 20% glycerine. Samples were denatured at 95°C for 20 min and 10 µl 
were loaded into the gel wells (NuPage 10 % Bis-Tris Gel, Novex High performance pre-cast 
gels, Fa. Invitrogen, the Netherlands). Electrophoresis was performed in a constant current 
mode of 40mA in a MES SDS Running Buffer (NuPage MES SDS Running Buffer (20x), Fa. 
Invitrogen). Gel staining and drying were accomplished with a silver staining kit 
(SilverXpress) and a drying system (DryEase), both provided from Invitrogen, Groningen, the 
Netherlands. 
 
2.6. Correlation: 
To investigate the ability of µDSC parameters, unfolding temperature (Tm) and degree of 
unfolding reversibility, to predict the physical stability of unbuffered GCSF formulation, the 
correlation between the value of each parameter and the outcome of the accelerated stress 
stability studies was studied. The parameter values from each method were plotted on an X 
and Y axis and a linear fit was performed between the resulting curve points. For such a 
fitting a Pearson product moment correlation coefficient (R2) could be calculated upon which 
the correlation is to be judged. Furthermore, rankings based on µDSC parameters and 
rankings based on accelerated stress studies were made and correlation between both rankings 
was studied as described above. For the ranking process it should be clear that the formulation 
ranked 1 is the best and the formulation ranked 12 is the worst. 
Generally, the interpretation of such correlation coefficients depends mainly on context and 
purposes. A correlation of 0.9 may be considered very low if one is verifying a physical law 
using high quality instruments but may be regarded as very high in the social sciences where 
there may be a greater contribution from complicating factors. Guidelines for the 
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interpretation of a correlation coefficient were suggested 9 where R2 of 1 indicates that the two 
values are equally scaled, a value between 0.5 – 1 indicates strong correlation, 0.3 – 0.5 a 
medium correlation and a value of 0.1 – 0.3 indicates a weak correlation.  
 
2.6.1. Ranking of formulations according to µDSC: 
Ranking was first made according to the apparent unfolding temperature (Tm) as a stability 
marker (RTm) and further optimized in a new ranking (RopTm) by considering the unfolding 
reversibility. Such procedure was suggested by Remmele 8. In case formulations showed 
equal Tms the formulation showing higher reversibility was ranked better (lower rank order).  
Furthermore, ranking based on degree of reversibility as a primary stability marker (RRev.) 
was performed and optimization was done by considering Tm (RopRev.) in formulations 
showing no reversibility. In order to use both Tm and degree of reversibility equally a 
combined ranking was made by taking the average of the Tm based ranking and the 
reversibility based ranking (Rcom.). In Tm ranking a minimum difference between 
formulations of 1°C was considered as significant. 
 
2.6.2. Ranking of formulations according to stress stability studies:: 
Different rankings based on SE-HPLC and light obscuration data from stress stability study 
were performed according to the following steps: 
1- 1st ranking (R1): The formulations were ranked according to the percentage monomer 
remaining in each formulation at the end of the stress test. 
2- 2nd ranking (R2): The formulations were ranked according to their particle count at each 
time point. The USP requirements for light obscuration test <788> specifies that particles 
over 10 µm size are controlled at or below 6000 particles / container and particles over 25 
µm are limited to or lower than 600 particles / container. No specifications were obtained 
for particles in the size range 1 – 10 µm. In order to implicate the USP requirements in the 
ranking the following limits of particle counts were applied: 
Formulation ranked 1: these are formulations which met the USP requirements and had 
less than 10,000 particles over 1 µm. 
Formulation ranked 2: these are formulations which met the USP requirements and had 
less than 100,000 particles over 1 µm. 
Formulation ranked 3: these are formulations which met the USP requirements and had 
more than 100,000 particles over 1 µm. 
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p). 
Formulation ranked 4: all formulations showing a particle count exceeding the USP 
requirements. 
3- Overall physical stability ranking (Rp): For each formulation the average of R1 and R2 
was calculated as the overall physical stability ranking (R
The previously described procedures were performed for both thermal and mechanical stress 
studies.  
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3. Results and discussion: 
 
3.1. µDSC measurements: 
For each GCSF formulation both Tm and degree of reversibility were measured. Figure 2.2 
shows a representative µDSC scan for the formulation at pH 3. Figure 2.3 shows the values 
for Tm together with degree of reversibility for the whole pH range (2-7) of the tested 
formulations.  
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Figure 2. 2: A representative µDSC scan for unbuffered GCSF formulation at pH 3 showing Tm (straight 
line) and a 2nd consecutive scan (dotted line). 
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Figure 2. 3: Effect of pH value on Tm (–■–) and degree of unfolding reversibility (bars) of 12 unbuffered 
GCSF formulations. All errors are reported as standard deviation from the mean (n=3) and represented 
as error bars in the curve.  
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Figure 2.3 shows that the reversibility of GCSF decreased with increasing pH value whereas 
Tm increased till pH 3.5. From pH 3.5 – 4 no significant increase in Tm was found. At higher 
pH values Tm decreased again till pH 6 and 7. It should be mentioned that GCSF did not show 
any reversibility in buffered formulations and therefore all formulations were formulated in 
absence of buffer. Table 2.1 shows a list of Tm and the degree of reversibility of the 12 
unbuffered GCSF formulations together with Tm based ranking (RTm) and “optimization” of 
the ranking using the degree of unfolding reversibility (RopTm), unfolding reversibility based 
ranking (RRev.) and “optimization” using Tm (RopRev) and Tm – reversibility combined ranking 
(Rcom). 
 
Table 2. 1: Values of Tm and degree of unfolding reversibility for the 12 unbuffered GCSF formulations 
together with the different predictive rankings. 
Formulation pH Tm Rev.1) RTm RopTm RRev. RopRev. Rcom. 
GCSFun01 2 62 91,9 9 9 1 1 8 
GCSFun02 3 68 84,4 7 7 2 2 6 
GCSFun03 3.5 71,8 63,4 1 1 3 3 1 
GCSFun04 3.6 72,3 52,7 1 2 4 4 2 
GCSFun05 3.7 72,2 22,2 1 3 5 5 3 
GCSFun06 3.8 72,3 3,5 1 5 7 7 5 
GCSFun07 3.9 72,7 11,6 1 4 6 6 4 
GCSFun08 4 71,5 0 1 6 8 8 6 
GCSFun09 4.5 67,2 0 8 8 8 9 9 
GCSFun10 5 60,23 0 10 10 8 10 10 
GCSFun11 6 57 0 12 12 8 12 12 
GCSFun12 7 59,8 0 11 11 8 11 11 
1) Degree of unfolding reversibility 
3.2. Accelerated stress stability studies: 
In appendix 2.I all data form the accelerated stability studies are presented in tables 2.I.1 – 4. 
 
3.2.1. Mechanical stress: 
The samples were analyzed at 2 time intervals (15 and 60 min). The % monomer remaining at 
both time points is illustrated in figure 2.4 A. At pH 3.5 an extreme reduction in monomer 
content was noticed after 60 min which was not the case after 15 min and which might be 
caused by the nucleation of small aggregates to larger ones. Therefore, all formulations were 
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judged based on the results after 15 min. The extreme monomer loss was confirmed by the 
particle count results from the light obscuration measurements (figure 2.4 B).  
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Figure 2. 4: Effect of mechanical stress on (A) monomer content and (B) the particle count over 1 µm 
particle diameter after 15 and 60 min. All errors are reported as standard deviation from the mean (n=3) 
and represented as error bars in the curve. 
 
Increasing the pH value of GCSF formulations in absence of buffer salts from 2 to 7 reduced 
the physical stability of GCSF against mechanical stress. That was shown by a reduction in 
monomer content and an increase in particle count as the pH value was increased from 2 to 7.  
 
3.2.2. Thermal stress: 
Formulations were analyzed at the beginning and after storage at 50°C at three time points 
(after 1 day, 7 days and 14 days) and the monomer content as well as the particle count were 
determined. SDS-PAGE was performed at the beginning and at the end of the stress study. 
Figure 2.5 A shows the effect of thermal stress on the monomer content of each formulation at 
each time point. Formulations having pH values 5, 6 and 7 were analyzed only till 7 days as 
they were already completely destroyed after that time point. However, for these formulations 
only SDS-PAGE was done at 14 days time point. From the results it seems obvious that the 
physical stability of GCSF against thermal stress differs from its stability against mechanical 
stress. This difference is shown in the 1st part of the curve: The monomer content after 14 
days thermal stress is highest at pH 3.5 and 3.6, whereas the highest monomer content after 
mechanical stress was at pH 2 (figure 2.4 A). This behaviour was also confirmed by SDS-
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PAGE (figure 2.6) where pH 3.5 showed the lowest aggregation after 14 days storage at 50°C. 
Particle count measurements did not show any significant difference in the pH range 2 - 3.5 
(figure 2.5 B).  Otherwise the rest of formulations behaved similarly in both stresses at higher 
pH values except pH 7 which showed low particle count although very low monomer content 
was recovered after 7 days storage at 50°C. This is most probably due to the formation of 
smaller size aggregates which could be seen in SDS-PAGE (figure 2.6.)  
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Figure 2. 5: Effect of Thermal stress on (A) monomer content and (B) the particle count over 1 µm particle 
diameter after 1, 7 and 14 days storage at 50°C. All errors are reported as standard deviation from the 
mean (n=3) and represented as error bars in the curve. 
 
pH values 
Figure 2. 6: SDS-PAGE for unbuffered GCSF formulations at different pH values after storage at 50°C 
for 14 days. The numbers on the graph are the corresponding pH values of each formulation. 
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3.3. Correlation: 
A comparison between Tm values and the % of monomer remaining after both stress methods 
is illustrated in figure 2.7. A good correlation between Tm and the monomer content of GCSF 
especially after applying thermal stress was found. Considering the degree of unfolding 
reversibility at the pH range 3.5 – 4 (Tm plateau) the monomer content was better predicted. 
After applying mechanical stress GCSF showed at pH 2 the best monomer content although 
Tm was low.  On the other hand the degree of unfolding reversibility showed the highest value 
at pH 2. Previous studies showed that pH range 3.5 – 4 is the best for GCSF stability10,11 due 
to hydrolysis of the protein at pH less than 3. During mechanical stress the chemical stability 
of the protein is not challenged as in thermal stress. In this case the degree of unfolding 
reversibility looked only for physical stability and Tm was better in predicting the best pH 
range for GCSF. Microcalorimetry as a predictive tool in protein formulation was judged by 
many authors by similar comparisons 5,8,12. However, the objective of this study is to evaluate 
whether Tm and/or unfolding reversibility are more precise to predict the stability ranking 
order and accordingly, the reliability of a µDSC based decision is to be evaluated. Therefore, 
the correlation coefficients between the compared parameters and furthermore, between 
rankings were thought to be a reliable parameter which could be used in judging such a 
predictive method. 
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Figure 2. 7: Correlation between effects of thermal (–□–) and mechanical (–∆–) stress on the monomer 
content of GCSF unbuffered formulations at different pH values and µDSC parameters (Tm (–■–) and 
unfolding reversibility (bars). 
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3.3.1. Predictive power of the µDSC parameters: 
The 2 parameters obtained form the µDSC study for each formulation are Tm and degree of 
unfolding reversibility. In addition, the % of monomer remaining after stress of each 
formulation as well as the particle count was measured. Each µDSC parameter was compared 
with either % monomer remaining or particle count of the formulations. In appendix 2.II 
(figures 2.II.1 and 2.II.2) correlation curves are shown. One of these curves is presented here 
as an example and shows the correlation between Tm values and % monomer remaining after 
14 days thermal stress (figure 2.8). The correlation coefficients resulting where compared 
with each other to evaluate the predictive power of the µDSC parameters towards each stress 
test (figure 2.9). The negative correlation coefficients shown in figure 2.9 B indicate the 
inversed relation between Tm and degree of unfolding reversibility with the particle count 
after stress.  
A correlation coefficient equal or even close to 1 or -1 was obtained in none of the correlation 
studies. The highest correlation coefficient was 0.714 obtained for the correlation of degree of 
unfolding reversibility with the particle count over 1 µm after isothermal stress. Having a 
correlation coefficient less than 1 denies the scalability of either µDSC parameters towards 
neither monomer content nor particle count after stress. However, this does not deny the 
strong correlation between them and the possibility of excellent prediction. 
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Figure 2. 8: Correlation between Tm values and % monomer remaining after 14 days storage at 50°C of 
12 unbuffered GCSF formulations at different pH values 
In most correlation curves (appendix 2.II, figures 2.II.1 and 2) the linear fit was made between 
two clusters of points (that can be noticed also in figure 2.8) which may cause over estimation 
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of the correlation coefficient as if it is made between 2 points only. The only exception is the 
correlation between the degree of unfolding reversibility and the particle count after thermal 
stress.  
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Figure 2. 9: Comparison between the resulted correlation coefficients from comparing µDSC parameters 
with % monomer content (A) and particle count > 1 µm (B)  after thermal and mechanical stress. 
 
3.3.2. Predictive power of µDSC based rankings: 
In table 2.1 the studied 12 unbuffered GCSF formulations were ranked based on µDSC 
parameters. Tables 2.2 and 2.3 show the ranking of the same formulations based on the stress 
stability study using either mechanical or thermal stress, respectively.  
 
Table 2. 2: Ranking of physical stability of GCSF formulations after vortex shaking for 15 min. 
Formulation pH 
% Monomer 
remaining 
R11) R22) 
Average 
(R1+R2/2) 
Rpm3) 
GCSFun01 2 93% 1 1 1 1 
GCSFun02 3 88% 2 1 1,5 2 
GCSFun03 3.5 73% 6 1 3,5 6 
GCSFun04 3.6 87% 2 1 1,5 2 
GCSFun05 3.7 77% 4 1 2,5 4 
GCSFun06 3.8 77% 4 1 2,5 4 
GCSFun07 3.9 59% 7 2 4,5 7 
GCSFun08 4 27% 8 3 5,5 8 
GCSFun09 4.5 6% 9 3 6 9 
GCSFun10 5 9% 9 3 6 9 
GCSFun11 6 1% 12 4 8 12 
GCSFun12 7 6% 9 3 6 9 
1) Ranking of the 12 formulations according to the % monomer remaining after stress 
2) Ranking based on light blockage measured particle count >1 µm (appendix 2.I, table 2.I.3) 
3) General physical stability ranking against mechanical stress based on the average of both R1 and R2 
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Table 2. 3: Ranking of physical stability of GCSF formulations after storing at 50°C for 14 days. 
Formulation pH 
% Monomer 
remaining 
R1 R21) 
Average 
(R1+R2/2) 
Rpt2) 
GCSFun01 2 74% 5 1 3 5 
GCSFun02 3 88% 3 1 2 3 
GCSFun03 3.5 91% 1 1 1 1 
GCSFun04 3.6 91% 1 1 1 1 
GCSFun05 3.7 81% 4 1 2,5 4 
GCSFun06 3.8 67% 6 1 3,5 6 
GCSFun07 3.9 63% 7 1 4 7 
GCSFun08 4 61% 7 1 4 7 
GCSFun09 4.5 2% 9 1 5 9 
GCSFun10 5 0% 9 3 6 11 
GCSFun11 6 0% 9 4 6,5 12 
GCSFun12 7 0% 9 2 5,5 10 
1) Ranking based on light blockage measured particle count >1 µm (appendix 2.I, table 2.I.4)   
2) General physical stability ranking against thermal stress based on the average of both R1 and R2 
 
 
 
 
Rankings from µDSC and stress stability studies were compared with each other and 
correlation coefficients were calculated. Correlation curves are presented in figures 2.10 and 
2.11 for µDSC based ranking against mechanical and thermal stress based rankings, 
respectively. A comparison between the resulting correlation coefficients is presented in 
figure 2.12 showing approximately similar correlation of the thermal stability ranking to both 
Tm and reversibility based rankings. On the other hand, mechanical stress stability ranking 
correlated significantly better to the reversibility based ranking. Optimization of Tm based 
ranking using the degree of reversibility and vice versa did improve the correlation 
significantly in both stress studies.  Furthermore, Tm- reversibility combined ranking (Rcom) 
was the best predictive for the thermal stability of the group of GCSF formulations.  
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Figure 2. 10: Correlation curves between µDSC based rankings and Physical stability based ranking after 
Mechanical stress (Rpm). (A) Tm based ranking (RTm), (B) Tm optimized ranking (RopTm), (C) reversibility 
based ranking (RRev), (D) reversibility optimized ranking (RopRev) and (E) Tm – Reversibility combined 
ranking (Rcom) 
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Figure 2. 11: Correlation curves between µDSC based rankings and Physical stability based ranking after 
Thermal stress (Rpt). (A) Tm based ranking (RTm), (B) Tm optimized ranking (RopTm), (C) reversibility 
based ranking (RRev), (D) reversibility optimized ranking (RopRev) and (E) Tm – Reversibility combined 
ranking (Rcom) 
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  42 
Accordingly, the stability of GCSF in a pH row against different stresses can be predicted by 
different µDSC based rankings. The stability against mechanical stress was predicted best 
when the degree of unfolding reversibility is considered as a primary ranking and when Tm is  
considered as an optimizing parameter (RopRev.  table 2.1). The stability against isothermal 
stress was predicted best when both parameters (Tm and unfolding reversibility) were equally 
considered in a combined ranking (Rcom.  table 2.1). 
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Figure 2. 12: Comparison between the correlation coefficient of different µDSC based rankings and each 
of thermal and mechanical stability based rankings. On x axis: Tm based ranking (RTm), Tm optimized 
ranking (RopTm), reversibility based ranking (RRev), reversibility optimized ranking (RopRev) and Tm – 
Reversibility combined ranking (Rcom). On Z-axis ranking based on the results of thermal stability (Rpt) 
and ranking based on mechanical stability (Rpm) 
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4. Conclusion: 
Absolute values of µDSC parameters can not be used to predict certain monomer content or 
particle count after stress of protein formulations as these parameters are not scaled with 
either monomer remaining or particle count after stress. The stability of GCSF in a pH row 
against different stresses can be predicted by different µDSC based rankings. These rankings 
are based on both Tm and the degree of unfolding reversibility and could be improved 
significantly through either optimized or combined rankings. Most interestingly, the degree of 
unfolding reversibility is powerful in predicting the effect of mechanical stress than the 
unfolding temperature (Tm). 
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6. Appendix 2.I: 
Table 2.I. 1: Monomer remaining after mechanical stress of 12 unbuffered GCSF formulations at different 
pH values. 
Formulations pH values 
15 min. Vortex 
(% monomer remaining) 
60 min. Vortex 
(% monomer remaining) 
GCSFun01 2 93% 90% 
GCSFun02 3 88% 93% 
GCSFun03 3.5 73% 21% 
GCSFun04 3.6 87% 75% 
GCSFun05 3.7 77% 49% 
GCSFun06 3.8 77% 40% 
GCSFun07 3.9 59% 24% 
GCSFun08 4 27% 10% 
GCSFun09 4.5 6% 4% 
GCSFun10 5 9% 3% 
GCSFun11 6 1% 1% 
GCSFun12 7 6% 4% 
 
 
 
Table 2.I. 2: Monomer remaining after thermal stress of 12 unbuffered GCSF formulations at different 
pH values. 
Formulations 
pH 
values 
1 day at 50°C 
(% monomer remaining) 
14 day at 50°C 
(% monomer remaining) 
14 days at 50°C 
(% monomer remaining) 
GCSFun01 2 99,19% 91,9% 73,7% 
GCSFun02 3 100,84% 95,1% 88,1% 
GCSFun03 3.5 102,31% 102,5% 90,7% 
GCSFun04 3.6 101,68% 101,3% 90,7% 
GCSFun05 3.7 101,01% 100,4% 80,7% 
GCSFun06 3.8 99,95% 108,6% 67,3% 
GCSFun07 3.9 101,93% 101,5% 62,7% 
GCSFun08 4 102,20% 104,2% 61,0% 
GCSFun09 4.5 97,75% 28,7% 2,1% 
GCSFun10 5 23,90% 1,1% N/A 
GCSFun11 6 0,76% 1,1% N/A 
GCSFun12 7 21,92% 0,9% N/A 
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Table 2.I. 3: Particle count after mechanical stress of 12 unbuffered GCSF formulations at different pH 
values measured by light obscuration. 
Formulations pH values Particle range T Zero 15 min 60 min Ranking (15 min) 
> 1 µm 694 883 4699 
> 10 µm 12 8 31 GCSFun01 2 
> 25 µm 0 0 3 
1 
> 1 µm 2072 1093 12706 
> 10 µm 38 31 84 GCSFun02 3 
> 25 µm 1 2 3 
1 
> 1 µm 1890 3323 63967 
> 10 µm 128 21 181 GCSFun03 3.5 
> 25 µm 11 0 3 
1 
> 1 µm 1319 1353 8167 
> 10 µm 16 89 32 GCSFun04 3.6 
> 25 µm 0 6 2 
1 
> 1 µm 152 1293 19364 
> 10 µm 3 31 52 GCSFun05 3.7 
> 25 µm 0 0 0 
1 
> 1 µm 1672 2212 9640 
> 10 µm 50 32 37 GCSFun06 3.8 
> 25 µm 0 1 3 
1 
> 1 µm 1301 11080 45146 
> 10 µm 9 52 147 GCSFun07 3.9 
> 25 µm 0 8 2 
2 
> 1 µm 257 125146 87983 
> 10 µm 11 101 637 GCSFun08 4 
> 25 µm 6 4 0 
3 
> 1 µm 3768 175781 161772 
> 10 µm 44 967 1910 GCSFun09 4.5 
> 25 µm 6 6 7 
3 
> 1 µm 13117 172239 181356 
> 10 µm 70 1009 754 GCSFun10 5 
> 25 µm 10 19 11 
3 
> 1 µm 22563 189854 191818 
> 10 µm 292 23816 24146 GCSFun11 6 
> 25 µm 9 24 20 
4 
> 1 µm 8792 170827 179686 
> 10 µm 59 5907 4806 GCSFun12 7 
> 25 µm 6 19 8 
3 
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Table 2.I. 4: Particle count after thermal stress of 12 unbuffered GCSF formulations at different pH 
values measured by light obscuration. 
Formulations pH values Particle range T Zero 1 day 7 days 14 days Ranking (14 days) 
> 1 µm 1419 1037 2411 152 
> 10 µm 8 9 11 7 GCSFun01 2 
> 25 µm 2 2 1 1 
1 
> 1 µm 5777 4743 227 1888 
> 10 µm 23 3 4 27 GCSFun02 3 
> 25 µm 1 0 3 7 
1 
> 1 µm 2584 5576 7570 388 
> 10 µm 12 12 12 2 GCSFun03 3.5 
> 25 µm 0 0 0 0 
1 
> 1 µm 888 15010 6750 1040 
> 10 µm 4 101 71 14 GCSFun04 3.6 
> 25 µm 0 0 1 1 
1 
> 1 µm 2568 11633 10900 2243 
> 10 µm 34 67 27 21 GCSFun05 3.7 
> 25 µm 0 0 0 1 
1 
> 1 µm 2798 9384 8179 4846 
> 10 µm 8 41 33 144 GCSFun06 3.8 
> 25 µm 0 0 1 7 
1 
> 1 µm 2317 12774 9738 3827 
> 10 µm 9 19 96 77 GCSFun07 3.9 
> 25 µm 0 0 3 1 
1 
> 1 µm 3391 10791 15328 6043 
> 10 µm 24 27 180 132 GCSFun08 4 
> 25 µm 4 1 10 7 
1 
> 1 µm 6044 25511 2683 8034 
> 10 µm 81 243 168 668 GCSFun09 4.5 
> 25 µm 4 8 22 67 
1 
> 1 µm 9951 50238 212078  
> 10 µm 106 461 168  GCSFun10 5 
> 25 µm 2 10 17  
3 
> 1 µm 11924 246400 217320  
> 10 µm 81 2020 24508  GCSFun11 6 
> 25 µm 1 22 76  
4 
> 1 µm 9141 24136 19243  
> 10 µm 31 703 411  GCSFun12 7 
> 25 µm 0 22 17  
2 
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7. Appendix 2.II: 
R2 = 0.5618
50
55
60
65
70
75
0% 20% 40% 60% 80% 100%
% monomer remaining 
Tm
 °C
       
R2 = 0.4793
-20.00%
0.00%
20.00%
40.00%
60.00%
80.00%
100.00%
0% 20% 40% 60% 80% 100%
% monomer remaining 
U
nf
ol
di
ng
 re
ve
rs
ib
ili
ty
 (%
)
 
(A) (B)
(C) (D) 
R2 = 0,5049
50
55
60
65
70
75
0 50000 100000 150000 200000 250000
Particle count > 1µm
Tm
 °C
       
R2 = 0,714
-20,00%
0,00%
20,00%
40,00%
60,00%
80,00%
100,00%
0 1000 2000 3000 4000 5000 6000
Particle count > 1µm
U
nf
ol
di
ng
 re
ve
rs
ib
ili
ty
 (%
)
 
Figure 2.II. 1: Correlation curves between µDSC parameters and Physical stability after thermal stress. 
(A) Correlation between Tm and % monomer remaining, (B) Unfolding reversibility and % monomer 
remaining, (C) Tm and Particle count > 1 µm and (D) is the correlation between Unfolding reversibility 
and particle count > 1 µm. 
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R2 = 0.3551
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(C) 
Figure 2.II. 2: Correlation curves between µDSC parameters and Physical stability after Mechanical 
stress. (A) Correlation between Tm and % monomer remaining, (B) Unfolding reversibility and % 
monomer remaining, (C) Tm and Particle count > 1 µm and (D) is the correlation between Unfolding 
reversibility and particle count > 1 µm. 
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Chapter 3 
 
A critical evaluation of microcalorimetry as a predictive tool for long term 
stability of liquid protein formulations 
 
1. Introduction: 
In protein formulation development studies the best solution conditions and stabilizers needed 
to protect the protein from possible chemical of physical deteriorations are to be defined. In 
early phases many analytical methods are involved to provide better prediction of the long 
term stability where the main target is to prevent aggregation during long term storage and to 
prevent unexpected stability problem lately in clinical trials. 
Differential scanning microcalorimetry (µDSC) is one of the most common methods used in 
protein pre-formulation and formulation studies where many solution conditions as well as 
excipients can be screened 1-3,3-5  
Several other techniques are available to determine Tm, monitoring either secondary or 
tertiary protein structure as a function of temperature. Rapid high throughput technologies are 
currently being applied to determine spectroscopy based Tms. Such technologies are based 
mainly on measuring samples in multi-well plates using either fluorescence or UV 
spectroscopy to optimize formulation factors and to choose suitable stabilizers. Such 
screening was successfully performed for Respiratory Syncytial Virus (RSV) 6 showing 
higher stability of RSV in formulations with sugars and polyols as indicated by an increase in 
Tm calculated from both secondary and tertiary structure loss.  
The main concern against using Tm as a marker for protein stability, either obtained from 
µDSC or other methods, is that the mechanism of protein denaturation under long term 
conditions at normal storage temperatures (2-8 °C) is not the same as at higher temperature 
(ca. 60 - 75°C).  
Many studies 3-5,7 proved correlation between Tm and protein physical stability where Tm was 
compared with data from accelerated stability studies, thereby comparing one surrogate study 
with another one instead of correlating real time stability studies at normal storage 
temperatures with Tm. There may be unpublished studies with predictive DSC studies in 
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industry, but comprehensive, systematic data from real time studies correlated with Tm 
determined by µDSC have not been published yet. 
In this chapter a systematic study on 3 different proteins, including 24 different Granulocyte 
Colony Stimulating Factor (GCSF), 15 Monoclonal antibody (MAB) and 14 Pegylated 
Interferon α2a (PEG-INF) liquid formulations is presented. All formulations were included in 
a µDSC study to determine Tm and unfolding reversibility, if applicable. The intention was to 
compare the stability prediction from the µDSC, based on Tm determinations, with the data 
from IsoSS up to 24 months for GCSF and 12 months for both MAB and PEG-INF. In the 
IsoSS the most important analytical techniques to rate physical and/or chemical stabilities 
were involved including size exclusion high performance liquid chromatography (SE-HPLC), 
turbidimetry, light obscuration, gel electrophoresis and reversed phase-HPLC (RP-HPLC). 
The stability of GCSF, MAB and PEG-INF formulations has been studied intensively before 
8-15. Also, many patents on stable formulations are available 16-21. The long term stability of 
GCSF is determined by both chemical and physical effects where pH and salt content of the 
formulation determine the extent of aggregation and chemical degradation. MAB is a unique 
protein class where physical stability mainly determines its long term stability. PEG-INF is an 
example of a pegylated protein and expected to be stable in long term. Therefore, these three 
proteins were considered as interesting and relevant candidates for the purpose of the study. 
It is essential to understand the study purpose which is not to find new or better formulations 
for the studied proteins, but to correlate long term stability data with predictive Tm 
measurements for a challenging set of formulation, i.e. formulations that are close to each 
other and difficult to rank from each other. For that reason formulations with obvious stability 
extremes were not included in the study. Thereby a challenging formulation grid including 
different buffer salts, excipients and different pH values was set up to evaluate the predictive 
power of µDSC. 
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I. Granulocyte Colony Stimulating Factor (GCSF): 
 
I.1. Materials and methods: 
I.1.1. Materials: 
Granulocyte Colony stimulating factor (GCSF) was obtained as a gift from Roche diagnostics 
GmbH (D-Penzberg, Germany). All other materials and solvent were of analytical grade. 
Deionized double-distilled water was used throughout the study. 
 
I.1.2. Formulations: 
GCSF was obtained in 20 mM Phosphate buffer at pH 4 with a concentration of 4.2 mg/ml. 
The original solution was dialyzed using Slide-A-LyzerR Dialysis Cassette 2000 MWCO, 12-
30 ml Capacity (Pierce, Rockford, USA), to the required buffer. After dialysis the sample 
concentration was examined using an Uvikon 810 UV spectrophotometer (Tegimenta, 
Rotkreutz, Switzerland), and the final concentration was adjusted to 0.2 mg/ml. The final pH 
of the sample was determined with a Mettler Toledo MP220 pH meter (Mettler-Toledo 
GmbH, Schwezenbach, Switzerland). After preparation all formulations were filtered using 
low protein binding syringe filters (25 mm, 0.2 µm, polyvinylidenefluoride (PVDF) 
membrane, Pall Corporation, MI, USA). A reference for each formulation containing the same 
buffer and the same excipients was also prepared and filtered using cellulose acetate disk 
filters, 0.2 µm pore size (VWR international, USA).  
For IsoSS the same formulations were prepared and filtered, filled into type I glass vials, 
stoppered, capped, and crimped under sterile conditions and then stored in the dark at ICH 
temperatures (4, 25, 40°C) in calibrated ovens. Each formulation was subjected to analysis at 
the beginning of the storage time (zero time) and in further time intervals.  
The effect of three buffer systems (phosphate, acetate, and citrate) was studied. Furthermore, 
in order to have a more challenging formulation set, factorial experimental designs were used. 
The effect of acetate and citrate buffers, different buffer concentrations, different pH values, 
and the effect of different concentrations of Tween 80 and/or HP-β-CD was studied. The 
IsoSS at 40°C were terminated after 3 months, at 25°C were terminated after 10 months, and 
at 4°C after 20-24 months according to the stating point of the analysis. 
The rationale behind using such an experimental design instead of using linear series with 
different pH values or excipient concentrations was to challenge the predictive power of Tm as 
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a marker for protein stability. Table 3.1 shows the 1st design of experiment (DOEa) which is a 
23 full factorial design. The effect of the studied factors was tested in the absence of any 
buffer system. Table 3.2 and 3.3 show the 2nd and the 3rd design of experiment (DOEb and 
DOEc) which are fractional factorial designs based on the partition of a 24 full factorial design 
using the (-1) generator form the third order interaction (-ABCD) 22. 
The effect of different factors on each DOE was calculated in the form of coefficients. 
Furthermore, to make these coefficients comparable when responses have different units, the 
coefficients were normalized, that is the coefficients were divided by the standard deviation of 
their respective response. All coefficient calculations as well as normalization were performed 
using MODDE8 software (Umetrics AB, Umea, Sweden). 
 
I.1.3. Thermal stability using microcalorimetry (µDSC): 
All formulations were analyzed using a VP-DSC (Microcal Inc., MA). The sample as well as 
the corresponding reference was degassed for 5 min prior to injection in the µDSC cells using 
a Thermo vac pump (Microcal. Inc., MA). Both sample and reference were loaded into cells 
using a gas tight Hamilton 2.5 ml glass syringe.  
Each formulation with its corresponding reference was heated from 20°C to 80-90°C 
(depending on the formulation Tm) using a 90K/hr heating rate. Thermal stability was 
determined three times for each formulation. 
 
Table 3. 1: GCSF formulation set of the 1st design of experiment (DOEa) (All Tms values are the mean of 
triplicate µDSC scans (Tm ±SD< 0.5°C) 
Formulation pH 
Tween 80 
(%) 
HP-β-CD 
(%) 
Tm RTm1) 
Reversibility 
(%) 
RopTm2) 
GCSFDa1 4.2 0.0005 1 71,7 2 52,1 2 
GCSFDa2 4.2 0.0005 10 69,4 5 32,8 6 
GCSFDa3 4.2 0.05 1 70,5 4 21,1 4 
GCSFDa4 4.2 0.05 10 66,9 8 62,7 8 
GCSFDa5 4.8 0.0005 1 72,3 1 0 1 
GCSFDa6 4.8 0.0005 10 69,4 5 55,5 5 
GCSFDa7 4.8 0.05 1 71,8* 2 49,3 3 
GCSFDa8 4.8 0.05 10 69* 7 32 7 
1) Ranking based on Tm before optimization using reversibility. 
2) Ranking based on Tm after optimization. 
 * Tm ±SD <1°C  
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Table 3. 2: GCSF formulation set of the 2nd design of experiment (DOEb) (All Tms values are the mean of 
triplicate µDSC scans (Tm ±SD< 0.5°C) 
Formulation Buffer pH  
Buffer  
Concentration 
Tween 80  
(%) 
Tm RTm 
Reversibility 
(%) 
GCSFDb1 No 4.5 No 0.05 69,5 4 N/A 
GCSFDb2 No 4.5 No 0.005 69,9* 2 N/A 
GCSFDb3 No 5 No 0.005 71,5* 1 N/A 
GCSFDb4 No 5 No 0.05 69,6 3 N/A 
GCSFDb5 Citrate 4.5 20 0.005 59 5 N/A 
GCSFDb6 Citrate 4.5 50 0.05 57,3 7 N/A 
GCSFDb7 Citrate 5 20 0.05 56,3 8 N/A 
GCSFDb8 Citrate 5 50 0.005 57,5 6 N/A 
  * Tm ±SD <1°C 
 
 
Table 3. 3: GCSF formulation set of the 3rd design of experiment (DOEc) (All Tms values are the mean of 
triplicate µDSC scans (Tm ±SD< 0.5°C) 
Formulation Buffer 
pH 
 
Buffer 
Concentration 
HP-β-CD  
(%) 
Tm RTm 
Rev. 
(%) 
RopTm 
GCSFDc1 No 4 No 5 70,3 4 61,5 4 
GCSFDc2 No 4 No 1 72,5 1 47,6 2 
GCSFDc3 No 4.5 No 1 72,6 1 53,2 1 
GCSFDc4 No 4.5 No 5 71,2* 3 45,2 3 
GCSFDc5 Acetate 4 20 1 66,2 5 0 2 
GCSFDc6 Acetate 4 100 5 61,7 7 0 7 
GCSFDc7 Acetate 4.5 20 5 62,9 6 0 6 
GCSFDc8 Acetate 4.5 100 1 60,5 8 0 8 
 * Tm ±SD <1°C 
 
The unfolding reversibility was investigated by temperature cycling using the upscan - upscan 
method which employed two consecutive upscans. After the first upscan the device is 
programmed to cool the sample again and repeat the heating cycle immediately. In case of 
reversible formulations, the reversibility was checked for all three heating replicates. The 
µDSC cell was pressurized to prevent boiling of the sample during heating. 
A base line run was performed before the sample run by loading both sample and reference 
cells with the corresponding reference. This base line was subtracted later from the protein 
thermal data and the excess heat capacity was normalized for protein concentration. For each 
formulation Tm and the degree of reversibility were determined. The degree of unfolding 
reversibility was the percentage of the enthalpy of the second upscan (∆H2) in relation to the 
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first one (∆H1). Both ∆H1 and ∆H2 were the apparent calorimetric enthalpies calculated by 
the area under the unfolding endotherm. For data analysis ORIGIN DSC data analysis 
software was used. 
 
 
I.1.4. Isothermal stability study (IsoSS): 
All formulations were stored under controlled conditions and analyzed immediately after 
sample withdrawal with the following methods. 
 
I.1.4.1. Reversed-phase high performance liquid chromatography (RP-HPLC): 
RP-HPLC was performed to study the chemical degradation of GCSF. The separation was 
achieved using a Thermo separation system with a Phenomenex (Jupiter 5 µ C18 300A 250 x 
4.6 mm 5 micron) column. The flow rate of 1 ml/min was set and a detection wavelength of 
215 nm was used. The mobile phase consisted of water with 60% acetonitril and 0.1% 
triflouroacetic acid. A protein concentration of 0.2 mg/ml was used in the analysis. The 
injection volume was 100 µl. All samples were filtered before injection using low protein 
binding syringe filters (4 mm, 0.2 µm, polyvinylidene Fluoride (PVDF) membrane, Whatman 
International Ltd. Maidstone England). After storage the protein content was not completely 
recovered in all formulations, most probably, due to the formation of insoluble aggregates 
which are filtered out before injected in the HPLC system. Therefore, the % of intact GCSF 
remaining after stress was calculated from the intact GCSF in each formulation at zero time 
point. Due to the large number of formulations, the storage of all formulations could not be 
started at exactly the same time. Therefore, at the end of the storage period (especially at 4°C) 
some samples were slightly older than others. To avoid the confusion that may be caused due 
to slightly different storage periods, at each time point the %remaining of intact GCSF was 
calculated and a 1st order degradation kinetic curve was used in order to determine the 
degradation rate constant at each storage temperature for each formulation. These constants 
were used as a parameter for ranking the formulations. 
 
I.1.4.2. Size-Exclusion-HPLC (SE-HPLC): 
Loss of GCSF monomer, due to aggregation or fragmentation, was monitored using SE-
HPLC. The separation was achieved using a Thermo separation system and a TSKgel 
G3000SWXL 7.8 mm ID x 30.0 cm L column (Tosoh Bioscience). A flow rate of 0.5 ml/min 
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was used, and the protein was detected at a wavelength of 215 nm. The mobile phase 
consisted of 31.7 g/L sodium hydrogen phosphate dibasic, and 1 g/L sodium dodecyl sulphate. 
The pH value was adjusted to 6.8 using 2N HCL. The injection volume was 20 µl. A protein 
concentration of 0.2 mg/ml was used in the analysis. All samples were filtered before 
injection using low protein binding filters (0.2 µm pore size). The % monomer remaining was 
calculated from the starting monomer content of each formulation at zero time point in order 
to overcome the incomplete protein recovery as in case of RP-HPLC. As mentioned above, in 
order to avoid confusion caused by slightly different storage periods, the monomer decline 
rate constant was calculated from the 1st order kinetic curves and used for ranking. 
 
I.1.4.3. Turbidity measurements: 
Turbidity was used as a simply but reliable value to determine the formation of insoluble 
aggregates of GCSF. At each time point the turbidity of each formulation was measured using 
a Dr. Lang Nephelometer (Dr. Bruno Lange GmbH, Berlin). 2 ml of each formulation were 
filled in a glass cuvette and the turbidity was measured in Formazin Nephelometric units 
(FNU). The FNU found for each formulation at the end of the storage period was used for 
ranking. 
 
I.1.4.4. Light obscuration: 
The insoluble aggregates were determined in each formulation by light obscuration 
measurements (PAMAS SVSS-CTM (Rutesheim, Germany)). Using a rinsing volume of 
0.5 ml and a measuring volume of 0.3 ml and the number of measurements was set to three. 
Before each measurement the device was rinsed with particle free water until there were less 
than 100 particles larger than 1 µm counted and no particles over 10 µm present. In order to 
simplify the ranking process only the turbidity results were used for ranking. Light 
obscuration measurements were carried out only to double check with turbidity measurements 
for the level of insoluble aggregates in each formulation.  
 
 
I.1.4.5. Sodium dodecyle sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE was conducted under non-reducing conditions using XCell II mini cell system 
(Novex, Sand Diego, CA). The protein solutions were diluted in a pH 6.8 tris-buffer, 
containing 4% SDS and 20% glycerine. Samples were denatured at 95°C for 20 min and 10 µl 
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were loaded into the gel wells (NuPage 10 % Bis-Tris Gel, Novex High performance pre-cast 
gels, Fa. Invitrogen, the Netherlands). Electrophoresis was performed in a constant current 
mode of 40mA in a MES SDS Running Buffer (NuPage MES SDS Running Buffer (20x), Fa. 
Invitrogen, the Netherlands). Gel staining and drying was accomplished with a silver staining 
kit (SilverXpress) and a drying system (DryEase), both provided by Invetrogen, Groningen, 
Netherlands. From SDS-PAGE results, ranking was not possible. However, it was used as a 
confirmative method.  
 
I.1.5. Correlation: 
To correlate the results of µDSC and the results of the IsoSS, formulations in each set as well 
as the whole 24 formulations were ranked according to Tm and separately according to their 
isothermal stability and then rank correlation was carried out. The ranking process was made 
in a way that for example in a 24 formulation set, the lower the ranking number the more 
stable is the formulation, i.e. the best formulation is ranked 1 and the worst is ranked 24. 
The ranking methods for µDSC as well as for the IsoSS results are described below. 
 
I.1.5.1. Ranking of formulations according to µDSC: 
In chapter 2 up to 5 different rankings were possible as Tm and degree of unfolding 
reversibility showed significant differences over the whole formulations set. In this chapter 
the degree of reversibility was only observed in 12 out of 24 formulations. Moreover, in many 
reversible formulations a large deviation (in some formulations over 20%) was noticed. 
Therefore Tm based ranking was first made (RTm) which was further optimized by considering 
the degree of unfolding reversibility (RopTm). Only when Tm showed no difference the 
formulation showing higher reversibility was ranked better (lower rank number). In tables 3.1- 
3.3 the rankings are shown for DOEa, DOEb, and DOEc, respectively. In table 3.2 none of the 
formulations in DOEb showed reversibility, therefore optimization of RTm was not applicable.  
 
 
I.1.5.2. Ranking of formulations according to IsoSS: 
A different ranking had to be made based on IsoSS. An example of the ranking procedures 
based on IsoSS is illustrated in table 3.4 for DOEa formulations. 
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Table 3. 4: IsoSS ranking of GCSF formulations in DOEa after 20 months storage at 4°C 
Formulations Kp41) R14 Tur.42) R24 
Avr. 
(R14+R24)/2 
Rp4 Kc43) Rc4 
Avr. 
(Rp4+Rc4)/2 
Rs4 
GCSFDa1 0,0027 1 0,8 1 1 1 0,0001 2 1,5 1 
GCSFDa2* -0,0447 6 0,62 1 3,5 5 0,0023 1 3 2 
GCSFDa3** -0,0085 4 0,96 1 2,5 4 -0,033 8 6 7 
GCSFDa4 -0,0498 7 1,1 6 6,5 7 -0,0031 6 6,5 8 
GCSFDa5* 0,002 2 0,98 1 1,5 2 -0,0003 4 3 2 
GCSFDa6 -0,0574 8 2,6 8 8 8 0,0001 2 5 4 
GCSFDa7 -0,0023 3 0,8 1 2 3 -0,0252 7 5 4 
GCSFDa8* -0,0381 5 1,47 6 5,5 6 -0,0018 5 5,5 6 
*formulations were stored for 24 months. 
** Formulation was not analyzed after 9 months  
1) Monomer denaturation constant at 4°C according to SE-HPLC results. 
2) Turbidity in FNU measured at the end of the IsoSS at 4°C. 
3) Chemical degradation constant at 4°C according to RP-HPLC results. 
 
I.1.5.2.1. Ranking based on physical stability (Rp): 
This ranking was based on both SE-HPLC and turbidity data. The ranking process includes 
the following steps: 
2- 1st ranking (R1): The formulations were ranked according to the monomer loss rate 
constant. 
3- 2nd ranking (R2): The formulations were ranked according to their turbidity at the end of 
the storage period. 
4- Overall physical stability ranking (Rp): For each formulation the average of R1 and R2 
was calculated (Rp = (R1 + R2)/2). 
These 3 rankings were done for each storage temperature to get Rp4, Rp25, and Rp40 for the 
ranking at 4, 25 and 40°C, respectively.  
 
I.1.5.2.2. Ranking based on chemical stability (Rc): 
Ranking was based on RP-HPLC data and was done for all formulations at each storage 
temperature (Rc4, Rc25, and Rc40). Degradation rate constants, calculated from the 1st order 
degradation curve of each formulation, were used as the ranking parameter.  
 
I.1.5.2.3. Ranking based on overall stability (Rs): 
For each formulation the average of Rp and Rc was calculated (Rs = (Rp + Rc)/2), equally 
presenting both chemical and physical stabilities. This was calculated at each storage 
temperature (Rs4, Rs25, and Rs40). 
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The previously mentioned ranking steps were repeated for each DOE and again for the whole 
24 formulations (handling the 3 DOEs as one formulation set).  
 
I.1.6. Prediction quality: 
In this study a new method for a formulator to make selection decisions based on predictive 
parameters was developed. After measuring Tm of 24 formulations, a formulator could make a 
decision and select the best 12 formulations and exclude the worst 12 based on Tm. To 
evaluate the reliability of such a decision, formulations that were selected either as the best or 
as the worst according to Tm and would also have been similarly selected in IsoSS at different 
storage temperatures (4, 25 and 40°C) were counted. This comparison was made regardless of 
the rank order of the formulations within the group of 12. 
Figure 3.1 A represents an example of such a process where the correlation matrix between 
RTm and physical stability at 4°C (Rp4) for the all 24 formulations was divided into 4 areas. 
The white square represents the group of formulations that were predicted as the best and 
were then confirmed by reality (IsoSS) to be the best. The black frame (figure 3.1), in 
contrast, represents the group of formulations predicted to be the worst and confirmed by 
IsoSS.  Both light and dark gray areas represent the number of formulations falsely selected 
by Tm as good and bad, respectively.  
The number of points in each box is presented as a part of a histogram as shown later in the 
results and discussion section (page 70 figure 3.6 A) where each bar consists of 4 coloured 
areas representing those in figure 3.1 A. The white and black areas represent the number of 
formulations correctly selected and both gray areas in the histogram represent the number of 
formulations falsely selected. The gray area, consisting of both light and dark; in such 
histogram represents the quality of the previous decision, where the formulator selected 50% 
of the whole formulation set based on the corresponding ranking. A large gray area in the 
curve means a lower prediction quality and accordingly the decision is less reliable and vice 
versa. Furthermore, the reliability of a closer decision where the formulator would choose 
only 5 formulations (approximately 20%) from the whole 24 and exclude 19 formulations was 
also evaluated. Such a process is presented in figure 3.1 B. 
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Figure 3. 1: Calculating the 50% (A) and 20% (B)  prediction quality of Tm based ranking (RTm) for the 
physical stability at 4°C based ranking (Rp4) of 24 GCSF different formulations. 
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I.2. Results and discussion: 
 
I.2.1. µDSC measurements: 
The µDSC thermographs for three tested buffers salts (phosphate, acetate, and citrate) at pH 4 
are shown in figure 3.2. In this short preliminary screening experiment the effect of three 
buffer salts was examined and judged from Tm values, acetate buffer is considered the 
favoured buffer whereas the citrate buffer exerted the lowest Tm. 
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Figure 3. 2: Tm of three GCSF formulations (∆) in citrate (■) in phosphate and (□) in acetate. All 20 mM 
buffer concentration and pH adjusted to 4 
  
Tables 3.1 – 3.3 (pages 54 and 55) show the Tm and degree of unfolding reversibility as found 
for the full and two fractional factorial designs DOEa, DOEb, and DOEc, respectively. Tables 
3.1 – 3.3 also display the formulation ranking as predicted from Tm (RTm). In formulations 
showing unfolding reversibility, optimization of RTm was considered only in case of 
formulations having equal Tms. 
The normalized coefficients of each DOE representing the effect of each factor on Tm and 
degree of unfolding reversibility are presented as bar charts in figure 3.3.  
The most significant effect was the effect of using a buffer salt for GCSF liquid formulation 
which has a pronounced negative effect on both Tm and degree of reversibility. Increasing 
buffer concentration, however, showed a similar but less dramatic effect on Tm of GCSF 
liquid formulations. That correlates well with the teachings of patents in which GCSF was 
favourably formulated in the absence of buffer. However, in practice, buffer is needed and 
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therefore, in GCSF formulations buffers should be kept at the lowest possible 
concentration17,18,23.   
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Figure 3. 3: Normalized coefficients for the effect of each factor on Tm (white bars) and unfolding 
reversibility (gray bars) of GCSF formulations of three studied DOEs. 
 
Increasing the concentration of HP-β-CD in DOEa showed a strong negative effect on Tm and 
a weaker positive effect on the degree of reversibility (figure 3.3). This allows at least a 
qualitative conclusion to be drawn. Cyclodextrins in rather high concentrations reduce the Tm 
of a protein, but allow in general high reversibility. This could be explained by the potential 
interaction of the cyclodextrin cavity with hydrophobic amino acid chains during their 
exposure in the course of unfolding. Reduction of the intramolecular binding energies by 
competitive binding of cyclodextrins should lead to lower Tms. On the other hand, 
cyclodextrin complexed hydrophobic amino acids could be protected from immediate 
interaction with other intra- or intermolecular hydrophobic species and reversibility is higher 
with cyclodextrins in place. Cyclodextrin may so interact with unfolded protein and acts as 
artificial chaperon 24,25.  
The effect of pH value on the stability of GCSF is reported by many authors8,26  where the 
acidic pH is favoured. Therefore, increasing the pH value a reduction in Tm was expected. A 
significant effect of increasing the pH value was shown in none of the studied DOE (figure 
3.3). In chapter 2 the effect of increasing the pH value was extensively studied showing a 
reduction in Tm by increasing the pH value in a pH rang from 4 to 5 (the pH range in all 
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DOE) and no reversibility was observed. A possible explanation to that is the interaction of 
different factors in one formulation set. Furthermore, DOEb and DOEc are composed of 
mixed buffered and un-buffered formulations. That represents qualitative difference which 
might have unexpected interaction with the other quantitative factors.  
The stability of GCSF is already reported to be affected by adding tween8027,28. Nevertheless, 
a significant effect neither on Tm nor on the degree of unfolding reversibility was obtained in 
each DOE. This behaviour is confirmed in another study where the effect of a surfactant on 
Tm of recombinant growth hormone studied by µDSC didn’t correlate with its physical 
stability29. Surfactants mainly protect protein by preventing adsorption induced aggregation at 
interfaces30. Such a protective mechanism is recognizable during isothermal storage of protein 
where aggregation might happen at the inner surface of a glass container as well as air-liquid 
interface. During a µDSC experiment such mechanism might be not applicable. First, the 
affinity of a protein solution to adsorb on the inner surface of the sample cell is different than 
its affinity to adsorb on the surface of a glass vial. Second, the air space in a µDSC sample 
cell is neglected. In addition the time of a µDSC experiment might be very short, in 
comparison to isothermal stability study, for adsorption to take place. Therefore, in a µDSC 
experiment a change in Tm might not be recognized. 
 
I.2.2. Isothermal stability study (IsoSS): 
24 GCSF liquid formulations were analyzed during isothermal storage at 4, 25 and 40°C over 
up to 24 months. At each time point the previously mentioned analytical methods were 
applied (section 1.4). In order to obtain comparable numbers for both SE-HPLC and RP-
HPLC, the monomer loss rates as well as the chemical degradation rates were calculated 
according to 1st order kinetics for each formulation. Figure 3.4 represents an example of the 
degradation of one GCSF formulation in three different temperatures. This was obtained by 
SE-HPLC and RP-HPLC represented in Figure 3.4 A and B, respectively. At each 
temperature the degradation as well as the monomer loss rates was obtained from the slope of 
the curve. 
Insoluble aggregates were determined in all formulations using both turbidity and light 
obscuration measurements. For ranking only the turbidity FNU measurements were 
considered as they are easier to rank compared to light obscuration measurements. In 
Appendix 3.I the light obscuration measurements for the 24 GCSF formulations at the end 
point were recorded and presented in table 3.I.1 – 3.I.3 for DOEa, DOEb and DOEc, 
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respectively. Turbidity measurements are recorded in the ranking tables in Appendix 3.I. 
(table 3.I.4 – 3.I.14) 
SDS-PAGE was made for all formulations at the beginning of the storage time and after 20 -
24 months storage at 4°C. In Appendix 3.II all SDS gels are presented in figure 3.II.1. 
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Figure 3. 4: Degradation of GCSFDb1 during isothermal stability study at 4°C (–■–), 25°C (–□–) and 40°C 
(–∆–). (A) Monomer loss as measured by SE-HPLC. (B) Chemical degradation as measured by RP-HPLC. 
 
 
 
I.2.3. µDSC as a predictive tool for IsoSS: 
Table 3.4 (Page 59) shows the IsoSS data after long term storage at 4°C as well as ranking of 
both physical and chemical stability for GCSF formulations of DOEa. The same rankings 
were made for 25°C and 40°C. The data collection and ranking were performed also for all 
other formulations in DOEb and DOEc and finally the ranking was done for the whole 24 
formulations in one group (Appendix 3.I, tables 3.I.4 – 3.I.14). 
The predictive power of µDSC determined Tms was judged in this chapter based on two main 
criteria. Primarily, the Pearson product moment correlation coefficient obtained from 
correlating predicted rankings against the IsoSS based ranking. Secondly, the prediction 
quality, explained above (section 1.6), to evaluate the selection decision based on µDSC 
parameter.  
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I.2.3.1. Correlation coefficients: 
In chapter 2 it was shown that Tm and the stability parameter are not scalable with each other 
and therefore the correlation between the rank orders was preferred. The Pearson product 
moment correlation coefficient was used as a judging parameter for the correlation. The 
correlation coefficients were studied in each DOE separately and finally the correlation was 
studied in the whole 24 formulations as one group. 
In Appendix 3.II figures 3.II.2 – 13 (pages 133 – 143) all resulting correlation curves are 
presented. A list of correlation coefficients resulting form each correlation is shown in table 
3.5. The data generated from such a high number of curves made it difficult to compare the 
correlation in each group of formulations. Accordingly, to allow such comparisons, an 
overview for all resulting correlation coefficients is presented in figure 3.5. Figure 3.5 A1 
represents the correlation between a Tm based ranking (RTm) and all IsoSS based rankings (Rp 
for ranking based on physical stability, Rc for ranking based on chemical stability and Rs for 
the ranking based on the overall stability) for DOEa. Figure 3.5 A2 shows the correlation of 
the same group but versus the optimized based ranking (RopTm) where the degree of unfolding 
reversibility was considered in case of equal Tm values. Figure 3.5 B1 represents the 
correlation in DOEb with RTm (None of the formulations in this group showed reversibility 
and accordingly an optimized ranking (RopTm) was not possible). Figures 3.5 C1 and C2 
represent the correlation of different IsoSS based rankings in DOEc with RTm and RopTm, 
respectively. Finally figures 3.5 D1 and D2 show the correlation coefficients when correlating 
the IsoSS based rankings of the whole 24 formulations (formulations of the three 
experimental designs DOEa, b and c) with RTm and RopTm, respectively. 
All histograms in figure 3.5 were structured similarly where the correlation coefficients (R2) 
are plotted on the y-axis, the different types of IsoSS ranking (Rp, Rc, and Rs) are plotted on 
the x-axis and the three different storage temperatures are plotted on the Z-axis.  
This study was conducted to evaluate the predictive power of µDSC for the long time storage 
stability of protein formulations. A protein formulator would expect from such work to 
answer some important questions: Can µDSC analysis predict the overall long term stability 
of a protein drug in a certain formulation at its typical storage temperature of 4-8°C and 25°C? 
Would physical stability alone be better predicted? Is prediction of chemical stability possible 
via µDSC at all? Furthermore, it is interesting to see whether prediction of storage stability via 
µDSC correlates to storage data at elevated temperature 40°C. It should be emphasized, that 
storage stability at 40°C is usually not performed to allow later long term storage (e.g. over 3-
6 months) at this temperature but to assess formulations for their tolerance towards higher 
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temperature and even more important to select the best formulation(s) from a group of 
candidates by studying them under stress conditions and to quantitative extrapolate to 4-8 °C. 
In that respect, 40°C storage can be considered also as a “predictive” method like µDSC Tm 
analysis. The correlation coefficients shown in figure 3.5 can provide useful information to 
answer such questions. 
 
Table 3. 5: Correlation coefficients resulting from correlating physical (Rp), chemical (Rc) and 
overall (Rs) stability based ranking at different temperatures with either Tm based ranking 
(RTm) or Optimized Tm based ranking (RopTm) 
RTm RopTm DOE Temp 
Rp Rc Rs Rp Rc Rs 
4°C 0.7094 0.0053 0.5013 0.6944 0.0032 0.4401 
25°C 0.339 0.0022 0.0197 0.3023 0.0023 0.0204 DOEa 
40°C -0.0384 0.035 0.0088 -0.0292 0.0686 0.0204 
4°C 0.609 0.3543 0.9182    
25°C 0.907 0.4768 0.7696    DOEb 
40°C 0.6553 0.5805 0.8278    
4°C 0.8154 0.4328 0.8752 0.7719 0.3049 0.679 
25°C 0.5919 0.2174 0.7651 0.6553 0.1741 0.7372 DOEc 
40°C 0.5384 0.4935 0.4922 0.8116 0.57 0.6753 
4°C 0.3436 0.1134 0.4042 0.3308 0.1334 0.4178 
25°C 0.5076 0.0979 0.3626 0.5146 0.1197 0.392 All 
40°C 0.1544 0.2633 0.2164 0.177 0.3168 0.2585 
 
None of the DOE data sets or the whole set of formulations showed a correlation coefficient 
of 1 to allow exact ranking prediction of IsoSS from µDSC data. It is obvious from figure 3.5 
that predictive power (especially for the IsoSS at 4°C) is lower in a larger group than in a 
smaller one. That was very clear when comparing the correlation coefficients of each design 
of experiment alone and for the whole 24 formulations as one set. Correlation trends are 
different for each experimental design as well, which proves an experimental design 
dependency of the prediction. RTm optimization using reversibility (RopTm) didn’t have a great 
effect on the predictive power of the method. 
In all groups the physical stability ranking (Rp) is better predicted by µDSC than the chemical 
stability ranking (Rc). Such a trend was expected as Tm is a measure of the physical strength 
of the protein integrity until unfolding occurs. But the overall stability ranking (Rs), based on 
the average ranking of physical and chemical stabilities, was predicted as good as the physical 
stability (Rp) in most cases.  
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Figure 3. 5: An overview of the correlation coefficients (y-axis) resulting from correlating the ranking 
based on physical stability (Rp), ranking based on Chemical stability (Rc), and ranking based on the 
average of both chemical and physical stabilities (Rs) (x-axis) with either Tm (graphs A1 – D1) or opTm 
(graphs A2 – D2) based rankings in the studied experimental designs. Graphs with the letter (A) show 
correlation for DOEa, (B) for DOEb, (C) for DOEc and (D) for the whole 24 formulations of the three 
designs together. The correlation was made at three different temperatures (z-axis) 
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For pure physical or chemical stabilities each design of experiment showed different trends 
with regards to the storage temperature. But surprisingly RTm was able to predict the overall 
stability ranking (Rs) best at 4°C in all experimental designs either separately or when 
combined in one set. Furthermore, RTm showed the lowest dependency on experimental 
design in predicting the overall stability. 
 
I.2.3.2. Prediction quality: 
Although it has to be accepted, that studying Tm alone does not allow predicting the absolute 
rank order of the stability of a wide range of different formulations, we had closer look on the 
reliability of Tm to exclude bad formulations and to pick the good ones. This was performed, 
as explained above, by monitoring the prediction quality for rankings based on µDSC 
measurements. Figures 3.6 A and B represent the 50% and 20% prediction quality, 
respectively for rankings based on either Tm or opTm of different kind of stability at different 
temperatures.  
Comparing the prediction quality in figure 3.6, neither Tm nor opTm were, of course, able to 
achieve complete selection certainty. Both rankings were more reliable in predicting physical 
stability than chemical stability. RTm showed higher 50% prediction quality in comparison 
with RopTm. However, both RTm and RopTm showed the highest 20% prediction quality towards 
predicting the overall stability at 4°C (figure 3.6 B) where 4 from 5 selected formulations 
based on Tm were selected in the best 5 by overall IsoSS ranking at 4°C. That supports the 
previously strong predictive power of Tm to IsoSS at 4°C compared with other temperatures.  
Despite the importance of physical stability in determining the long term stability of protein 
pharmaceuticals, chemical stability has to be insured for a protein formulation as well. 
Therefore, an overall (physically and chemically) stable formulation is the main target in 
protein formulation development. Many authors have evaluated the physical degradation of 
GCSF 9,31 which is affected greatly by the solution conditions like pH and buffer salts. On the 
other hand, the GCSF molecule contains 4 methionine residues 32 which increase the 
sensitivity of the GCSF molecule for oxidation. The use of a mixed factorial experimental 
design in this study provided a great challenge for µDSC predictive power due to the small 
changes in factor levels which makes formulation ranking, to some extent, difficult. 
Furthermore, the two main excipients included in the study affect the overall stability of 
GCSF through different mechanisms. HP-β-CD affects mainly the physical properties of the 
protein molecule and, according to our knowledge; no chemical effect of HP-β-CD on protein 
has been reported. 
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Figure 3. 6: Reliability of Tm and opTm to pick the good 12 formulations and exclude the bad 12 (50% 
prediction quality (A)) and to pick up 5 and exclude 19 (20% prediction quality (B)) in a 24 GCSF 
formulation set. White and black bars represent the number of formulations predicted correctly and the 
gray area represents the number of formulation falsely predicted. 
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On the other hand, Tween 80 as a non-ionic surfactant affects protein physical stability 29,30 
and can contain peroxide residues which would cause oxidation of methionine residues in the 
GCSF molecule affecting its chemical stability as well 27. Therefore, different contributions of 
both physical and chemical stability in the overall stability ranking are expected which makes 
prediction of the overall stability ranking of GCSF using µDSC a great challenge. This study 
showed that Tm was able to predict the overall stability ranking similarly or even better than 
physical stability especially at 4°C. Such conclusion was based not only on the higher 
correlation coefficients obtained from correlating RTm, but also on the higher 20% prediction 
quality obtained when selection was made based on RTm. That proves that Tm is not only able 
to predict physical stability as previously assumed, but also chemical stability is predicted to a 
certain extent. Doing so Tm showed even better predictive power for the overall stability 
ranking.  
 
I.2.4. µDSC in comparison with classical accelerated IsoSS: 
In most protein formulation laboratories performing IsoSS at elevated temperatures (40 – 
60°C) is a routine step upon which the decision for the best formulation(s) is mostly based. 
The predictive power of such strategies in comparison to other predictive strategies, for 
example µDSC, has not yet been evaluated. 
Which method is more predictive for the long term stability of protein formulations, µDSC or 
routinely used accelerated IsoSS at elevated temperatures?  
This section intends to answer this question by comparing the predictive powers of RTm and 
RopTm with that of ranking based on either IsoSS at 25°C or 40°C which are considered in this 
section as predictive methods. The ranking based on each was compared with that based on 
IsoSS at 4°C. The predictive powers of these two approaches (conformational stability and 
classical accelerated stability testing) were compared based primarily on the Pearson product 
moment correlation coefficients and secondarily on the prediction quality. 
 
I.2.4.1. Correlation coefficients: 
Figure 3.II.14 in Appendix 3.II shows the correlation curves between ranking based on IsoSS 
at elevated temperatures (Rp25, Rp40, Rc25, Rc40, Rs25, and Rs40) and the real IsoSS at 4°C 
(Rp4, Rc4, Rs4). An overview of the resulting correlation coefficients is presented in figure 
3.7 to allow better comparison. Accordingly, the predictive powers of 2 µDSC based rankings 
(ranking based on Tm (RTm) and optimized ranking by considering the degree of unfolding 
reversibility (RopTm)) were compared with the predictive power of IsoSS at elevated 
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temperatures (25°C and 40°C), in predicting the real stability ranking (at 4°C). This 
comparison was made only for the whole 24 formulations. 
IsoSS at 25°C obtained the highest correlation coefficient in predicting the physical stability 
and overall stability ranking at 4°C and together with IsoSS at 40°C in predicting the chemical 
stability. 
Surprisingly, physical stability and overall stability ranking at real storage temperatures are 
significantly better predicted by just measuring Tm using µDSC than the routinely more 
complicated IsoSS at 40°C. However, chemical stability is predicted significantly better by 
the accelerated IsoSS at elevated temperatures. 
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Figure 3. 7: An overview of the correlation coefficients (y-axis) resulting from correlating IsoSS based 
ranking at 4°C (x-axis) with either Tm , opTm, IsoSS at 25°C or IsoSS at 40°C (z-axis) for the whole 24 
formulations of three GCSF DOEs.  
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I.2.4.2. Prediction quality: 
50% and 20% prediction qualities of RTm and RopTm in comparison with those of IsoSS at 
elevated temperature were evaluated and are presented in figures 3.8 A and B, respectively. 
For predicting physical stability, Tm and IsoSS at 25°C showed the highest 50% prediction 
quality, whereas IsoSS at 40°C showed the lowest. Chemical stability was predicted with 
higher 50% prediction quality by IsoSS at 25 and 40°C. Comparing the 20% prediction 
quality for both physical and chemical stability µDSC parameters did not show great 
difference in comparison with IsoSS at elevated temperature but generally the superiority of 
Tm in predicting physical stability at 4°C to accelerated stability studies at 40°C is confirmed. 
On the other hand, IsoSS at 40°C had better predictive power with regards to chemical 
stability beside IsoSS at 25°C. The prediction of the overall stability based on Tm showed the 
highest 50% and 20% prediction quality and that support the higher correlation coefficient 
obtained in figure 3.7. 
This study provides a critical evaluation of two commonly used predictive approaches for 
protein stability. Accelerated stability studies are commonly performed by observing the rate 
of monomer loss or chemical degradation. This is experimentally quantified in terms of the 
fraction of monomer as well as intact GCSF remains at a given time during isothermal stress 
at a given elevated temperature. In case of physical stability, the measured monomer loss rate 
represents, indirectly, the observed rate of aggregation which is, in contrast to chemical 
degradation kinetics, a complicated process. Such process is controlled by several coefficients 
including aggregation kinetics and two main thermodynamic contribution, the free energy of 
unfolding (ΔGunf) and the osmotic second virial coefficient (B22) 33. Accelerated stability 
studies are commonly used in predicting real time physical stability based on the assumption 
that, as in chemical degradation, the observed rate of aggregation at elevated temperatures 
shows linear Arrhenius behaviour and therefore, extrapolation of such aggregation rates with 
respect to temperature should be able to predict the rate of aggregation at normal storage 
temperatures. Such approach would be true if all rate coefficients involved in determining the 
overall observed aggregation rate constant obey a linear Arrhenius temperature dependence. 
ΔGunf, which is the most important factor involved in such process, is highly dependent on 
temperature (Equation 1) and this is one of many possible reasons, reviewed by Weiss et al 34, 
why such linear Arrhenius behaviour is not observed and accordingly predictions of protein 
physical stability based on IsoSS at elevated temperature is expected to fail as shown in this 
study. That in turn causes further failure in predicting the overall stability ranking where 
physical stability is highly weighed in the overall ranking. 
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Figure 3. 8: 50% (A) and 20% (B) prediction quality of ranking based on Tm, opTm, IsoSS at 25°C and 
IsoSS at 40°C in predicting the real stability at 4°C (rankings based on IsoSS at 4°C). 
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The second approach evaluated in this work was the prediction based on conformational 
stability which is typically quantified by the standard free energy of unfolding (ΔGunf). This 
parameter is determined by performing chemical unfolding temperature experiments 35 or by 
using thermal scanning techniques such as µDSC which has the advantage of being sensitive 
to conformational transitions that may be spectroscopically invisible if they don’t cause strong 
changes in either 2ry or 3ry protein structure 34. ΔGunf is calculated from Gibbs-Helmholtz 
equation 36. 
 
∆Gunf = ∆Hunf (1 – T/Tunf) + ∆Cp(unf) (T – Tunf  – T ( ln ( T / Tunf )))    (1) 
 
Where Tunf is the unfolding temperature at which ΔGunf = 0, T is the temperature at which 
ΔGunf is to be calculated, ΔHunf the enthalpy change at unfolding and ΔCp(unf) is the difference 
in heat capacity between folded and unfolded states of protein.  
In practice most proteins undergo formation of irreversible aggregates 4,7,37,38, which makes 
the extraction of accurate parameter to calculate ΔGunf based on equation (1) impossible and it 
is only possible to determine Tm.  
In comparison with the previously discussed Arrhenius extrapolation approach, measured Tm 
is a direct component of ΔGunf, the most essential in aggregation thermodynamics, which may 
explain the significant higher predictive power of Tm compared to isothermal stability studies 
at 40°C. Of course this was not the case in predicting the chemical degradation rates where 
isothermal stability studies at elevated temperature are more successful.  
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II. Monoclonal Antibody (MAB): 
 
II.1. Materials and methods: 
II.1.1. Materials: 
A monoclonal antibody (MAB) was obtained as a gift from Roche Diagnostics GmbH (D-
Penzberg, Germany). All other materials and solvents were of analytical grade. Deionized 
double-distilled water was used throughout the study. 
 
II.1.2. Formulations: 
MAB was obtained in 10 mM Phosphate buffer pH 6.4 at a concentration of 13.8 mg/ml. The 
original solution was dialyzed using Slide-A-LyzerR Dialysis Cassette 10000 MWCO, (Pierce, 
Rockford, USA), to the required buffer. After dialysis MAB concentration was examined 
using Uvikon 810 UV spectrophotometer (Tegimenta, Rotkreutz, Switzerland.) and the final 
concentration was adjusted to 0.5 mg/ml for µDSC measurements and 5 mg/ml for the long 
term stability study. The final pH of the sample was determined using a Mettler Toledo 
MP220 pH meter (Mettler-Toledo GmbH, Schwezenbach, Switzerland). After preparation all 
formulations were filtered using low protein binding syringe filters (25 mm, 0.2 µm, 
polyvinylidenefluoride (PVDF) membrane, Pall Corporation, MI, USA). A reference for each 
formulation containing the same buffer and the same excipients was also prepared and filtered 
using cellulose acetate disk filters, 0.2 µm pore size (VWR International, USA).  
For IsoSS formulations were filled into type I glass vials, stoppered, capped, and crimped 
under sterile condition and then stored in the dark at ICH temperatures (4, 25, 40°C) in 
calibrated ovens. Each formulation was subjected to analysis at the beginning of the storage 
time (zero time) and at further time intervals.  
A total of 15 different MAB liquid formulations were included in this study. The effects of 3 
pH values (4.2, 5, and 6), three buffer systems (phosphate, histidine and succinate) and 
different excipients (tween 80, hydroxy propyl beta cyclodextrin (HP-β-CD), sorbitol, 
sucrose, glycerol and sodium chloride) were tested.  
 
Table 3.6 shows the composition of the studied 15 MAB formulations. 
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Table 3. 6: Composition of 15 MAB formulations and the corresponding µDSC parameters (All Tms value 
and degree of unfolding reversibility are the mean of triplicate µDSC scans (Tm ±SD < 0.5°C) 
(reversibility ±SD < 3%)) 
Formulation Buffer 1) pH Excipient Conc. Tm1 RTm1 Tm2 RTm2 Tm3 RTm3 Rev.2) 
MABF001 Pho. 4.2 No  60 15 73,9 15 79,3 14 48 
MABF002 Pho. 5 No  66,1 14 76,6 13 82,2 2 24,6 
MABF003 Pho. 6 No  71,3 7 77,2 7 81,4 4 0 
MABF004 His 6 No  68,4 13 76,9 10 82,4 1 10 
MABF005 Pho. 6 Tween 80 0,05 % 70,9* 10 77,27 3 81,4 4 0 
MABF006 Pho. 6 Sorbitol 5% 72,2 1 77,9 1 82** 3 0 
MABF007 Pho. 6 Sucrose 5% 72,1 2 77,7 2 81,2 6 0 
MABF008 Pho. 6 Glycerol 2.5% 71,4 6 77,3 3 80,7 9 0 
MABF009 Pho. 6 NaCl 150 mM 70,2 12 76,9 10 80,5 11 0 
MABF010 Pho. 6 HP-β-CD 1% 71,5 4 77,2 7 80,9 8 0 
MABF011 Pho. 6 HP-β-CD 10% 71,3 7 75,4 14 77 15 0 
MABF012 Succ. 6 No  71,1 9 77,1 9 81,2 6 0 
MABF013 Pho. 6 Tween 80 0,0005% 71,5 4 77,3 3 80,6 10 0 
MABF014 Pho. 6 Sucrose 1% 70,9 3 77,27 3 81,4 12 0 
MABF015 Pho. 6 NaCl 50 mM 72,2 11 77,9 10 82 13 0 
1) Buffer concentration is 10 mM in all formulations. Abbreviations are: Pho. for Phosphate, His for Histidine and Succ. For Sccinate.  
2) Degree of unfolding reversibility.   * ±SD = 0.5°C  ** ±SD = 0.6°C 
 
II.1.3. Thermal stability using µDSC: 
All formulations were analyzed using a VP-DSC (Microcal Inc., MA). Samples, as well as the 
corresponding references were degassed for 5 min prior to injection in the µDSC cells using a 
Thermo vac pump (Microcal. Inc., MA). Both sample and reference were loaded into cells 
using a gas tight Hamilton 2.5 ml glass syringe.  
Each formulation with its corresponding reference was heated from 30°C to 100°C using a 
60K/hr heating rate. The unfolding reversibility was investigated by temperature cycling using 
the upscan-upscan method which employed two consecutive upscans. After the first upscan 
the device is programmed to cool the sample again and repeat the heating cycle immediately. 
The µDSC cell was pressurized to prevent boiling of the sample during heating. 
A base line run was performed before the sample run by loading both sample and reference 
cells with the corresponding reference. This base line was subtracted later from the protein 
thermal data and the excess heat capacity was normalized for protein concentration. For each 
formulation Tm and degree of reversibility were determined. The degree of unfolding 
reversibility was the percentage of the enthalpy of the second upscan (∆H2) in relation to the 
first one (∆H1). Both ∆H1 and ∆H2 were the apparent calorimetric enthalpies calculated by 
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the area under the unfolding endotherm. For data analysis ORIGIN DSC data analysis 
software was used. 
 
II.1.4. Isothermal stability study (IsoSS): 
All formulations were stored under controlled conditions and analyzed immediately after 
sample withdrawal. The IsoSS of 11 from 15 MAB formulations was studied for a period of 
12 months. Due to different starting time 4 formulations were studied only for 6 months. The 
following analytical methods were applied. 
 
II.1.4.1. Size-exclusion HPLC (SE-HPLC): 
Loss of MAB monomer, due to aggregation or fragmentation, was monitored using SE-
HPLC. The separation was achieved using Dionex HPLC system (P680 pump, ASI 100 auto 
sampler, UVD170U) and two Superose 12 (10/300 GL) columns (Amersham Biosciences AB, 
Uppsala, Sweden). A flow rate of 0.5 ml/min was used, and the protein was detected at a 
wavelength of 280 nm. The mobile phase consisted of 200 mM Potassium phosphate, 
150 mM potassium chloride, pH 6.9. A protein concentration of 1 mg/ml was used in the 
analysis. All samples were centrifuged before injection into the HPLC system. The % 
monomer remaining was calculated from the starting monomer content of each formulation at 
zero time point in order to overcome the incomplete protein recovery in some formulations. 
The monomer decline rate constant was calculated from the slope of the 1st order kinetic 
curves and used for ranking. 
 
II.1.4.2. Light obscuration:  
The insoluble aggregates were determined in each formulation by light obscuration 
measurements (PAMAS SVSS-CTM (Rutesheim, germany)). Using a rinsing volume of 
0.5 ml and a measuring volume of 0.3 ml and the number of measurements was set to three. 
Before each measurement the device was rinsed with particle free water until there were less 
than 100 particles larger than 1 µm counted and no particles over 10 µm. Samples were 
diluted five times before measurements to 1 mg/ml using particle free water. The resulted 
particle count was multiplied by five and the final numbers were used in ranking. 
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II.1.4.3. Sodium dodecyle sulphate polyacrylamide gel electrophoresis (SDS-PAGE): 
SDS-PAGE was conducted under non-reducing conditions using an XCell II mini cell system 
(Novex, Sand Diego, CA). Protein solutions were diluted in a pH 6.8 tris-buffer, containing 
4% SDS and 20% glycerine. Samples were denatured at 95°C for 20 min and 10 µl were 
loaded into the gel wells (NuPage 7% Tris-Acetate Gel, Novex High performance pre-cast 
gels, Fa. Invitrogen, The Netherlands). Electrophoresis was performed in a constant current 
mode of 40mA in a Tris-Acetate SDS Running Buffer (Fa. Invitrogen). Gel staining and 
drying was accomplished with a Colloidal Coomassie blue stain (Fa. Novex) and a drying 
system (DryEase), both provided from Invetrogen, Groningen, Netherlands. SDS-PAGE was 
used as a confirmative method  
 
II.1.4.4. Isoelectric focusing gel electrophoresis (IEF): 
IEF is reported as a method to monitor chemical stability of monoclonal antibody 
formulations 39-41 and was used in this study for the same purpose. It was performed using 
Multiphor II electrophoresis system (GE healthcare bio-Sciences Ab, Uppsala, Sweden). 
Samples are diluted to 2 mg/ml using particle free water, centrifuged for 5 min and 5 µl were 
loaded into the gel (Servalyt Precotes, Range pH 6-9, Serva electrophoresis, Heidelberg, 
Germany). Electrophoresis was performed in constant current of 2000 volt. The duration of 
the electrophoresis was 150 min and was performed using Electrophoresis power supply, 
EPS3501XL (GE healthcare bio-Sciences Ab, Uppsala, Sweden). Gel staining was performed 
with Coomassie blue stain (Serva electrophoresis, Heidelberg, Germany).  
 
II.1.5. Correlation: 
The correlation was studied as explained in the GCSF section. The formulations were ranked 
according to Tm and separately according to their isothermal stability and then rank 
correlations were carried out. The ranking methods for µDSC as well as for the IsoSS results 
are described below. 
 
II.1.5.1. Ranking of formulations according to µDSC: 
The MAB molecule showed three different transitions and each of these transitions displayed 
different unfolding temperatures (as discussed later in the results section). Therefore, it was 
possible to perform three different rankings based on each Tm (RTm1. RTm2 and RTm3). The 
unfolding reversibility was found for only three formulations. These were already 
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differentiated based on Tm values and therefore optimization was not possible. Rankings 
based on each Tm were correlated with ranking based on IsoSS. Table 3.6 (Page 77) shows 
different rankings for 15 MAB formulations where, RTm1, RTm2 and RTm3 are rankings based 
on Tm1, Tm2 and Tm3 respectively. 
 
II.1.5.2. Ranking of formulations according to IsoSS: 
IsoSS ranking was only possible for physical stability based on SE-HPLC and light 
obscuration measurements. The chemical stability was monitored using IEF which showed no 
difference between formulations and no acidic or basic species. Therefore, the chemical 
stability was considered equal for all formulations and thus was excluded from the ranking. 
 
Accordingly the ranking process involved the following steps: 
1- 1st ranking (R1): The formulations were ranked according to the monomer loss rate 
constant. 
2- 2nd ranking (R2): The formulations were ranked according to their particle count at the end 
of the storage period. Ranking limits were as in chapter 2 (See chapter 2 section 2.6.2., 
Pages 31 and 32). 
3- Overall physical stability ranking (Rp): For each formulation the average of R1 and R2 
was calculated (Rp = (R1 + R2)/2). 
These rankings were carried out for each storage temperature to obtain Rp4, Rp25, and Rp40 
for the ranking at 4, 25 and 40°C, respectively. 
Ranking for the IsoSS at 4°C was done after 12 months for 11 formulations. This was 
repeated for the same formulation at 25 and 40°C. The other four formulations were studied 
for 6 months at 4°C and at 25°C no significant stability differences were noticed but they were 
included in a ranking for the whole 15 formulations for the IsoSS at 40°C. Table 3.7 shows an 
example for the ranking process of the 11 MAB formulations after 12 months at 4°C. It was 
obvious that the physical stability of the selected formulations very high as minor differences 
were obtained between formulations after 12 months storage at 4°C and only 4 from 11 
formulations showed lower stability. In Appendix 3.I rankings for the 11 MAB formulations 
at 25 and 40°C are shown in tables 3.I.15 and 16. Ranking of the whole 15 MAB formulations 
based on IsoSS at 40°C after 6 months is represented in table 3.I.17. 
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Table 3. 7: Ranking procedures for 11 MAB formulations based on IsoSS at 4°C after 12 months 
Formulation Kp41) R14 R242) 
Avr. 
(R14+R24)/2 
Rp43) 
MABF001 -0.0015 10 1 5.5 10 
MABF002 0.0001 1 1 1 1 
MABF003 0.0001 1 1 1 1 
MABF004 -0.0016 11 1 6 11 
MABF005 0.0011 1 1 1 1 
MABF006 0.0003 1 1 1 1 
MABF007 0.0002 1 1 1 1 
MABF008 -0.0001 9 1 5 9 
MABF009 -0.00006 8 1 4.5 8 
MABF010 0.0004 1 1 1 1 
MABF011 0.0005 1 1 1 1 
1) Monomer denaturation constant at 4°C according to SE-HPLC results. 
2) Ranking based on light blockage measured particle count (table 3.I.18) 
3) Ranking based on physical stability at 4°C 
 
II.1.6. Prediction quality: 
Both 50% and 20% prediction qualities were determined for the correlation of each Tm with 
physical stability ranking at different temperature.  
Determining the prediction quality was discussed in details in section I.1.6 of this chapter 
(Pages 60, 61). 
. 
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II.2. Results and discussion: 
 
II.2.1. µDSC measurements: 
A representative µDSC thermogram for the formulation MABF003 is shown in figure 3.9 
where the MAB molecule showed two main transitions at approximately 71 and 77°C. 
Temperature induced unfolding of different monoclonal antibodies was extensively studied 
using µDSC13,42-45  where similar two transitions were obtained. However, a thermogram of 
IgG of isotype 1, which showed only one transition peak, was reported46.  In these studies Fab 
and Fc fragments were studied separately from the intact antibody and in almost all cases 2 
different transitions were obtained for Fc segments and only one strong transition was 
obtained for the Fab segment. It was shown that the experimental enthalpy of unfolding may 
be used to determine which transition represents the Fab fragment which unfold in a 
cooperative manner45. Based on these finding it was suggested that the first transition in 
figure 3.9 should correspond to the Fc fragment and the second large transition correspond to 
the Fab fragment.  
 
Using Origin software the deconvolutions of the transition envelope was possible to obtain 
the individual domain transitions. This results in three different Tms as shown in the dotted 
lines in figure 3.9 including the two main transitions plus a small transition at about 81.4°C. 
This was applied for all MAB formulations included in this study and the resulted Tms are 
recorded in table 3.6.  
 
The unfolding temperature showed no concentration dependency for MAB (figure 3.10). 
Therefore, it was decided to use lower concentration for µDSC scans (0.5 mg/ml) to avoid 
extreme aggregations in the µDSC cell. 
 
Reversibility was obtained in 3 formulations and recorded in table 3.6 as well. 
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Figure 3. 9: Representative µDSC thermogram for MABF003 showing three Tms. The solid line illustrates 
the total transition envelope and dotted lines represent the deconvolutions carried out using Origin 
software.  
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Figure 3. 10: Unfolding of MAB (in phosphate buffer 10 mM pH 6) at different concentrations (0.2, 0.5, 1 
and 5 mg/ml).  
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II.2.2. Isothermal stability study (IsoSS): 
MAB formulations were analyzed during isothermal storage at 4, 25 and 40°C according to a 
certain time table using different analytical methods. As previously done in the GCSF study 
the monomer loss rates were calculated according to 1st order kinetics for each formulation. 
Figure 3.11 represents an example of denaturation rate of MABF003 after 12 months storage 
obtained by SE-HPLC. The monomer loss rates at 3 different temperatures were obtained 
from the slope of each curve.  
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Figure 3. 11: Monomer loss of MABF003 during isothermal stability study at 4°C (–■–), 25°C (–□–) and 
40°C (–∆–).  
 
Light obscuration measurements were used to determine insoluble aggregates in each 
formulation. In Appendix 3.I particle counts at the end of the stability study are listed in table 
3.I.18. 
SDS-PAGE and IEF were carried out for all formulations at zero time and after the last time 
point of the IsoSS. In appendix 3.II SDS-PAGE and IEF gels are presented in figures 3.II.15 
and 16, respectively. The chemical stability of the MAB formulations included in this study 
seems not to be affected at 4°C as seen from the IEF gels. Furthermore at 40°C, where all 
formulation showed smearing, no specific ranking could be obtained. Therefore, all 
formulations were ranked equal with regard to chemical stability.  
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II.2.3. µDSC as a predictive tool for IsoSS: 
The predictive power of µDSC was judged (as in GCSF study) primarily on the resulted 
Pearson product moment correlation coefficients from correlating the ranking based on µDSC 
with those based on IsoSS. Secondarily, the prediction quality (selection of best 50% or 20% 
formulations) was tested.  
 
II.2.3.1. Correlation coefficients: 
Correlation curves are presented in figures 3.12 – 3.14 for Tm based rankings and physical 
stability based ranking for 11 MAB formulations after 12 months storage at 4, 25, and 40°C. 
Figure 3.15 show the correlation curves for Tm based rankings and physical stability of 15 
MAB formulations after 6 months storage at 40°C.  
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Figure 3. 12: Correlation curves of 11 MAB formulations. That includes correlation between Tm based 
rankings (RTm1, RTm2 and RTm3) and ranking based on IsoSS at 4°C (Rp4) after 12 months. 
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Figure 3. 13: Correlation curves of 11 MAB formulations. That includes correlation between Tm based 
rankings (RTm1, RTm2 and RTm3) and ranking based on IsoSS at 25°C (Rp25) after 12 months. 
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Figure 3. 14: Correlation curves of 11 MAB formulations. That includes correlation between Tm based 
rankings (RTm1, RTm2 and RTm3) and ranking based on IsoSS at 40°C (Rp40) after 12 months. 
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Figure 3. 15: Correlation curves of 15 MAB formulations. That includes correlation between Tm based 
rankings (RTm1, RTm2 and RTm3) and ranking based on IsoSS at 40°C (Rp40) after 6 months. 
, and Rp40).  
 
An overview for all correlation coefficients is presented in figure 3.16 for 3 Tm based 
rankings (RTm1, RTm2 and RTm3) and physical stability based rankings at different storage 
temperatures (Rp4, Rp25
In this section the predictive power of µDSC in formulation development of a monoclonal 
antibody was studied. Similar to GCSF study, in the first part of this chapter, an important 
question is to be answered. Can µDSC analysis predict the overall long term physical stability 
of a monoclonal antibody in a certain formulation at its typical storage temperature of 4-8°C? 
Monoclonal antibodies usually show 3 Tms in µDSC experiments as mentioned in section 
II.2.1. A formulator will expect from such work to find out which is the most predictive Tm. 
Microcalorimetry Tm based ranking showed superior predictive power than routinely 
conducted IsoSS at elevated temperatures (40 – 60°C) in predicting the long term stability of 
GCSF formulations at 4°C. Will that be also the case with respect to monoclonal antibodies?  
Figure 3.16 showed that none of the Tm based rankings showed really high correlation 
coefficients with physical stability based rankings at different storage temperatures. At 4°C 
correlations were between 2 clusters of point (figure 3.12) and, except with Tm1 based 
ranking, extremely week correlations were obtained. However, this might be due to the small 
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differences in physical stability of the MAB formulations after 12 months storage at 4°C. In 
the ranking based on physical stability after 12 months storage at 4°C 7 formulations from 11 
were stable through the study. Accordingly formulations ranked from 1 to 7 based on Tm are 
all ranked 1 based on physical stability at 4°C. At 25°C the formulations were easier to 
differentiate and a reasonable ranking based on physical stability was possible. Accordingly, 
the points in the correlation curve were better distributed (figure 3.13). The highest correlation 
coefficient was obtained from RTm3 for the physical stability after 12 months storage at 25°C. 
After 12 as well as 6 months storage at 40°C (figures 3.14 and 3.15, respectively) all Tm based 
rankings showed very poor correlation to physical stability based ranking.  
µDSC could achieve a powerful prediction of the physical stability of MAB at 25°C using the 
Tm3 based ranking. At 4°C MAB formulations didn’t show significant differences in physical 
stability even after 12 months. Judging the predictive power of µDSC based on the correlation 
coefficients, although RTm1 showed relatively better correlation coefficient, is not enough and 
therefore, studying the prediction quality might be very useful in this case. 
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Figure 3. 16: An overview of the correlation coefficients (Y-axis) resulting from correlating the ranking 
based on physical stability (Rp) at different temperatures (Rp4, Rp25, and Rp40) (Z-axis) with ranking 
based on three different Tms (RTm1, RTm2 and RTm3) of 11 MAB formulation after 12 months IsoSS . 
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II.2.3.2. Prediction quality: 
The prediction quality is studied in this chapter to evaluate how reliable a selection process 
based on Tm is. In such process a formulator will choose the formulations having the highest 
Tm and exclude those having the lowest. It is important to highlight that after selection the 
main focus is not on the excluded candidates but in fact the selected ones in order to go 
forward in clinical trials and parallel in long term stability studies. Consequently, in order to 
avoid unexpected failure in clinical studies due to instability issues false selection is not 
acceptable. 
Figure 3.17 A and B show the 50% and 20% prediction quality, respectively, of three Tm 
based rankings (RTm1, RTm2 and RTm3) in predicting the physical stability of 11 MAB 
formulations at three different temperatures (4, 25 and 40°C).  
At 4°C Tm based rankings showed higher 50% quality in predicting the physical stability of 
MAB formulations in comparison with 25°C and 40°C. That was not clear from only 
comparing the correlation coefficients in section II.2.3.1. Most interestingly, the selected best 
2 formulations based on Tm1 or Tm2 were included in the selected best stable formulations at 
4°C (figure 3.17 B). However, as shown in figure 3.17 B, the 20% quality of physical stability 
prediction at 4°C showed larger gray area than at 25°C and 40°C which indicates lower 
prediction quality. But having a complete white bar indicates that the best 2 formulations 
based on Tm didn’t fail in stability after 12 months storage at 4°C. The absent, or even 
incomplete, white bars as in case of the prediction quality of Tm based ranking at 25°C and 
40°C means that all or at least part of the selected best formulations based on Tm didn’t 
achieve good stability through the study period.  
The predictive power of all Tm based rankings for the physical stability at 4°C showed similar 
50% prediction quality (figure 3.17 A). On the other hand, Tm1 and Tm2 showed better 20% 
prediction quality than Tm3 (figure 3.17 B). Using Tm1 or Tm2 as predictive tool for physical 
stability of MAB formulations at 4°ّC no false selection happened and the selected 2 best 
formulations showed no instability after 1 year at 4°C. 
At 25°C Tm3 showed the highest prediction quality (50% as well 20%) in comparison with 
Tm1 and Tm2 which was expected from the high correlation coefficient as shown in section 
II.2.3.1. However, a false selection could not be avoided as at least 1 of the 2 selected best 
formulations didn’t achieve high physical stability after 1 year. 
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Figure 3. 17: prediction quality of three different Tms to pick up the best 6 formulations and exclude the 
bad 5 (50% prediction quality (A)) and to pick up the best 2 and exclude the rest (20% prediction quality 
(B)) in 11 MAB formulation.  
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Prediction of the physical stability of MAB formulations at 40°C using Tm based rankings 
showed the highest 50 % quality with Tm1. On the other hand, all Tm based rankings showed 
bad 20% prediction quality for the physical stability at 40°C. 
Despite the lower correlation coefficient, physical stability based ranking of 11 MAB 
formulations was best predicted at 4°C based on Tm. Using Tm1 or Tm2 in a predictive 
ranking, false prediction of the best 2 formulations was completely avoided. Moreover, Tm1 
showed higher correlation coefficient in predicting the physical stability at 4°C. Accordingly, 
using the 1st transition temperature (Tm1) as predictive parameter is recommended.  
 
II.2.4. µDSC in comparison with classical accelerated IsoSS: 
Here isothermal stability studies at elevated temperatures (25°C and 40°C) are considered as 
“predictive” methods. The predictive power, of those accelerated stability studies, was 
compared with that of µDSC Tms. The IsoSS based ranking after 12 months storage at 25°C 
and after 3 months at 40°C, were compared with 3 Tm based rankings in predicting the 
stability of MAB formulations after 12 months storage at 4°C. The correlation curves of the 3 
Tm based rankings were presented previously in figure 3.12 (page 85). Figure 3.18 shows the 
correlation curves between ranking based on IsoSS at 25°C and 40°C and the IsoSS at 4°C. 
Figure 3.19 shows an overview for all correlation coefficients.  
In general all methods showed very low correlation coefficients. That is (as shown in 
correlation curves in figure 3.12 and 3.18) due to the insignificant differences between the 
MAB formulations after 12 months storage at 4°C. Therefore, the correlation is always 
between 2 clusters of points. Tm1 based ranking showed a higher correlation coefficient in 
comparison with ranking based on Tm2 and Tm3 as well as those based on accelerated IsoSS 
at 25 and 40°C (figure 3.19). However, further evaluation of the prediction quality is needed 
for a meaningful evaluation of the predictive power of µDSC measured Tms in comparison 
with classical accelerated stability studies. 
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Figure 3.18: Correlation curves of 11 MAB formulations. That includes correlation between ranking 
based on IsoSS at 4°C (Rp4) after 12 months, and ranking based on IsoSS at 25°C (Rp25) after 12 months 
and at 40°C (Rp40) after 3 months.  
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Figure 3. 19: An overview of the correlation coefficients resulting from correlating the IsoSS based 
ranking at 4°C (Rp4) (Z-axis) with rankings based on either µDSC determined Tms (RTm1, RTm2, and 
RTm3) or accelerated stability studies at 25 and 40°C (Rp25 and Rp40). 
 
The 3 Tm based rankings showed significantly higher 50% prediction quality than that of 
classical accelerated stability studies (figure 3.20 A). Furthermore, studying the 20% 
prediction qualities (figure 3.20 B) Tm1 and Tm2 based rankings were able to achieve the best 
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prediction quality and no false selection of the best 2 formulations. Neither ranking based on 
Tm3 nor those based on classical accelerated stability studies could achieve the same quality. 
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Figure 3. 20: 50% (A) and 20% (B) prediction quality of three µDSC measured Tms and IsoSS at 25°C 
and 40°C in predicting IsoSS at 4°C. 
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III. Pegylated Interferon α2a (PEG-INF): 
 
III.1. Materials and methods: 
III.1.1. Materials: 
Pegylated Interferon α2a (PEG-INF) was obtained as a gift from Roche Diagnostics GmbH 
(D-Penzberg, Germany). All other materials and solvents were of analytical grade. Deionized 
double-distilled water was used throughout the study. 
 
III.1.2. Formulations: 
PEG-INF was obtained in 20 mM Sodium acetate buffer pH 6.0 with 50 mM NaCl. Protein 
concentration of the bulk solution was determined to be approximately 1.4 mg/ml. The 
original solution was dialyzed using Slide-A-LyzerR Dialysis Cassette 2000 MWCO, (Pierce, 
Rockford, USA), to the required buffer. After dialysis the sample concentration was examined 
using an Uvikon 810 UV spectrophotometer (Tegimenta, Rotkreutz, Switzerland.). The final 
concentration was adjusted to 0.4 mg/ml for both µDSC measurements and the isothermal 
stability study (IsoSS). The final pH of the sample was determined using a Mettler Toledo 
MP220 pH meter (Mettler-Toledo GmbH, Schwezenbach, Switzerland). After preparation all 
formulations were filtered using low protein binding syringe filters (25 mm, 0.2 µm, 
polyvinylidenefluoride (PVDF) membrane, Pall Corporation, MI, USA). A reference for each 
formulation containing the same buffer and the same excipients was also prepared and filtered 
using cellulose acetate disk filters, 0.2 µm pore size (VWR International, USA).  
For IsoSS formulations were filled into type I glass vials, stoppered, capped, and crimped 
under sterile condition and then stored in the dark at ICH temperatures (4, 25, 40°C) in 
calibrated ovens. Formulations were subjected to analysis at the beginning of the storage time 
(zero time) and at further time intervals.  
A total of 14 different PEG-INF liquid formulations were included in this study. The effects 
of 4 pH values (4, 5, 6 and 7.4), three buffer systems (acetate, phosphate and citrate) and 
different excipients (tween 80, hydroxy propyl beta cyclodextrin (HP-β-CD), sucrose, and 
sodium chloride) were tested.  
Table 3.8 shows the composition of the studied PEG-INF formulations. 
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Table 3. 8: Composition of 14 PEG-INF formulations and the corresponding Tm (All Tms value are the 
mean of triplicate µDSC scans (Tm ±SD < 0.25°C) 
Formulation Buffer 1) pH Excipient Conc. Tm RTm 
P-INFF001 Acet. 4 No - 64,1* 14 
P-INFF002 Acet. 5 No - 68,7 8 
P-INFF003 Acet. 6 No - 68,8* 5 
P-INFF004 Acet. 7.4 No - 67,8 13 
P-INFF005 Pho. 6 No - 68,8 5 
P-INFF006 Cit. 6 No - 69,1 2 
P-INFF007 Acet. 6 NaCl 50 mM 69,1 2 
P-INFF008 Acet. 6 NaCl 200 mM 69,8 1 
P-INFF009 Acet. 6 HP-β-CD 1% 68,8 5 
P-INFF010 Acet. 6 HP-β-CD 10% 68,6 9 
P-INFF011 Acet. 6 Tween 80 0,0005% 68,5 10 
P-INFF012 Acet. 6 Tween 80 0,05% 68,1 12 
P-INFF013 Acet. 6 Sucrose 50 mM 68,5 10 
P-INFF014 Acet. 6 Sucrose 200 mM 68,9 4 
1) Buffer concentration was 20 mM in all formulations. Abbreviations are: Acet for Acetate, Pho. for Phosphate and Cit. for Citrate.  
* ±SD < 0.6°C  
 
III.1.3. Thermal stability using µDSC: 
All formulations were analyzed using a VP-DSC (Microcal Inc., MA). Samples as well as 
corresponding references were degassed for 5 min prior to injection into the µDSC cells using 
a Thermo vac pump (Microcal. Inc., MA). Both sample and reference were loaded into cells 
using a gas tight Hamilton 2.5 ml glass syringe.  
Each formulation with its corresponding reference was heated from 30°C to 80°C using a 
60K/hr heating rate. The unfolding reversibility was investigated by temperature cycling using 
the upscan-upscan method. The µDSC cell was pressurized to prevent boiling of the sample 
during heating. 
A base line run was performed before the sample run by loading both sample and reference 
cells with the corresponding reference. This baseline was subtracted later form the protein 
thermal data and excess heat capacities were normalized for protein concentration.  
 
III.1.4. Isothermal stability study (IsoSS): 
All formulations were stored under controlled conditions and analyzed immediately after 
sample withdrawal. Isothermal stabilities of 11 PEG-INF formulations were studied for a 
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period of 12 months. Due to different starting time the remaining three formulations were 
studied only for 6 months. The following analytical methods were applied. 
 
III.1.4.1. Size-exclusion-high performance liquid chromatography (SE-HPLC): 
Loss of PEG-INF monomer, due to aggregation or fragmentation, was monitored using SE-
HPLC. The separation was achieved using Dionex HPLC system (P680 pump, ASI 100 auto 
sampler, UVD170U) and a Superose 6 (10/300 GL) column (Amersham Biosciences AB, 
Uppsala, Sweden). A flow rate of 0.4 ml/min was used, and the protein was detected at a 
wavelength of 210 nm. The mobile phase consisted of 20 mM sodium phosphate, 150 mM 
sodium chloride, 1% diethyleneglycol and 10% ethanol. The pH of the mobile phase was 
adjusted to 6.8. A protein concentration of 0.4 mg/ml was used in the analysis. All samples 
were centrifuged before injected in the HPLC system. The % monomer remaining was 
calculated from the starting monomer content of each formulation at zero time point in order 
to overcome the incomplete protein recovery in some formulations. The monomer decline rate 
constant was calculated, over 12 months, from the slope of the 1st order kinetic curves and 
used for ranking. 
 
III.1.4.2. Reversed phase – HPLC (RP-HPLC): 
RP-HPLC was performed to study the chemical degradation of PEG-INF. The separation was 
achieved using Dionex HPLC system (P680 pump, ASI 100 auto sampler, UVD170U) using a 
Hypersil BDS-C18 4 x 125 mm, 5 µm (Agilant Technologies). As a mobile phase a gradient 
flow from solution A (30% acetonitril, 0.2% triflouroacetic acid (TFA)) and solution B (80% 
acetonitril, 0.2% TFA) was used. A flow rate of 0.4 ml/min was set and a detection 
wavelength of 215 nm was used. A protein concentration of 0.4 mg/ml was used in the 
analysis. The injection volume was 50 µl. All samples were centrifuged before injected into 
the HPLC system. The % of intact PEG-INF remaining after stress was calculated from the 
intact PEG-INF in each formulation at zero time point and the degradation rate constant was 
calculated, over 6 months, from the slope of the 1st order kinetic curves and used for ranking. 
. 
III.1.4.3. Light obscuration: 
The insoluble aggregates were determined in each formulation by light obscuration 
measurements (PAMAS SVSS-CTM (Rutesheim, germany)). Using a rinsing volume of 
0.5 ml and a measuring volume of 0.3 ml and the number of measurements was set to three. 
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Before each measurement the device was rinsed with particle free water until there were less 
than 100 particles larger than 1 µm counted and no particles over 10 µm. The resulting 
particle counts at the end point of the stability study were used in ranking. 
 
III.1.4.4. Sodium dodecyle sulphate polyacrylamide gel electrophoresis (SDS-PAGE): 
SDS-PAGE was conducted under non-reducing conditions using XCell II mini cell system 
(Novex, Sand Diego, CA). Protein solutions were diluted in a pH 6.8 tris-buffer, containing 
4% SDS and 20% glycerine. Samples were denatured at 95°C for 20 min and 10 µl were 
loaded into the gel wells (NuPage 7% Tris-Acetate Gel, Novex High performance pre-cast 
gels, Fa. Invitrogen, The Netherlands). Electrophoresis was performed in a constant current 
mode of 40mA in a Tris-Acetate SDS Running Buffer (Fa. Invitrogen). Gel staining and 
drying was accomplished with a silver staining kit (SilverXpress) and a drying system 
(DryEase), both provided from Invitrogen, Groningen, Netherlands. Based on SDS-PAGE no 
ranking was possible but it was used as a confirmative method. 
 
III.1.5. Correlation: 
All formulations were ranked according to Tm and separately according to their isothermal 
stability and then rank correlations were carried out. The ranking methods for µDSC as well 
as for the IsoSS results are described below. 
 
III.1.5.1. Ranking of formulations according to µDSC: 
The PEG-INF molecule showed no unfolding reversibility in all formulations. Therefore 
ranking was made only based on Tm (RTm for PEG-INF formulations is shown in table 3.8). 
 
III.1.5.2. Ranking of formulations according to IsoSS: 
III.1.5.2.1. Ranking based on physical stability (Rp): 
This ranking was based on both SE-HPLC and light obscuration data. The ranking process has 
the following steps: 
1- 1st ranking (R1): The formulations were ranked according to the monomer loss rate 
constant. 
2- 2nd ranking (R2): The formulations were ranked according to their particle count at the 
end of the storage period. Ranking limits were the same used in chapter 2 (See chapter 2 
section 2.6.2.) 
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3- Overall physical stability ranking (Rp): For each formulation the average of R1 and R2 
was calculated (Rp = (R1 + R2)/2). 
These 3 rankings were done for each storage temperature to get Rp4, Rp25, and Rp40 for the 
ranking at 4, 25 and 40°C, respectively.  
 
III.1.5.2.2. Ranking based on chemical stability (Rc): 
Ranking was based on RP-HPLC data and was done for all formulations at each storage 
temperature (Rc4, Rc25, and Rc40). Degradation rate constants, calculated from the 1st order 
degradation curve of each formulation, were used in ranking.  
 
III.1.5.2.3. Ranking based on overall stability (Rs): 
For each formulation the average of Rp and Rc was calculated (Rs = (Rp + Rc)/2), equally 
presenting both chemical and physical stabilities. This was calculated at each storage 
temperature (Rs4, Rs25, and Rs40). 
Ranking procedures were carried out after 12 months for only 11 formulations at 4°C, 25°C 
and 40°C. The remaining three formulations were studied for 6 months and therefore at 4°C 
and at 25°C no significant stability differences were noticed but they were included in a 
separate ranking for the whole 14 formulations for the IsoSS at 40°C. Table 3.9 shows an 
example for the ranking process of the 11 PEG-INF formulations after 12 months at 4°C. In 
Appendix 3.I rankings for the 11 PEG-INF formulations at 25 and 40°C are shown in tables 
3.I.19 and 20. Ranking of the whole 14 PEG-INF formulations based on IsoSS at 40°C after 6 
months is represented in table 3.I.21.   
 
III.1.6. Prediction quality: 
Both 50% and 20% prediction qualities were determined for the correlation of Tm with 
stability rankings at different temperatures.  
Determining the prediction quality was discussed in details in section I.1.6 of this chapter 
(Pages 60, 61). 
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Table 3. 9: Ranking procedures for 11 PEG-INF formulations based on IsoSS at 4°C after 12 months 
Formulation Kp41) R14 R242) 
Avr. 
(R14+R24)/2 
Rp4 Kc43) Rc4 
Avr. 
(Rp4+Rc4)/2 
Rs4 
P-INFF001 0,002 1 1 1 1 0,0074 1 1 1 
P-INFF002 -0,0035 10 1 5,5 10 0,0068 1 5,5 5 
P-INFF003 0,0004 1 1 1 1 0,003 7 4 3 
P-INFF004 -0,0025 8 1 4,5 8 0,0047 4 6 6 
P-INFF006 -0,0064 11 1 6 11 0,0048 4 7,5 10 
P-INFF007 0,001 1 1 1 1 0,0047 4 2,5 2 
P-INFF008 -0,0024 7 1 4 7 0,0063 1 4 3 
P-INFF009 -0,0003 4 1 2,5 4 -0,0002 10 7 8 
P-INFF010 -0,0029 9 1 5 9 -0,0016 11 10 11 
P-INFF012 -0,0008 5 1 3 5 0,0008 8 6,5 7 
P-INFF014 -0,0017 6 1 3,5 6 0,0008 8 7 8 
1) Monomer denaturation constant at 4°C according to SE-HPLC results. 
2) Ranking based on light blockage measured particle count (table 3.I.22) 
3) Chemical degradation rate constant at 4°C after 6 months IsoSS according to RP-HPLC results 
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III.2. Results and discussion: 
 
III.2.1. µDSC measurements: 
A representative µDSC thermogram for P-INFF003 is shown in figure 3.21 where the PEG-
INF molecule showed only one transition at approximately 68.8°C. This was applied for all 
PEG-INF formulations included in this study and the resulted Tms are listed in table 3.8.  
None of the studied PEG-INF formulations showed reversibility. 
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Figure 3. 21: P-INFF003 µDSC thermogram showing unfolding transition temperature at 68.8°C. PEG-
INF was formulated in 20 mM acetate buffer pH 6. 
 
 
 
 
III.2.2. Isothermal stability study (IsoSS): 
PEG-INF formulations were analyzed during isothermal storage at 4, 25 and 40°C according 
to certain time table using different analytical methods. The monomer loss rate was calculated 
according to 1st order kinetics for each formulation. Figure 3.22 represents an example of 
denaturation rate of P-INFF003 after 12 months storage obtained by SE-HPLC (A) and RP-
HPLC (B).  
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Figure 3. 22: Degradation of P-INFF003 during isothermal stability study at 4°C (–■–), 25°C (–□–) and 
40°C (–∆–). (A) Monomer loss as measured by SE-HPLC over 12 months. (B) Chemical degradation as 
measured by RP-HPLC. 
 
 
Light obscuration measurements were used to determine insoluble aggregates in each 
formulation. In Appendix 3.I particle counts at the end point are listed in table 3.I.22. 
SDS-PAGE was carried out for all formulations at zero time and after 6 months of the IsoSS. 
SDS-PAGE gels are presented in figures 3.23. The bands showed broadening and after stress 
some formulations showed smearing. Such behaviour was reported for pegylated proteins 
when analyzed by SDS-PAGE 47-49 where such effects increased with increasing either PEG 
or SDS concentrations. An explanation for that might be the complex interaction between 
PEG chains and SDS micelles 50. After 6 months storage at 40°C many PEG-INF 
formulations showed smearing indicating increased concentrations of free poly ethylene 
glycol (PEG) in the formulation. 
 
 
 
III.2.3. µDSC as a predictive tool for IsoSS of PEG-INF: 
The predictive power of µDSC was judged primarily on the resulted Pearson product moment 
correlation coefficients from correlating the ranking based on µDSC with those based on 
IsoSS. Secondary, the predictive power was tested with regards to the prediction quality. 
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Figure 3. 23: SDS-PAGE for 14 PEG-INF formulations at the beginning (A) of the IsoSS and after 6 
months storage at 4°C (B) and 25°C (C) and 40°C (D).  Composition of formulations P-INFF001 – P-
INFF014  (see table 3.8) 
 
III.2.3.1. Correlation coefficients: 
All correlation curves are presented in appendix 3.II figures 3.II.17 – 20. An overview for the 
resulting correlation coefficients is presented in figure 3.24. Figure 3.24 A shows the 
correlation coefficients (presented on the y-axis) of Tm based ranking and physical, chemical, 
and overall stability ranking (Rp, Rc, and Rs, respectively and presented on the z-axis) after 12 
months storage at 4 and 25 °C and 6 months storage at 40°C (temperatures are presented on 
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the x-axis) for the 11 PEG-INF formulations. Figure 3.24 B is similarly constructed and 
presenting the correlation coefficients resulting from correlating the Tm based ranking with 
the physical chemical and overall stability after 6 months storage at 40°C but for the whole 14 
PEG-INF formulations. 
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(A) (B) 
Figure 3. 24: An overview for the correlation coefficients (y-axis) resulting from correlating the ranking 
based on physical stability (Rp), chemical stability (Rc) and overall stability ranking (Rs) (z-axis) at 
different temperatures (4, 25, and 40°C) (x-axis) with ranking based on Tm (RTm) of 11 PEG-INF 
formulations after 12 months IsoSS (A) and for the whole 14 PEG-INF formulations at 40°C after 6 
months IsoSS (B). 
 
From the correlation coefficients represented in figure 3.24 and similar to the correlation 
found for GCSF and MAB in the 1st and 2nd part of this chapter, Tm was not able to predict the 
exact rank order of the formulations after 12 months isothermal stability study. Surprisingly 
and in contrast to GCSF and MAB, the higher correlation coefficients were obtained for IsoSS 
at 40°C. On the other hand at 4 and 25°C very weak predictions were observed. This behavior 
was also seen in predicting the IsoSS stability of the whole 14 PEG-INF formulations at 40°C. 
As shown from the correlation coefficients the prediction of chemical stability is weaker than 
predicting both physical and overall stability of the PEG-INF formulations. 
Pegylation of therapeutic proteins is performed in order to improve molecule life time in 
blood and reduce immune responses 51,52. In such process one or more PEG molecules are 
covalently attached to the protein. Pegylation of Interferon α2a caused an increase in Tm 
indicating higher conformation stability 14. The same was reported for many other proteins 
molecule where Tm showed higher values due to pegylation 53,54. In literature the main 
hypothesis describing the molecular mechanism by which pegylation increases the 
thermodynamic stability is that the protein structure becomes more rigid53,55. During storage 
of PEG-INF formulation chemical dissociation of the PEG molecule from the protein (de-
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pegylation) may take place. Once that happens the protein molecule would not be protected 
any more and therefore will denature faster. That would explain the degradation profile of 
some PEG-INF formulations involved in this study. Figure 3.25 shows the monomer loss of 
P-INFF001, as an example of such behaviour, at three different temperatures. At 25°C the 
monomer loss was very slow during the first 6 months and faster during the last 6 months. 
This biphasic denaturation behaviour could be explained by the first de-pegylation step and 
once it happens fast monomer loss takes place. Such behaviour seems to be temperature 
dependent (figure 3.25) seeing that at 4°C approximately no reduction in monomer content is 
noticed where the de-pegylation is not happening or very slow. Increasing the temperature to 
25°C the first step was faster and the second step begun somewhere in the last 6 months while 
at 40°C the first step is very fast and was not detected by the used sampling intervals. The 
suggestion that the first slow step is de-pegylation is supported by the results of SDS-PAGE 
shown above and represented in figure 3.23 where at 40°C formulations showed smearing 
which indicates the presence of free PEG molecule. This smearing was weaker at 25°C and 
almost absent at 4°C proving that de-pegylation is a temperature dependent process in these 
formulations. 
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Figure 3. 25: Monomer loss of P-INFF001 during isothermal stability study at 4°C (–■–), 25°C (–□–) and 
40°C (–∆–). 
During a µDSC measurement samples were heated from room temperature to 80°C. 
Assuming that the theory of de-pegylation is true and that it is a temperature dependent 
process, then it is expected that it will happen during the temperature ramp in the µDSC. This 
means that during the measurement the pegylated protein will be de-pegylated somewhere, 
most probably, before reaching Tm. Accordingly the resulting Tm might come later but the 
unfolding is happening to the naked INF molecule without pegylation. On the other hand, if 
the de-pegylation theory were true, then the denaturation of the PEG-INF molecule at 40°C 
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would be also a denaturation of a naked INF without pegylation and therefore excellently 
predicted with Tm. In contrast, that would not be the case at 4°C where de-pegylation either 
very slow or never takes place. Therefore, predicting the stability of the PEG-INF 
formulations at 4°C was not successful using Tm.  
 
III.2.3.2. Prediction quality: 
Figure 3.26 A and B represent the 50% and 20% prediction, respectively for Tm based ranking 
in predicting physical, chemical and overall stability of 11 PEG-INF formulations at three 
different temperatures (4, 25 and 40°C). Tm was able to predict the stability of PEG-INF 
formulation with higher 50% prediction quality at 40°C regarding all stability rankings (figure 
3.26 A). 20% prediction quality showed that Tm is still able to predict one of the best 2 
formulations in IsoSS at 4°C.  
Based on both correlation coefficients and the “prediction quality” tool Tm was not able to 
predict well the long term stability at 4°C but, in contrast to GCSF and MAB studies,  the best 
prediction was to the stability of the PEG-INF at 40°C. 
 
III.2.4. µDSC in comparison with classical accelerated IsoSS: 
Although predicting the long term stability of PEG-INF formulations at 4°C was not possible 
using Tm based ranking, but selecting the best formulations and excluding the bad ones was 
still possible (figure 3.26) even for the stability at 4°C. 
Therefore, it still makes sense to compare Tm with classical accelerated stability studies in 
predicting the long term stability of PEG-INF at 4°C. Such information is very useful 
especially when a formulator has only few methods to predict the stability of a pegylated 
protein. With this respect, the predictive power of µDSC Tm against classical accelerated 
stability studies was investigated. The IsoSS based rankings after 12 months storage at 25°C 
and after 6 months at 40°C were correlated with the IsoSS based ranking after 12 months at 
4°C and correlation curves are presented in figure 3.27. The predictive power of those 
accelerated stability studies were compared with that of µDSC. Figure 3.28 shows an 
overview of the resulting correlation coefficients. The comparison showed stronger 
correlation with IsoSS at 25°C than both Tm and IsoSS at 40°C. Such behaviour would fit 
with the correlation discussed in the last section as the 1st de-pegylation step at 25°C has the 
closest rate to that at 4°C and both fast Tm determination and higher temperature IsoSS are 
completely uncorrelated with the ranking based on IsoSS at 4°C.  
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(B) 
Figure 3. 26: Reliability of  Tm based ranking to pick up the best 6 formulations and exclude the bad 5 
(50% prediction quality (A)) and to pick up the best 2 and exclude the rest (20% prediction quality (B)) in 
an 11 PEG-INF formulation set.  
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Figure 3.27: Correlation curves of 11 PEG-INF formulations. That includes correlation between rankings 
based on IsoSS at 4°C (Rp4, Rc4 and Rs4) after 12 months, and ranking based on IsoSS at elevated 
temperatures (25 and 40°C) 
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Figure 3. 28: An overview for the correlation coefficients resulting from correlating the IsoSS based 
rankings at 4°C (Rp4, Rc4 and Rs4) (z-axis) with rankings based on either µDSC determined Tm (RTm) or
accelerated stability studies at elevated temperatures (25 and 40°C). 
 
 
Studying the 50% and 20% prediction quality in figures 3.29 A and B, respectively, the 
selection was best made based on IsoSS at 25°C too. But despite the very weak correlation 
coefficients the prediction quality showed the possibility of selecting the best formulations 
based on Tm. Such selection proved to be more successful than a selection based on IsoSS at 
40°C.  
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Figure 3. 29: 50% (A) and 20% (B) prediction quality of µDSC measured Tm and IsoSS at 25°C and 40°C 
in predicting IsoSS at 4°C 
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2. Conclusion:  
µDSC determined Tm was critically evaluated with regards to its predictive power of long 
term stability of three different protein molecules. Those three proteins were considered as 
interesting and relevant candidates for the purpose of the study as each protein represents a 
unique class and shows different stability behaviour. The long term stability of GCSF is 
determined by both chemical and physical effects where pH and salt content of the 
formulation determine the extent of aggregation and chemical degradation. MAB is a protein 
class where physical stability mainly determines its long term stability. PEG-INF is an 
example of a pegylated protein and expected to be stable on long term.  
Even in large groups of formulations, where Tm was not able to predict the exact rank order, 
selecting the good formulations and excluding the bad ones was an excellent approach to 
reduce the work load in long term stability studies. Surprisingly, Tm showed stronger 
correlation and more reliability than routinely applied accelerated stability studies (at 40°C). 
This was even true in the case of PEG-INF where accelerated prediction is generally not 
successful. 
µDSC provided different information about the protein conformational stability. In this study 
each protein showed a different µDSC profile and thus the predictive power was not the same 
for the 3 studied proteins. 
In 24 GCSF formulations, where Tm and unfolding reversibility could be determined, further 
optimization of Tm based ranking by considering the degree of unfolding reversibility did not 
show any significant benefit on predictions. Tm showed superior predictive power, in 
predicting the overall stability ranking especially at 4°C. Moreover, predictive studies based 
on Tm measurements had proved superiority in predicting physical and accordingly overall 
stability ranking to the routinely performed accelerated isothermal stability studies at 40°C. 
Although ranking based on IsoSS at 25°C showed higher correlation coefficients and higher 
prediction quality toward real time stability at 4°C, 9 to 12 months are needed to reach 
predictive results. Predictive studies using µDSC for 24 formulations can be carried out in an 
experimental plan which needs maximum 4 weeks to be done and delivers approximately 
similar correlation coefficients and equal prediction quality compared to IsoSS at 25°C. 
Concerning chemical stability, IsoSS at elevated temperatures (e.g. 40°C) showed 
significantly higher correlation coefficients and higher prediction quality.  
In a µDSC study of 15 MAB formulations three different transitions were determined. 
Selecting the good formulations and excluding the bad ones was very successful based on the 
earliest transition (Tm1) especially for long term stability at 4°C. Predictive studies based on 
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Tm1 measurements had proved superiority in predicting physical stability ranking to the 
routinely performed accelerated isothermal stability studies at elevated temperatures.  
For PEG-INF formulations Tm based ranking was not able to predict the long term stability at 
4°C but selecting the good formulations and excluding the bad ones still did work. Pegylation 
of a protein molecule makes the prediction process much more complicated. This might be 
due to a complex degradation biphasic process where an assumed “de-pegylation” process 
might happen prior to the expected physical denaturation. On the other hand, prediction of the 
accelerated stability at 40°C was excellent using Tm. 
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4. Appendix 3.I: 
Table 3.I. 1: Particle count after isothermal storage of GCSF liquid formulation of DOEa at 4, 25 and 
40°C. 
Formulations Particle range 
4°C 
(20 - 24 months) 
25°C 
(10 months) 
40°C 
(3 months) 
> 1 µm 53 200 463 
> 10 µm 0 4 0 GCSFDa1 
> 25 µm 0 1 0 
> 1 µm 271 682 9493 
> 10 µm 11 36 144 GCSFDa2 
> 25 µm 2 2 10 
> 1 µm 214 340 1078 
> 10 µm 16 29 24 GCSFDa3 
> 25 µm 0 0 3 
> 1 µm 211 227 4778 
> 10 µm 8 3 22 GCSFDa4 
> 25 µm 3 1 0 
> 1 µm 1848 14179 15929 
> 10 µm 6 10 263 GCSFDa5 
> 25 µm 3 1 10 
> 1 µm 448 7811 3156 
> 10 µm 8 511 100 GCSFDa6 
> 25 µm 3 78 0 
> 1 µm 96 292 2477 
> 10 µm 0 11 4 GCSFDa7 
> 25 µm 0 1 0 
> 1 µm 238 299 1234 
> 10 µm 16 3 20 GCSFDa8 
> 25 µm 6 1 2 
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Table 3.I. 2: Particle count after isothermal storage of GCSF liquid formulation of DOEb at 4, 25 and 
40°C. 
Formulations Particle range 
4°C 
(20 months) 
25°C 
(10 months) 
40°C 
(3 months) 
> 1 µm 52 99 56 
> 10 µm 2 2 1 GCSFDb1 
> 25 µm 2 1 0 
> 1 µm 49 158 137 
> 10 µm 4 3 2 GCSFDb2 
> 25 µm 2 1 1 
> 1 µm 183 273 1044 
> 10 µm 3 2 14 GCSFDb3 
> 25 µm 0 0 1 
> 1 µm 91 312 350 
> 10 µm 9 18 6 GCSFDb4 
> 25 µm 1 1 2 
> 1 µm 19910 14704 12009 
> 10 µm 166 320 328 GCSFDb5 
> 25 µm 12 26 168 
> 1 µm 3991 2002 11750 
> 10 µm 169 344 3499 GCSFDb6 
> 25 µm 17 94 2011 
> 1 µm 3041 15871 389 
> 10 µm 12 40 18 GCSFDb7 
> 25 µm 3 3 11 
> 1 µm 14049 9076 6652 
> 10 µm 289 946 57 GCSFDb8 
> 25 µm 12 103 2 
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Table 3.I. 3: Particle count after isothermal storage of GCSF liquid formulation of DOEc at 4, 25 and 
40°C. 
Formulations Particle range 
4°C 
(20 months) 
25°C 
(10 months) 
40°C 
(3 months) 
> 1 µm 699 568 1451 
> 10 µm 6 20 14 GCSFDc1 
> 25 µm 2 7 1 
> 1 µm 826 731 1300 
> 10 µm 8 3 4 GCSFDc2 
> 25 µm 1 1 0 
> 1 µm 1007 857 1836 
> 10 µm 13 18 12 GCSFDc3 
> 25 µm 3 2 0 
> 1 µm 786 1214 989 
> 10 µm 7 10 12 GCSFDc4 
> 25 µm 0 2 0 
> 1 µm 850 373 260 
> 10 µm 63 10 9 GCSFDc5 
> 25 µm 10 3 0 
> 1 µm 4910 2554 8401 
> 10 µm 101 90 119 GCSFDc6 
> 25 µm 10 10 26 
> 1 µm 3232 4554 1599 
> 10 µm 37 47 29 GCSFDc7 
> 25 µm 8 12 7 
> 1 µm 11831 3539 4713 
> 10 µm 266 442 93 GCSFDc8 
> 25 µm 23 28 12 
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Table 3.I. 4: IsoSS ranking of GCSF formulations in DOEa after 10 months storage at 25°C 
Formulations Kp25 R125 Tur.251) R225 
Avr. 
(R125+R225)/2 
Rp25 Kc25 Rc25 
Avr. 
(Rp25+Rc25)/2 
Rs25 
GCSFDa1 -0,0019 1 0.82 1 1 1 -0,0017 2 1,5 1 
GCSFDa2 -0,0388 7 0.7 1 4 4 0,0008 1 2,5 2 
GCSFDa3 -0,0139 4 1.1 6 5 7 -0,0262 7 7 8 
GCSFDa4 -0,0134 3 1.34 6 4.5 5 -0,0236 6 5,5 5 
GCSFDa5 -0,0097 2 0.73 1 1.5 2 -0,0051 4 3 3 
GCSFDa6 -0,0141 5 1.18 6 5.5 8 -0,0026 3 5,5 6 
GCSFDa7 -0,0194 6 0.71 1 3.5 3 -0,0652 8 5,5 7 
GCSFDa8 -0,0393 8 0.95 1 4.5 5 -0,0146 5 5 4 
1) Turbidity in FNU measured at the end of the IsoSS at 25°C 
 
 
Table 3.I. 5: IsoSS ranking of GCSF formulations in DOEa after 3 months storage at 40°C 
Formulations Kp40 R140 Tur.401) R240 
Avr. 
(R140+R240)/2 
Rp40 Kc40 Rc40 
Avr. 
(Rp40+Rc40)/2 
Rs40 
GCSFDa1 -0,0088 1 0.58 1 1 1 -0,0011 1 1 1 
GCSFDa2 -0,0175 2 1.66 3 2.5 2 -0,0331 4 3 3 
GCSFDa3 -0,0764 5 3.24 7 6 7 -0,1593 7 7 7 
GCSFDa4 -0,1081 7 1.6 3 5 5 -0,087 5 5 5 
GCSFDa5 -0,502 8 1.86 3 5.5 6 -0,0318 3 4,5 4 
GCSFDa6 -0,0514 4 0.89 1 2.5 2 -0,0118 2 2 2 
GCSFDa7 -0,1001 6 4.22 8 7 8 -0,1766 8 8 8 
GCSFDa8 -0,0251 3 1.75 3 3 4 -0,1012 6 5 6 
1) Turbidity in FNU measured at the end of the IsoSS at 40°C 
 
 
Table 3.I. 6: IsoSS ranking of GCSF formulations in DOEb after 20 months storage at 4°C 
Formulations Kp4 R14 Tur.41) R24 
Avr. 
(R14+R24)/2 
Rp4 Kc4 Rc4 
Avr. 
(Rp4+Rc4)/2 
Rs4 
GCSFDb1 -0.0003 2 1 5 3.5 3 -0.0056 5 4 3 
GCSFDb2 -0.0001 1 0.7 1 1 1 -0.0012 4 2.5 2 
GCSFDb3 -0.0007 4 0.6 1 2.5 2 -0.00005 1 1.5 1 
GCSFDb4 -0.0011 6 0.8 1 3.5 3 -0.0066 6 4.5 4 
GCSFDb5 -0.0009 5 1.6 5 5 7 -0.0005 2 4.5 4 
GCSFDb6 -0.0006 3 1 5 4 5 -0.0119 8 6.5 7 
GCSFDb7 -0.0017 8 0.8 1 4.5 6 -0.0101 7 6.5 7 
GCSFDb8 -0.0011 6 1.2 5 5.5 8 -0.0011 3 5.5 6 
1) Turbidity in FNU measured at the end of the IsoSS at 4°C 
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Table 3.I. 7: IsoSS ranking of GCSF formulations in DOEb after 10 months storage at 25°C 
Formulations Kp25 R125 Tur.251) R225 
Avr. 
(R125+R225)/2 
Rp25 Kc25 Rc25 
Avr. 
(Rp25+Rc25)/2 
Rs25 
GCSFDb1 -0.016 6 0.48 1 3.5 4 -0.039 7 5.5 6 
GCSFDb2 0.001 1 0.55 1 1 1 -0.006 2 1.5 1 
GCSFDb3 -0.005 4 0.52 1 2.5 2 -0.004 1 1.5 1 
GCSFDb4 -0.015 5 0.49 1 3 3 -0.030 5 4 3 
GCSFDb5 -0.003 2 2.94 7 4.5 5 -0.007 3 4 3 
GCSFDb6 -0.027 8 1.28 5 6.5 8 -0.048 8 8 8 
GCSFDb7 -0.017 7 1.28 5 6 7 -0.033 6 6.5 7 
GCSFDb8 -0.003 3 2.92 7 5 6 -0.008 4 5 5 
1) Turbidity in FNU measured at the end of the IsoSS at 25°C 
 
 
Table 3.I. 8: IsoSS ranking of GCSF formulations in DOEb after 3 months storage at 40°C 
Formulations Kp40 R140 Tur.401) R240 
Avr. 
(R140+R240)/2 
Rp40 Kc40 Rc40 
Avr. 
(Rp40+Rc40)/2 
Rs40 
GCSFDb1 -0.103 3 1.87 3 3 3 -0.243 6 4.5 3 
GCSFDb2 -0.021 1 0.61 1 1 1 -0.030 1 1 1 
GCSFDb3 -0.040 2 1.17 3 2.5 2 -0.038 2 2 2 
GCSFDb4 -0.136 4 1.19 3 3.5 4 -0.239 5 4.5 3 
GCSFDb5 -0.163 6 1.79 3 4.5 6 -0.167 3 4.5 3 
GCSFDb6 -0.718 8 14.25 8 8 8 -0.610 8 8 8 
GCSFDb7 -0.608 7 0.61 1 4 5 -0.540 7 6 7 
GCSFDb8 -0.156 5 3.71 7 6 7 -0.168 4 5.5 6 
1) Turbidity in FNU measured at the end of the IsoSS at 40°C 
 
 
Table 3.I. 9: IsoSS ranking of GCSF formulations in DOEc after 20 months storage at 4°C 
Formulations Kp4 R14 Tur.41) R24 
Avr. 
(R14+R24)/2 
Rp4 Kc4 Rc4 
Avr. 
(Rp4+Rc4)/2 
Rs4 
GCSFDc1 -0.0387 7 0.7 1 4 5 0.0003 2 3.5 3 
GCSFDc2 -0.0005 2 1.1 4 3 2 0.0004 1 1.5 1 
GCSFDc3 0.00004 1 0.9 1 1 1 -0.0002 4 2.5 2 
GCSFDc4 -0.0377 5 0.7 1 3 2 -0.0005 6 4 4 
GCSFDc5 -0.0011 3 1.1 4 3.5 4 -0.0004 5 4.5 5 
GCSFDc6 -0.0383 6 2.9 7 6.5 8 -0.0005 7 7.5 8 
GCSFDc7 -0.0398 8 1.6 4 6 6 0.0003 3 4.5 5 
GCSFDc8 -0.0021 4 5.2 8 6 6 -0.0006 8 7 7 
1) Turbidity in FNU measured at the end of the IsoSS at 4°C 
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Table 3.I. 10: IsoSS ranking of GCSF formulations in DOEc after 10 months storage at 25°C 
Formulations Kp25 R125 Tur.251) R225 
Avr. 
(R125+R225)/2 
Rp25 Kc25 Rc25 
Avr. 
(Rp25+Rc25)/2 
Rs25 
GCSFDc1 -0.015 7 0.65 1 4 5 0.000 2 3.5 3 
GCSFDc2 -0.011 4 0.62 1 2.5 4 0.001 1 2.5 1 
GCSFDc3 -0.003 1 0.52 1 1 1 -0.002 4 2.5 1 
GCSFDc4 -0.009 3 0.76 1 2 3 -0.003 7 5 6 
GCSFDc5 -0.006 2 0.51 1 1.5 2 -0.002 6 4 4 
GCSFDc6 -0.018 8 1.17 6 7 8 -0.002 4 6 7 
GCSFDc7 -0.014 5 1.8 6 5.5 6 0.000 3 4.5 5 
GCSFDc8 -0.014 5 3.32 8 6.5 7 -0.004 8 7.5 8 
1) Turbidity in FNU measured at the end of the IsoSS at 25°C 
 
 
 
Table 3.I. 11: IsoSS ranking of GCSF formulations in DOEc after 3 months storage at 40°C 
Formulations Kp40 R140 Tur.401) R240 
Avr. 
(R140+R240)/2 
Rp40 Kc40 Rc40 
Avr. 
(Rp40+Rc40)/2 
Rs40 
GCSFDc1 -0.038 5 0.69 1 3 3 -0.011 1 2 2 
GCSFDc2 -0.035 3 1.04 4 3.5 4 -0.020 5 4.5 5 
GCSFDc3 -0.028 2 0.94 1 1.5 1 -0.013 2 1.5 1 
GCSFDc4 -0.039 6 0.82 1 3.5 4 -0.014 3 3.5 4 
GCSFDc5 -0.020 1 1.53 4 2.5 2 -0.016 4 3 3 
GCSFDc6 -0.045 7 1.23 4 5.5 6 -0.036 7 6.5 6 
GCSFDc7 -0.037 4 9.91 8 6 7 -0.029 6 6.5 6 
GCSFDc8 -0.069 8 1.04 4 6 7 -0.059 8 7.5 8 
1) Turbidity in FNU measured at the end of the IsoSS at 40°C 
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Table 3.I. 12: IsoSS ranking of 24 GCSF formulations (DOEa, DOEb and DOEc) after 20 months storage 
at 4°C 
Formulations Kp4 R14 Tur.41) R24 
Avr. 
(R14+R24)/2 
Rp4 Kc4 Rc4 
Avr. 
(Rp4+Rc4)/2 
Rs4 
GCSFDa1 0.0027 1 0.8 1 1 1 0.0001 5 3 1 
GCSFDa2 -0.0447 22 0.62 1 11.5 16 0.0023 1 8.5 6 
GCSFDa3 -0.0125 16 0.96 1 8.5 9 -0.033 24 16.5 19 
GCSFDa4 -0.0498 23 1.1 13 18 21 -0.0031 18 19.5 24 
GCSFDa5 0.002 2 0.98 1 1.5 2 -0.0003 9 5.5 2 
GCSFDa6 -0.0574 24 2.6 22 23 24 0.0001 6 15 16 
GCSFDa7 -0.0023 15 0.8 1 8 8 -0.0252 23 15.5 17 
GCSFDa8 -0.0381 18 1.47 13 15.5 19 -0.0018 17 18 21 
GCSFDb1 -0.0003 5 1 13 9 10 -0.0056 19 14.5 15 
GCSFDb2 -0.0001 4 0.7 1 2.5 4 -0.0012 16 10 8 
GCSFDb3 -0.0007 8 0.6 1 4.5 5 -0.00005 7 6 4 
GCSFDb4 -0.0011 10 0.8 1 5.5 6 -0.0066 20 13 11 
GCSFDb5 -0.0009 9 1.6 13 11 15 -0.0005 11 13 11 
GCSFDb6 -0.0006 7 1 13 10 13 -0.0119 22 17.5 20 
GCSFDb7 -0.0017 13 0.8 1 7 7 -0.0101 21 14 13 
GCSFDb8 -0.0011 10 1.2 13 11.5 16 -0.0011 15 15.5 17 
GCSFDc1 -0.0387 20 0.7 1 10.5 14 0.0003 3 8.5 6 
GCSFDc2 -0.0005 6 1.1 13 9.5 12 0.0004 2 7 5 
GCSFDc3 0.00004 3 0.9 1 2 3 -0.0002 8 5.5 2 
GCSFDc4 -0.0377 17 0.7 1 9 10 -0.0005 12 11 9 
GCSFDc5 -0.0011 12 1.1 13 12.5 18 -0.0004 10 14 13 
GCSFDc6 -0.0383 19 2.9 22 20.5 23 -0.0005 13 18 21 
GCSFDc7 -0.0398 21 1.6 13 17 20 0.0003 4 12 10 
GCSFDc8 -0.0021 14 5.2 24 19 22 -0.0006 14 18 21 
1) Turbidity in FNU measured at the end of the IsoSS at 4°C 
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Table 3.I. 13: IsoSS ranking of 24 GCSF formulations (DOEa, DOEb and DOEc) after 10 months storage 
at 25°C 
Formulations Kp25 R125 Tur.251) R225 
Avr. 
(R125+R225)/2 
Rp25 Kc25 Rc25 
Avr. 
(Rp25+Rc25)/2 
Rs25 
GCSFDa1 -0.0019 2 0.82 1 1.5 2 -0,0017 5 3,5 1 
GCSFDa2 -0.0388 23 0.7 1 12 13 0,0008 1 7 6 
GCSFDa3 -0.0139 14 1.1 15 14.5 19 -0,0262 19 19 22 
GCSFDa4 -0.0134 11 1.34 15 13 15 -0,0236 18 16,5 17 
GCSFDa5 -0.0097 9 0.73 1 5 7 -0,0051 13 10 10 
GCSFDa6 -0.0141 15 1.18 15 15 20 -0,0026 9 14,5 12 
GCSFDa7 -0.0194 21 0.71 1 11 12 -0,0652 24 18 21 
GCSFDa8 -0.0393 24 0.95 1 12.5 14 -0,0146 17 15,5 16 
GCSFDb1 -0.016 18 0.48 1 9.5 11 -0,0389 22 16,5 18 
GCSFDb2 0.0014 1 0.55 1 1 1 -0,0056 14 7,5 7 
GCSFDb3 -0.0049 6 0.52 1 3.5 4 -0,004 11 7,5 8 
GCSFDb4 -0.0147 16 0.49 1 8.5 9 -0,0298 20 14,5 13 
GCSFDb5 -0.0031 4 2.94 22 13 15 -0,0069 15 15 15 
GCSFDb6 -0.0272 22 1.28 15 18.5 24 -0,0476 23 23,5 24 
GCSFDb7 -0.0166 19 1.28 15 17 21 -0,0328 21 21 23 
GCSFDb8 -0.0032 5 2.92 22 13.5 17 -0,0081 16 16,5 19 
GCSFDc1 -0.0147 16 0.65 1 8.5 9 0,00008 3 6 4 
GCSFDc2 -0.0109 10 0.62 1 5.5 8 0,0005 2 5 3 
GCSFDc3 -0.0025 3 0.52 1 2 3 -0,0017 6 4,5 2 
GCSFDc4 -0.0088 8 0.76 1 4.5 6 -0,0026 10 8 9 
GCSFDc5 -0.0059 7 0.51 1 4 5 -0,0023 8 6,5 5 
GCSFDc6 -0.018 20 1.17 15 17.5 22 -0,0017 7 14,5 14 
GCSFDc7 -0.0138 12 1.8 15 13.5 17 -0,0003 4 10,5 11 
GCSFDc8 -0.0138 12 3.32 24 18 23 -0,004 12 17,5 20 
1) Turbidity in FNU measured at the end of the IsoSS at 25°C 
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Table 3.I. 14: IsoSS ranking of 24 GCSF formulations (DOEa, DOEb and DOEc) after 3 months storage at 
40°C 
Formulations Kp40 R140 Tur.401) R240 
Avr. 
(R140+R240)/2 
Rp40 Kc40 Rc40 
Avr. 
(Rp40+Rc40)/2 
Rs40 
GCSFDa1 -0.0088 1 0.58 1 1 1 -0,0011 1 1 1 
GCSFDa2 -0.0175 2 1.66 8 5 4 -0,0331 11 7,5 8 
GCSFDa3 -0.0764 15 3.24 20 17.5 21 -0,1593 17 19 20 
GCSFDa4 -0.1081 18 1.6 8 13 16 -0,087 15 15,5 16 
GCSFDa5 -0.502 22 1.86 8 15 19 -0,0318 10 14,5 15 
GCSFDa6 -0.0514 13 0.89 1 7 9 -0,0118 3 6 6 
GCSFDa7 -0.1001 16 4.22 22 19 22 -0,1766 20 21 22 
GCSFDa8 -0.0251 5 1.75 8 6.5 8 -0,1012 16 12 10 
GCSFDb1 -0.1027 17 1.87 8 12.5 15 -0,2434 22 18,5 18 
GCSFDb2 -0.0205 4 0.61 1 2.5 2 -0,0303 9 5,5 4 
GCSFDb3 -0.0399 11 1.17 8 9.5 11 -0,0384 13 12 11 
GCSFDb4 -0.1359 19 1.19 8 13.5 17 -0,2393 21 19 21 
GCSFDb5 -0.1627 21 1.79 8 14.5 18 -0,1672 18 18 17 
GCSFDb6 -0.7183 24 14.25 24 24 24 -0,6095 24 24 24 
GCSFDb7 -0.608 23 0.61 1 12 14 -0,5401 23 18,5 19 
GCSFDb8 -0.1562 20 3.71 20 20 23 -0,1681 19 21 23 
GCSFDc1 -0.0378 9 0.69 1 5 4 -0,011 2 3 2 
GCSFDc2 -0.035 7 1.04 8 7.5 10 -0,01996 7 8,5 9 
GCSFDc3 -0.0277 6 0.94 1 3.5 3 -0,0131 4 3,5 3 
GCSFDc4 -0.0393 10 0.82 1 5.5 6 -0,0138 5 5,5 5 
GCSFDc5 -0.0197 3 1.53 8 5.5 6 -0,0155 6 6 7 
GCSFDc6 -0.0446 12 1.23 8 10 12 -0,0355 12 12 12 
GCSFDc7 -0.0369 8 9.91 23 15.5 20 -0,0293 8 14 14 
GCSFDc8 -0.0692 14 1.04 8 11 13 -0,0586 14 13,5 13 
1) Turbidity in FNU measured at the end of the IsoSS at 40°C 
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Table 3.I. 15: Ranking procedures for 11 MAB formulation based on 
 IsoSS at 25°C after 12 months 
Formulation Kp25 R125 R2251) 
Avr. 
(R14+R24)/2 
Rp25 
MABF001 -0.0041 11 1 6 11 
MABF002 -0.0005 4 1 2.5 4 
MABF003 -0.0003 3 1 2 3 
MABF004 -0.00003 2 1 1.5 2 
MABF005 0.0003 1 1 1 1 
MABF006 -0.0013 8 1 4.5 8 
MABF007 -0.0005 4 1 2.5 4 
MABF008 -0.0007 7 1 4 6 
MABF009 -0.0006 6 2 4 6 
MABF010 -0.0013 8 1 4.5 8 
MABF011 -0.0014 10 1 5.5 10 
1) Ranking based on light blockage measured particle count  (table 3.I.18) 
 
 
 
 
 
Table 3.I. 16: Ranking procedures for 11 MAB formulation based on 
 IsoSS at 40°C after 12 months 
Formulation Kp40 R140 R2401) 
Avr. 
(R14+R24)/2 
Rp40 
MABF001 -0.0214 11 1 6 10 
MABF002 -0.0121 7 1 4 7 
MABF003 -0.0105 4 2 3 4 
MABF004 -0.0128 8 1 4.5 8 
MABF005 -0.0099 2 1 1.5 1 
MABF006 -0.0178 10 2 6 10 
MABF007 -0.0134 9 2 5.5 9 
MABF008 -0.0093 1 2 1.5 1 
MABF009 -0.0102 3 2 2.5 3 
MABF010 -0.0113 5 1 3 4 
MABF011 -0.0115 6 1 3.5 6 
1) Ranking based on light blockage measured particle count (table 3.I.18) 
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Table 3.I. 17: Ranking procedures for 15 MAB formulation based on 
 IsoSS at 40°C after 6 months 
Formulation Kp40 R140 R2401) 
Avr. 
(R14+R24)/2 
Rp40 
MABF001 -0.0316 14 1 7.5 13 
MABF002 -0.0178 12 2 7 11 
MABF003 -0.0143 5 1 3 5 
MABF004 -0.0128 4 1 2.5 4 
MABF005 -0.0127 3 1 2 3 
MABF006 -0.0226 13 1 7 12 
MABF007 -0.0161 8 1 4.5 7 
MABF008 -0.015 6 2 4 6 
MABF009 -0.0155 7 2 4.5 8 
MABF010 -0.0101 2 1 1.5 1 
MABF011 -0.0089 1 2 1.5 2 
MABF012 -0.0171 10 2 6 10 
MABF013 -0.0168 9 2 5.5 9 
MABF014 -0.0174 11 4 7.5 14 
MABF015 -0.163 15 3 9 15 
1) Ranking based on light blockage measured particle count  (table 3.I.18) 
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Table 3.I. 18: Particle count for 15 MAB formulations after isothermal storage at 4, 25 and 40°C  
Formulations Particle range 
4°C 
(12 mon.) R24 
25°C 
(12mon.) R225 
40°C 
(12 mon.) R240 
40°C 
(6 mon.) 
R240 
(6mon.) 
> 1 µm 1080 1 1870 1 2935 1 1950 1 
> 10 µm 50  110  80  5  MABF001 
> 25 µm 50  90  55  0  
> 1 µm 6390 1 2310 1 7060 1 13810 2 
> 10 µm 220  290  385  220  MABF002 
> 25 µm 80  250  255  10  
> 1 µm 3680 1 6380 1 16180 2 8620 1 
> 10 µm 105  380  1095  220  MABF003 
> 25 µm 95  300  490  10  
> 1 µm 1765 1 630 1 2100 1 785 1 
> 10 µm 150  50  230  5  MABF004 
> 25 µm 110  35  130  0  
> 1 µm 1720 1 2510 1 5770 1 2350 1 
> 10 µm 50  40  215  15  MABF005 
> 25 µm 5  15  90  0  
> 1 µm 2960 1 3570 1 15220 2 5230 1 
> 10 µm 70  80  540  15  MABF006 
> 25 µm 35  20  285  5  
> 1 µm 4855 1 3780 1 12590 2 5045 1 
> 10 µm 90  160  405  65  MABF007 
> 25 µm 35  60  255  0  
> 1 µm 6845 1 2770 1 16200 2 10255 2 
> 10 µm 205  155  210  160  MABF008 
> 25 µm 110  95  50  10  
> 1 µm 2065 1 25445 2 91480 2 46430 2 
> 10 µm 120  240  465  380  MABF009 
> 25 µm 60  85  110  15  
> 1 µm 3785 1 5600 1 4955 1 9160 1 
> 10 µm 10  10  650  70  MABF010 
> 25 µm 0  0  35  15  
> 1 µm 805 1 4000 1 6690 1 11910 2 
> 10 µm 30  20  195  250  MABF011 
> 25 µm 5  0  35  145  
> 1 µm       92055 2 
> 10 µm       390  MABF012 
> 25 µm       0  
> 1 µm       80335 2 
> 10 µm       280  MABF013 
> 25 µm       55  
> 1 µm       565055 4 
> 10 µm       9390  MABF014 
> 25 µm       780  
> 1 µm       173055 3 
> 10 µm       4500  MABF015 
> 25 µm       335  
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Table 3.I. 19: Ranking procedures for 11 PEG-INF formulations based on IsoSS at 25°C after 12 months 
Formulation Kp25 R R
(
125 R2251) 
Avr. 
(R125+R225)/2 
Rp25 Kc25 c25 
Avr. 
Rp25+Rc25)/2 
Rs25 
P-INFF001 -0,0757 11 1 1 6 10 0,0039 5,5 4 
P-INFF002 -0,0432 10 7 
3 
8 
5 
6 
4 
1 
10 
11 
9 
2 6 10 -0,0032 8,5 10 
P-INFF003 -0,0005 1 1 1 1 -0,0005 2 1 
P-INFF004 -0,0032 4 1 2,5 4 -0,0045 6 5 
P-INFF006 -0,0087 8 1 4,5 8 -0,0016 6,5 6 
P-INFF007 -0,0022 2 1 1,5 2 -0,0031 4 3 
P-INFF008 -0,0185 9 1 5 9 -0,0008 6,5 6 
P-INFF009 -0,0031 3 1 2 3 0,0032 2 1 
P-INFF010 -0,0057 7 1 4 7 -0,0112 8,5 10 
P-INFF012 -0,0037 5 1 3 5 -0,0161 8 9 
P-INFF014 -0,0043 6 1 3,5 6 -0,0089 7,5 8 
1) Ranking based on light blockage measured particle count (table 3.I.22) 
 
 
 
 
 
Table 3.I. 20: Ranking procedures for 11 PEG-INF formulations based on IsoSS at 40°C after 6 months 
Formulation Kp40 R R
(
140 R2401) 
Avr. 
(R140+R240)/2 
Rp40 Kc40 c40 
Avr. 
Rp40+Rc40)/2 
Rs40 
P-INFF001 - -2 11 0,8582 11 2 6,5 11 11 11 
P-INFF002 - - 9 
- - 5 
- - 8 
- - 3 
- - 7 
- - 4 
- - 1 
- - 6 
- - 10 
- - 2 
0,1245 10 1 5,5 9 0,1456 9 9 
P-INFF003 0,0435 7 2 4,5 7 0,0511 6 7 
P-INFF004 0,06 8 2 5 8 0,0686 8 8 
P-INFF006 0,0392 3 1 2 3 0,0489 3 3 
P-INFF007 0,0341 2 1 1,5 1 0,0531 4 4 
P-INFF008 0,0324 1 2 1,5 1 0,0496 2,5 1 
P-INFF009 0,0394 4 2 3 4 0,0456 2,5 1 
P-INFF010 0,0412 5 1 3 4 0,0529 5 6 
P-INFF012 0,111 9 2 5,5 9 0,1514 9,5 10 
P-INFF014 0,0412 5 2 3,5 6 0,0486 4 4 
1) Ranking based on light blockage measured particle count (table 3.I.22) 
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Table 3.I. 21: Ranking procedures for 14 PEG-INF formulations based on IsoSS at 40°C after 6 months 
Formulation Kp40 R R
(
140 R2401) 
Avr. 
(R140+R240)/2 
Rp40 Kc40 c40 
Avr. 
Rp40+Rc40)/2 
Rs40 
P-INFF001 -0,8582 14 14 1 7,5 14 -2 14 14 
P-INFF002 -0,1245 13 12 
5 
11 
10 
3 
7 
4 
1 
6 
10 8 
12 13 
11 9 
2 
1 7 13 -0,1456 12,5 12 
P-INFF003 -0,0435 7 1 4 7 -0,0511 6 7 
P-INFF004 -0,06 9 1 5 9 -0,0686 10 10 
P-INFF005 -0,0572 8 1 4,5 8 -0,0672 9 8 
P-INFF006 -0,0392 3 1 2 3 -0,0489 3 3 
P-INFF007 -0,0341 2 1 1,5 2 -0,0531 4,5 5 
P-INFF008 -0,0324 1 1 1 1 -0,0496 2,5 1 
P-INFF009 -0,0394 4 1 2,5 4 -0,0456 2,5 1 
P-INFF010 -0,0412 5 1 3 5 -0,0529 5,5 6 
P-INFF011 -0,0628 1 5,5 10 -0,0599 9 8 
P-INFF012 -0,111 1 6,5 12 -0,1514 12,5 12 
P-INFF013 -0,0633 1 6 11 -0,0629 10 10 
P-INFF014 -0,0412 6 1 3,5 6 -0,0486 4 4 
1) Ranking based on light blockage measured particle count (table 3.I.22) 
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Table 3.I. 22: Particle count for 14 PEG-INF formulations after isothermal storage at 4, 25 and 40°C 
 
Formulations Particle range 
4°C 
(12 mon.) R24 
25°C 
(12mon.) R225 
40°C 
(6 mon.) R240 
> 1 µm 1333 1 9178 1 203 1 
> 10 µm 33  89  8  P-INFF001 
> 25 µm 11  22  1  
> 1 µm 1233 1 17144 2 152 1 
> 10 µm 44  78  4  P-INFF002 
> 25 µm 11  0  0  
> 1 µm 4156 1 2378 1 288 1 
> 10 µm 44  367  7  P-INFF003 
> 25 µm 0  33  2  
> 1 µm 2044 1 1311 1 310 1 
> 10 µm 44  22  6  P-INFF004 
> 25 µm 0  11  1  
> 1 µm     4700 1 
> 10 µm     22  P-INFF005 
> 25 µm     11  
> 1 µm 722 1 544 1 378 1 
> 10 µm 22  33  4  P-INFF006 
> 25 µm 0  0  0  
> 1 µm 1189 1 2756 1 204 1 
> 10 µm 44  56  2  P-INFF007 
> 25 µm 11  0  0  
> 1 µm 1744 1 2933 1 773 1 
> 10 µm 33  22  8  P-INFF008 
> 25 µm 11  11  2  
> 1 µm 2056 1 1933 1 311 1 
> 10 µm 33  44  6  P-INFF009 
> 25 µm 0  0  2  
> 1 µm 2222 1 2344 1 358 1 
> 10 µm 111  144  6  P-INFF010 
> 25 µm 11  22  0  
> 1 µm     3044 1 
> 10 µm     33  P-INFF011 
> 25 µm     0  
> 1 µm 3011 1 1400 1 221 1 
> 10 µm 22  11  2  P-INFF012 
> 25 µm 0  0  1  
> 1 µm     7422 1 
> 10 µm     22  P-INFF013 
> 25 µm     0  
> 1 µm 4111 1 3156 1 997 1 
> 10 µm 233  44  12  P-INFF014 
> 25 µm 11  11  7  
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5.  Appendix 3.II: 
DOEa Zero Time     DOEa 4°C (20-24 months)*  
       
GCSFDa1       2       3         4         5        6          7           8 GCSFDa1           3           4            5           6             7            8   
* GCSFDa2 was not analyzed after 9 months and not included in the gel 
 
        
GCSFDb1     2         3         4         5           6           7          8 
DOEb Zero Time 
GCSFDb1       2          3         4          5           6          7          8 
    DOEb 4°C (20 months) 
 
     
GCSFDc1          2          3        4          5          6        7            8 
DOEc Zero Time 
GCSFDc1          2          3        4          5           6         7           8 
    DOEc 4°C (20 months) 
Figure 3.II. 1: SDS-PAGE for GCSF formulations of DOEa, DOEb and DOEc before and after storage at 
4 °C for 20 – 24 months.   
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Figure 3.II. 2: Correlation curves of GCSF formulations in DOEa. That includes correlation between RTm 
(ranking based on Tm) or RopTm (ranking after optimization of RTm using the degree of unfolding 
reversibility), and physical, chemical or overall stabilities (Rp, Rc and Rs, respectively) of the formulations 
at 4°C.  
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Figure 3.II. 3: Correlation curves of GCSF formulations in DOEa. That includes correlation between RTm 
(ranking based on Tm) or RopTm (ranking after optimization of RTm using the degree of unfolding 
reversibility), and physical, chemical or overall stabilities (Rp, Rc and Rs, respectively) of the formulations 
at 25°C.  
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Figure 3.II. 4: Correlation curves of GCSF formulations in DOEa. That includes correlation between RTm 
(ranking based on Tm) or RopTm (ranking after optimization of RTm using the degree of unfolding 
reversibility), and physical, chemical or overall stabilities (Rp, Rc and Rs, respectively) of the formulations 
at 40°C.  
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Figure 3.II. 5: Correlation curves of GCSF formulations in DOEb. That includes correlation between RTm 
(ranking based on Tm) and physical, chemical or overall stabilities (Rp, Rc and Rs, respectively) of the 
formulations at 4°C.  
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Figure 3.II. 6: Correlation curves of GCSF formulations in DOEb. That includes correlation between RTm 
(ranking based on Tm) and physical, chemical or overall stabilities (Rp, Rc and Rs, respectively) of the
formulations at 25°C. 
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Figure 3.II. 7: Correlation curves of GCSF formulations in DOEb. That includes correlation between RTm 
(ranking based on Tm) and physical, chemical or overall stabilities (Rp, Rc and Rs, respectively) of the
formulations at 40°C. 
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Figure 3.II. 8: Correlation curves of GCSF formulations in DOEc. That includes correlation between RTm 
(ranking based on Tm) or RopTm (ranking after optimization of RTm using the degree of unfolding 
reversibility), and physical, chemical or overall stabilities (Rp, Rc and Rs, respectively) of the formulations 
at 4°C.  
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Figure 3.II. 9: Correlation curves of GCSF formulations in DOEc. That includes correlation between RTm 
(ranking based on Tm) or RopTm (ranking after optimization of RTm using the degree of unfolding 
reversibility), and physical, chemical or overall stabilities (Rp, Rc and Rs, respectively) of the formulations 
at 25°C.  
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Figure 3.II. 10: Correlation curves of GCSF formulations in DOEc. That includes correlation between 
RTm (ranking based on Tm) or RopTm (ranking after optimization of RTm using the degree of unfolding 
reversibility), and physical, chemical or overall stabilities (Rp, Rc and Rs, respectively) of the formulations 
at 40°C.  
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Figure 3.II. 11: Correlation curves of 24 GCSF formulations in DOEa, DOEb and DOEc. That includes 
correlation between RTm (ranking based on Tm) or RopTm (ranking after optimization of RTm using the 
degree of unfolding reversibility), and physical, chemical or overall stabilities (Rp, Rc and Rs, respectively) 
of the formulations at 4°C.  
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Figure 3.II. 12: Correlation curves of 24 GCSF formulations in DOEa, DOEb and DOEc. That includes 
correlation between RTm (ranking based on Tm) or RopTm (ranking after optimization of RTm using the
degree of unfolding reversibility), and physical, chemical or overall stabilities (R
 
p, Rc and Rs, respectively) 
of the formulations at 25°C. 
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Figure 3.II. 13: Correlation curves of 24 GCSF formulations in DOEa, DOEb and DOEc. That includes 
correlation between RTm (ranking based on Tm) or RopTm (ranking after optimization of RTm using the
degree of unfolding reversibility), and physical, chemical or overall stabilities (R
 
p, Rc and Rs, respectively) 
of the formulations at 40°C. 
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Figure 3.II. 14: Correlation curves of 24 GCSF formulations in DOEa, DOEb and DOEc. That includes 
correlation between ranking based on IsoSS at 4°C (Rp4, Rc4 and Rs4) and ranking based on different
IsoSS at 25°C (R
 
 p25, Rc25 and Rs25) and at 40°C (Rp40, Rc40 and Rs40). 
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Figure 3.II. 15: SDS-PAGE for the whole 15 MAB formulations at the beginning (A) of the IsoSS and after 
12 months storage at 4°C (B) and 25°C (C) and 40°C (D) for 11 MAB formulations and after 6 months 
storage at 40°C for 4 MAB formulations (E).  
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Figure 3.II. 16: IEF for the whole 15 MAB formulations at the beginning (A) of the IsoSS and after 12 
months storage at 4°C (B) and 25°C (C) and 40°C (D) for 11 MAB formulations and after 6 months 
storage at 40°C for 4 MAB formulations (E).  
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Figure 3.II. 17: Correlation curves of 11 PEG-INF formulations. That includes correlation between Tm 
based ranking (RTm) and rankings based on IsoSS at 4°C (Rp4, Rc4 and Rs4) after 12 months 
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Figure 3.II. 18: Correlation curves of 11 PEG-INF formulations. That includes correlation between Tm 
based ranking (RTm) and rankings based on IsoSS at 25°C (Rp25, Rc25 and Rs25) after 12 months 
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Figure 3.II. 19: Correlation curves of 11 PEG-INF formulations. That includes correlation between Tm 
based ranking (RTm) and rankings based on IsoSS at 40°C (Rp40, Rc40 and Rs40) after 6 months 
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Figure 3.II. 20: Correlation curves of 14 PEG-INF formulations. That includes correlation between Tm 
based ranking (RTm) and rankings based on IsoSS at 40°C (Rp40, Rc40 and Rs40) after 6 months 
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Chapter 4 
 
Other strategies for the prediction of long term stability of GCSF liquid 
formulations 
 
1. Introduction: 
As mentioned before proteins undergo many degradation pathways mainly physical or 
chemical. The main degradation pathway for protein is, as considered in most cases, physical 
denaturation and aggregates formation. In fact such assumption should be justified according 
to each individual protein. The extent to which either physical or chemical stability is 
involved in overall stability can vary from one protein molecule to another. Furthermore, 
stabilizing excipients may affect the protein degradation either through chemical, physical or 
even both mechanisms. In the last chapter a systematic study to evaluate the predictive power 
of Tm (measured by µDSC) as a stability marker for three different proteins was presented. 
That was furthermore evaluated in comparison to the predictive power of the classical 
accelerated stability studies where Tm proved to be more powerful in predicting long term 
physical stability. On the other hand classical accelerated stability studies showed higher 
power in predicting chemical stability. 
Other methods to predict stability are also used in protein formulation development. Such 
methods aim mainly to determine the protein unfolding temperature(Tm) based on 
spectroscopic measurements. Those include Fourier transform infrared spectroscopy (FTIR), 
2nd derivative UV spectroscopy, circular dichroism and fluorescence spectroscopy 1-4. 
Predictive studies with such techniques are not published intensively. However, all such 
studies evaluate either µDSC or spectroscopic Tms depending on comparing Tms with 
accelerated stability data.  
In this chapter 16 GCSF formulations were selected to evaluate the predictive power of other 
strategies. Both isothermal stability data at 40°C and µDSC Tms determined in the previous 
work were used and added to that Tm measurements from both FTIR and 2nd derivative UV 
spectroscopy. Moreover, we developed a new method where the temperature at which 50% of 
GCSF monomer is denatured was measured by non-isothermal strategies. All the above 
mentioned methods were tested for their predictive power of the isothermal stability study at 
4°C. 
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2. Materials and methods: 
2.1. Materials: 
Granulocyte Colony stimulating factor (GCSF) was obtained as a gift from Roche diagnostics 
GmbH (D-Penzberg). All other materials and solvent were of analytical grade. Deionised 
double-distilled water was used throughout the study. 
 
2.2. Formulations: 
In the present work we have selected 16 GCSF formulations from the previously, in chapter 3 
part I, studied set to evaluate other high throughput stability predictive strategies. The 
formulations were included in 2 designs of experiments (DOE), DOEb and DOEc, which are 
already presented in chapter 3, page 55, in tables 3.2 and 3.3, respectively. The effect of 
acetate and citrate buffers in different concentrations, different pH values, and the effect of 
different concentrations of Tween 80 or HPBCD were studied. These 2 DOEs were designed 
as fractional factorial designs based on the partition of a 24 full factorial design using the (-1) 
generator form the third order interaction (-ABCD)5. 
GCSF was obtained in Phosphate buffer 20 mM at pH 4 with a concentration of 4.2 mg/ml. 
The original solution was dialyzed using Slide-A-LyzerR Dialysis Cassette 2000 MWCO, 12-
30 ml Capacity (Pierce, Rockford, USA), to remove the buffer salt. After dialysis the sample 
concentration was examined using an Uvikon 810 UV spectrophotometer (Tegimenta, 
Rotkreutz, Switzerland.). To the dialyzed stock the intended buffer salt and excipients were 
added and the final GCSF concentration was adjusted to 0.2 mg/ml for 2nd derivative UV 
spectroscopic measurements, and for the non-isothermal accelerated stability study. For FTIR 
measurements the final concentration was adjusted to 2 mg/ml. The final pH of the sample 
was adjusted and rechecked with a Mettler Toledo MP220 pH meter (Mettler-Toledo GmbH, 
Schwezenbach, Switzerland). After preparation all formulations were filtered through low 
protein binding syringe filters (25 mm, 0.2 µm, polyvinylidenefluoride (PVDF) membrane, 
Pall Corporation, MI, USA). A reference for each formulation containing the same buffer and 
the same excipients was also prepared and filtered using cellulose acetate disk filters, 0.2 µm 
pore size (VWR international, USA).  
 
2.3. Fourier Transform Infrared Spectroscopy (FTIR): 
The temperature-induced changes in the secondary structure of GCSF were monitored by 
attenuated total reflection (ATR)-FTIR, using Bio-ART unit. The spectra were collected in the 
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wave-number range from of 4000 to 850 cm-1. The temperature was ramped according to 
thermal profile of each formula as revealed from µDSC previous measurements. Generally the 
temperature range was between 20-80°C. The secondary structure was monitored in closer 
intervals near µDSC Tm.   
Before recording the spectrum the cell was equilibrated for 60 seconds. Each spectrum was 
obtained with 120 scans at a resolution of 4cm-1. The protein spectra were automatically 
background corrected by the buffer spectra at the respective temperature. The adsorption 
spectra were further processed by vector-normalisation. Afterwards, the second derivatives 
were calculated and again vector-normalised (OPUS, Bruker Optik, Ettlingen, Germany). 
Figure 4.1 A shows the vector normalized 2nd derivative spectra for one of the tested 
formulations (GCSFDb1) in a temperature range of 20 to 80°C. Different interpretation 
methods are available in the literature to extract the unfolding temperature (TmFTIR) from the 
spectral changes 4. Plotting the intensities of the increasing  β-sheet band at 1620 cm-1 
(TmFTIR1 in figure 4.1 B), Plotting the intensities of the decreasing α-helix band at 1655 cm-1 
(TmFTIR2 in figure 4.1 C) and using the cross section point between the increasing β-sheet 
band at 1620cm-1 and the decreasing α-helix band at 1655cm-1 (TmFTIR3 in figure 4.1 D). The 
midpoints of thermal denaturation in figure 4.1 B and C were obtained by performing sigmoid 
fit.  
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Figure 4. 1: FTIR measurement for GCSFDb1 formulation. Vector normalized second derivative spectra 
(A), Intensity change of the β-sheet band at 1620cm-1 (B), Intensity change of α-helix band at 1655 cm-1 
(C) and cross section point between increasing β-sheet and decreasing α-helix intensities(D). 
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2.4. 2nd derivative UV spectroscopy: 
UV absorption spectra were obtained generally from 20 - 80 °C. The exact temperature range 
was selected according to the previously measured µDSC Tm. Absorption spectra were 
recorded in a 5°C interval and in 2 °C intervals in the area just before and during unfolding. 
Measurements were done using Agilant 8453 UV spectrophotometer equipped with an 
Agilant 89090A temperature control device. Second derivatives of the absorption spectra were 
obtained employing a nine data point, quadratic-cubic formula using UV-Visible 
Chemstation® software from Agilent Technologies™. Second derivative spectra were fit to 
spline functions with 99 points of interpolation. The combined tyrosine and tryptophan peak 
near 284 nm and the tryptophan peak near 292 nm were used to monitor change in the tertiary 
structure of different GCSF formulations. As an effect of increasing temperature the above 
mentioned minima perform either blue (towards lower wavelengths) or red (towards higher 
wavelengths) shift indicating either unfolding or aggregation, respectively 6. The position of 
each minimum was plotted as a function of temperature (figure 4.2 B and C) and the 
midpoints of thermal denaturation (TmUV) were obtained by performing sigmoid fit. 
Accordingly, two different Tms were obtained TmUV1 and TmUV2 for combined tyrosine 
tryptophan peak and tryptophan peak, respectively (figure 4.2 B and C). Moreover, the optical 
density at 350nm (turbidity) was monitored over the same temperature range to assess the 
aggregation behaviour of the formulation (figure 4.2 A). The resulted curves were fitted to 
exponential growth fitting function. 
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Figure 4. 2: Denaturation of GCSFDb1 monitored by 2nd derivative UV spectroscopy. Optical density at 
350 nm (OD) versus temperature (A). Negative peak positions as a function of temperature near 282 nm 
(B) and 290 nm (C) for the absorbance of a combination of Tyr/Trp and Trp, respectively. 
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2.5. Non-isothermal accelerated stability study (Non-IsoSS): 
Non-IsoSS was reported as a fast alternative to obtain linear Arrhenius parameters 7,8 for small 
drug molecules and also for protein drugs. These studies considered monitoring the chemical 
degradation of a drug substance during heating and from the collected data the degradation 
rate at each temperature could be determined from which a linear Arrhenius plot is calculated. 
Protein physical denaturation doesn’t obey a linear Arrhenius behaviour 9 therefore, we didn’t 
aim to determine any Arrhenius parameters. Using non-isothermal procedures we aimed to 
determine the temperature at which 50% of the native monomer is denatured (we called it in 
this work Temp50 to differentiate it from thermal or spectroscopic determined Tms) but instead 
thermal or spectroscopic measurements the monomer content was monitored during the 
heating cycle using size exclusion chromatography (SE-HPLC).  
GCSF formulations were heated from 20 to Ca. 80°C using a Thermo-mixer device 
(ComfortTM, Eppendorf AG 2233, Hamburg). No mixing was applied during the whole ramp. 
Each formulation was divided in small aliquots each in an Eppendorf tube and left in the 
thermo-mixer to equilibrate at 20°C for 5 min. The temperature was increased according to a 
programmed temperature ramps. At several temperature intervals the set was left to 
equilibrate for 5 min and one tube was withdrawn, centrifuged at 14000 rpm for 5 min using 
Neo lab 16/18TM centrifuge (Hermle labortechnik, Wehingen, Germany). SE-HPLC analysis 
was performed to monitor the monomer content of each formulation at each temperature. 
Separation was achieved using Spectra-Physics HPLC system and a TSKgel G3000SWXL 7.8 
mm ID x 30.0 cm L (Tosoh Bioscience). A flow rate of 0.6 ml/min was used, and the protein 
was detected at a wavelength of 215 nm. Mobile phase consists of 100 mM phosphate buffer 
pH 7. At each temperature the found monomer content was plotted against temperature. It was 
noticed that the monomer content decreased slowly at the early phase and then suddenly the 
monomer content drops very fast. Fitting such a curve was achieved by dividing it into two 
parts and each part was fitted using two terms polynomial fitting using Excel® software. An 
example of such a fitting is presented in figure 4.3. The temperature at which 50% of 
monomer is denatured (Temp50) is calculated from the polynomial equation: 
 
cbxaxy  2     (1) 
 
By knowing y equal to 50 then two value of x can be calculated: 
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In all cases Temp50 was determined by x1.  
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Figure 4. 3: Monomer content during Non-Iso-thermal stress for GCSFDb1 formulation. The curve left 
part is the slow degradation part and the right part the fast part. 
 
 
 
2.6. Isothermal stability study (IsoSS): 
All formulations were subjected to IsoSS at 4°C (20 months) and 40°C (3 months). At several 
time intervals formulations were analyzed for their monomer denaturation rate, turbidity, and 
chemical degradations rates. All methods and formulations were described in the last chapter 
in details. The results from chapter 3 part I are again used in this study too.  
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2.7. Ranking: 
2.7.1. Ranking for the IsoSS: 
This was described in details in the chapter 3 part I. in section I.1.5.2, pages 58 - 60. Table 4.1 
show the ranking procedures for the 16 formulations included in 2 DOEs (DOEb and DOEc) 
based on IsoSS stability study at 4°C. The formulations were ranked with regards to physical 
stability (Rp4), chemical stability (Rc4) and the overall stability (Rs4). 
 
Table 4. 1: Ranking of GCSF formulations in DOEb and DOEc after 20 months storage at 4°C 
 
Formulations Kp4 R14 Tur.4 R24 
Avr. 
(R14+R24)/2 
Rp4 Kc4 Rc4 
Avr. 
(Rp4+Rc4)/2 
Rs4 
GCSFDb1 -0.0003 3 1 8 5.5 5 -0.0056 13 9 10 
GCSFDb2 -0.0001 2 0.7 1 1.5 2 -0.0012 12 7 5 
GCSFDb3 -0.0007 6 0.6 1 3.5 3 -0.00005 4 3.5 2 
GCSFDb4 -0.0011 8 0.8 1 4.5 4 -0.0066 14 9 10 
GCSFDb5 -0.0009 7 1.6 8 7.5 10 -0.0005 7 8.5 8 
GCSFDb6 -0.0006 5 1 8 6.5 8 -0.0119 16 12 15 
GCSFDb7 -0.0017 11 0.8 1 6 6 -0.0101 15 10.5 12 
GCSFDb8 -0.0011 8 1.2 8 8 11 -0.0011 11 11 13 
GCSFDc1 -0.0387 15 0.7 1 8 11 0.0003 2 6.5 4 
GCSFDc2 -0.0005 4 1.1 8 6 6 0.0004 1 3.5 2 
GCSFDc3 0.00004 1 0.9 1 1 1 -0.0002 5 3 1 
GCSFDc4 -0.0377 13 0.7 1 7 9 -0.0005 7 8 6 
GCSFDc5 -0.0011 8 1.1 8 8 11 -0.0004 6 8.5 8 
GCSFDc6 -0.0383 14 2.9 15 14.5 16 -0.0005 7 11.5 14 
GCSFDc7 -0.0398 16 1.6 8 12 14 0.0003 2 8 6 
GCSFDc8 -0.0021 12 5.2 16 14 15 -0.0006 10 12.5 16 
2.7.2. Predictive rankings: 
In this chapter, 5 different stability studies were evaluated for their predictive power of the 
real time stability ranking (table 4.1.). Consequently, different ranking methods were studied. 
 
2.7.2.1. Individual ranking: 
For 16 GCSF formulations 5 different predictive rankings were calculated. Each of those was 
based on one of the studied predictive strategies. In table 4.2 rankings based on TmµDSC, TmUV, 
TmFTIR and Temp50 are presented. Furthermore, the accelerated stability study at 40°C was 
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also evaluated as a predictive method and the ranking based on it is presented also in table 4.2 
(IsoSS40°C ranking) for physical (Rp40), chemical (Rc40) and overall (Rs40) stability.  
 
 
 
Table 4. 2: Individual ranking based on different stability predictive strategies 
 
µDSC 2nd UV FTIR Temp50 IsoSS40°C ranking 
Formulations 
TmµDSC Rank TmUVav Rank TmFTIR1 Rank Temp50 Rank Rp40 Rc40 Rs40 
GCSFDb1 69,5 7 66,2 7 52,9 8 81,5 3 11 14 13 
GCSFDb2 69,9 6 68,4 3 53 7 82,7 2 1 7 4 
GCSFDb3 71,5 3 67,1 6 50,7 13 79 4 7 9 7 
GCSFDb4 69,6 7 66 8 50,9 12 72,8 6 12 13 13 
GCSFDb5 59 13 57,9 13 48,5 15 58,2 12 13 11 11 
GCSFDb6 57,3 15 55,6 15 51,4 11 54,4 15 16 16 16 
GCSFDb7 56,3 16 54,4 16 47,3 16 53,2 16 9 15 11 
GCSFDb8 57,5 14 56,9 14 50,2 14 57,9 14 15 12 15 
GCSFDc1 70,3 5 68 4 53,1 6 70,8 7 3 1 1 
GCSFDc2 72,5 1 71 1 62,9 1 86,4 1 6 5 6 
GCSFDc3 72,6 1 70,1 2 56 4 74,5 5 2 2 1 
GCSFDc4 71,2 4 67,7 5 57,14 2 70,4 8 5 3 4 
GCSFDc5 66,2 9 62,2 9 56,8 3 63,9 9 3 4 3 
GCSFDc6 61,7 11 59 11 52 9 61,1 11 8 8 7 
GCSFDc7 62,9 10 59,8 10 53,4 5 62 10 13 6 9 
GCSFDc8 60,5 12 58,2 12 51,9 10 58 13 9 10 9 
 
 
 
2.7.2.2. Combined ranking: 
In a trial to improve the predictive power of each method a combined ranking was performed 
in which the average of two or more rankings was calculated and compared with the 
IsoSS4°C ranking. The number of possible combinations was huge. Therefore, and due to 
limited space, not all ranking tables are presented but only a representative table for the 
combined ranking between TmµDSC and TmUV is presented in table 4.3. 
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Table 4. 3: Combined µDSC and 2nd derivative UV ranking for 16 GCSF formulations 
µDSC 2nd UV 
Average 
(RµDSC + RUV)/2 Formulations 
Tm Rank TmUVav Rank Aver. Rank 
GCSFDb1 69,5 7 66,2 7 7,5 7 
GCSFDb2 69,9 6 68,4 3 4,5 3 
GCSFDb3 71,5 3 67,1 6 4,5 3 
GCSFDb4 69,6 7 66 8 7,5 7 
GCSFDb5 59 13 57,9 13 13 13 
GCSFDb6 57,3 15 55,6 15 15 15 
GCSFDb7 56,3 16 54,4 16 16 16 
GCSFDb8 57,5 14 56,9 14 14 14 
GCSFDc1 70,3 5 68 4 4,5 3 
GCSFDc2 72,5 1 71 1 1,5 1 
GCSFDc3 72,6 1 70,1 2 1,5 1 
GCSFDc4 71,2 4 67,7 5 4,5 3 
GCSFDc5 66,2 9 62,2 9 9 9 
GCSFDc6 61,7 11 59 11 11 11 
GCSFDc7 62,9 10 59,8 10 10 10 
GCSFDc8 60,5 12 58,2 12 12 12 
 
 
2.8. Correlation: 
The correlations were judged as in chapter 3 according to two parameters. 
1- Pearson product moment correlation coefficient obtained from correlation curves 
between each predictive rankings and ranking based on IsoSS at 4°C 
2- The 50% and 20% prediction quality.  
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3. Results and discussion: 
3.1. Measured parameters: 
Table 4.4 shows different Tms measured using UV and FTIR for 16 GCSF liquid formulations 
involved in our study. µDSC measured Tm and Temp50 were listed in table 4.2.  
 
Table 4. 4: TmUV and TmFTIR for 16 GCSF formulations of DOEb and DOEc 
2nd derivative UV FTIR 
Formulations 
TmUV1 TmUV2 TmUVav TmFTIR1 TmFTIR2 TmFTIR3 
GCSFDb1 66,1 66,2 66,2 52,9 52,8 58,8 
GCSFDb2 68,7 68,0 68,4 53 51,2 58,5 
GCSFDb3 67,5 66,7 67,1 50,7 47,1 57 
GCSFDb4 66,3 65,7 66 50,9 51,18 59,8 
GCSFDb5 57,3 58,5 57,9 48,5 46,9 59,4 
GCSFDb6 56 55,1 55,6 51,4 58,8 60,4 
GCSFDb7 52,9 55,9 54,4 47,3 44,2 60,3 
GCSFDb8 56 57,8 56,9 50,2 49,4 59,8 
GCSFDc1 68,4 67,6 68 53,1 64 64,3 
GCSFDc2 72,1 69,8 71 62,9 63,9 64,7 
GCSFDc3 70,7 69,5 70,1 56 65,6 59,3 
GCSFDc4 67,7 67,6 67,7 57,14 58,3 59,2 
GCSFDc5 62,4 61,9 62,2 56,8 57,9 58,3 
GCSFDc6 59,5 58,5 59 52 55,4 55,5 
GCSFDc7 59,7 59,9 59,8 53,4 54,1 57 
GCSFDc8 57,2 59,1 58,2 51,9 51,5 56 
 
 
3.2. Correlation: 
In this section it should be highlighted, as explained in chapter 3, that the stability of the 
GCSF molecule is affected by both physical and chemical stability. In DOEb physical 
stability of the formulations was driven from chemical stability, due to the oxidative effect of 
the peroxide residue in Tween 80, which was not the case in DOEc formulations.  
Normally in protein formulation development the objective is not to develop physically or 
chemically stable formulation but one that is both physically and chemically stable. In such a 
situation, the prediction power of a method would be rather judged based on its ability to 
predict the overall stability rather than either physical or chemical stability alone.    
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Theoretically most of the studied parameters in this chapter should only be able to reflect the 
changes in physical properties. Therefore, prediction of the overall stability will be a great 
challenge.  
In the following section the predictive power of each method will be discussed.  
 
3.2.1. Prediction based on individual rankings: 
Ranking based on each parameter was correlated to rankings based on IsoSS 4°C for physical, 
chemical, and overall stabilities. The predictive power of each method was judged based 
primarily on correlation coefficients, and second on the 50 % as well as 20 % prediction 
quality. Figure 4.4 shows an overview of the resulting correlation coefficients and figure 4.5 
shows the 50% and 20% prediction quality.  (Due to the huge number of correlation curves 
obtained in this chapter as well as the limited space no correlation curves are presented). 
 
 
Figure 4. 4: An overview of the correlation coefficients resulting form correlating rankings based on 
different predictive methods and IsoSS at 4°C (physical, chemical, or overall) based rankings. 
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Figure 4. 5: Prediction quality of different methods in predicting physical, chemical or overall IsoSS at 
4°C. 50% as well as 20 % prediction quality are shown beside each other for each method. 
 
 
 
 
3.2.1.1. Differential scanning microcalorimetry (µDSC): 
TmµDSC showed a slightly lower correlation coefficient for physical than that for chemical 
stabilities (figure 4.4). Despite lower correlation coefficient, TmµDSC showed a higher 50% and 
20% quality in predicting the physical stability (figure 4.5). TmµDSC measurement was affected 
by chemical oxidation of GCSF formulations in DOEb (8 from the total 16 formulations) and 
that caused (when ranking both DOEb and DOEc as one group) a reduced correlation to 
physical stability than to chemical stability and therefore, lower correlation coefficient for 
physical stability has been observed. Predicting the overall stability ranking, TmµDSC showed a 
significantly strong predictive power revealed by a high correlation coefficient, a very high 
50% prediction quality and surprisingly a full 20% prediction quality. TmµDSC was able 
without error to select the best 3 formulations and to exclude the worst 13 from a group of 16 
GCSF liquid formulations (figure 4.5) 
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3.2.1.2. Fourier Transform Infrared spectroscopy (FTIR): 
In order to choose which of the FTIR measured Tms shall be used preferably, rankings based 
on each of the different Tms was studied in correlation to the IsoSS rankings at 4°C (appendix 
4.I figure 4.I.1). TmFTIR1, which showed the highest correlation coefficients, was used further 
in the correlation study (the ranking shown in table 4.2 is made based on TmFTIR1). TmFTIR 
based ranking showed a very low correlation coefficient and a bad prediction quality 
especially for physical stability as shown in figures 4.4 and figure 4.5, respectively. The 
correlation with chemical stability was better. For measuring the unfolding temperature 
(TmFTIR) of liquid protein formulations high protein concentration is needed to omit the 
interference of the water absorption peak in the amide I region10. In this study the 
concentration used for TmFTIR measurements was 2 mg/ml while only 0.2 mg/ml GCSF was 
included in formulations for IsoSS. This higher concentration most probably would affect the 
measured Tm and consequently false ranking may be obtained. Furthermore, the measurement 
in the Bio-ART unit takes place on the crystal surface and not in solution bulk and therefore 
the measured Tm would be mainly affected by protein stability at interfaces1,10. In the 
presence of factors like Tween80 and HPBCD where they act on both levels (interface and 
solution bulk) the effect on the interface would be exaggerated leading to a wrong 
determination of Tms. The reason for the high correlation with chemical stability is not clear. 
A possible explanation can be that FTIR monitors changes in secondary structure which take 
place mainly through breaking of hydrogen bonds11,12. Such bonds might break due to other 
covalent chemical reactions and thus would also cause secondary structure changes and Tm 
would be highly affected by chemical changes.  
 
3.2.1.3. 2nd derivative UV spectroscopy: 
As mentioned in section 2.4, page 152, two different Tms were obtained: TmUV1 and TmUV2 
(figure 4.2 B and C). Each one was tested for it correlation to the IsoSS 4°C. Moreover, the 
average of these two TmUV (TmUVav.) listed in table 4.4 was also tested to find out which Tm 
could be used further in the correlation studies. Figure 4.I.2 in appendix 4.I shows the 
comparison based on correlation coefficients of the two TmUV1 and TmUV2 as well as the 
average TmUVav. All three were found to be equal in terms of correlation coefficients and for 
further correlation studies TmUVav was used (the ranking shown in table 4.2 is made based on 
TmUVav). The prediction quality was very similar to that for TmµDSC. Physical stability was 
predicted with a slightly lower correlation coefficient than chemical stability with higher 
prediction quality to physical stability prediction, and a high correlation to overall stability 
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prediction was obtained (figure 4.4 and 4.5). This ability to reflect some chemical degradation 
process gave this method an advantage in predicting the overall stability ranking of GCSF 
formulations.  
 
3.2.1.4. Non-IsoSS measured Temp50: 
The monomer content of each formulation was monitored during a temperature ramp from 20 
to ca. 80°C as described in section 2.5. Temp50, which is the temperature at which 50% of the 
monomer is denatured, should in theory be equal to Tms determined from other techniques but 
practically that was not true as shown in table 4.2. It was noticed that Tms determined from 
other techniques (µDSC, UV or FTIR) are also not identical. A reason for this deviation might 
be due to the different measuring principles in each technique. However, Temp50 is a direct 
measure for the monomer content and therefore it would represent the true temperature at 
which really 50% of the protein molecule is denatured.   
Temp50 showed, in comparison to other predictive strategies, the highest correlation 
coefficient to physical stability and the lowest to chemical stability (figure 4.4). Temp50 based 
rankings were not that good in predicting the overall stability of the studied GCSF 
formulations.  
 
3.2.1.5. IsoSS40°C: 
IsoSS40°C showed the best correlation to chemical stability and very weak correlation to 
physical stability with a middle correlation to overall stability (figure 4.4). The same 
behaviour was noticed when studying the correlation of the whole 24 GCSF formulation set in 
chapter 3, part I (figure 3.7. page 72). The chemical degradation, of many proteins showed 
linear Arrhenius plots 13-15 which should allow us to apply extrapolation of the Arrhenius 
curve to predict shelf life at real storage temperature. And that agrees with the strong 
predictive power of IsoSS40°C to chemical stability of GCSF formulations. In contrast, for 
physical denaturation involving conformational changes, only phenomenological 
extrapolation approaches for aggregation rate prediction were published 16. An excellent 
review criticizing the application of the Arrhenius plot in predicting aggregation rates under 
real time conditions is available from Weiss et al 9. This review explains how protein 
molecules show non Arrhenius behaviour and there are many concerns in predicting 
aggregation rate using extrapolation Arrhenius approaches. That might explain the bad 
prediction observed by using IsoSS40°C in predicting physical stability not only in the present 
study but also in chapter 3 with three different proteins. IsoSS40°C is chemically biased 
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method therefore the prediction of the overall stability was not satisfactory in comparison 
with other predictive methods like µDSC and 2nd derivative UV spectroscopy.  
 
3.2.2. Prediction based on combined-ranking: 
In this section it was investigated if the predictive power would be improved by combining of 
more than one method in a combined predictive ranking.. Effects of such combinations on 
both correlation coefficients and prediction quality of each predictive method are studied. The 
effect of combined rankings on the predictive power of TmµDSC is graphically presented in 
figures 4.6, 4.7 and 4.8 for the effect on correlation coefficients, 50% and 20% prediction 
quality, respectively. The effect on predictive powers of the other techniques (UV, FTIR, 
Temp50 and IsoSS40°C) is presented in figures 4.I.3 – 14 in appendix 4.I. 
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Figure 4. 6: Effect of combining different predictive rankings with ranking based on TmµDSC on the 
correlation coefficients resulting from correlating each combined ranking with the real stability based 
ranking. Rp states for ranking based on physical stability, Rc for ranking based on chemical stability and 
Rs for ranking based on overall stability 
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Figure 4. 7: Effect of combined rankings on the 50% prediction quality of TmµDSC in predicting physical 
stability (A), chemical stability (B) and the overall stability ranking (C) of 16 GCSF formulations after 20 
months storage at 4°C 
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(C) 
Figure 4. 8: Effect of combined rankings on the 20% prediction quality of TmµDSC in predicting physical 
stability (A), chemical stability (B) and the overall stability ranking (C) of 16 GCSF formulations after 20 
months storage at 4°C 
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3.2.2.1. Physical stability: 
No significant improvement in physical stability prediction of TmµDSC, as observed on the 
correlation coefficients, by combining rankings from other predictive techniques (figure 4.6) 
The same was also observed for TmUV and Temp50 based rankings (figures 4.I.3, page 171 and 
figure 4.I.9, page 177, respectively). TmFTIR and accelerated stability studies (IsoSS 40°C) 
based rankings showed improvement in correlation coefficients when combined with one or 
more of TmµDSC, TmUV and Temp50 based rankings (figure 4.I.6, page 174 and Figure 4.I.12, 
page 180, respectively). Studying both 50% and 20% prediction qualities, no improvement 
was observed for TmµDSC (Figure 4.7 A and 4.8 A), TmUV (Figures 4.I.4 A and 4.I.5 A, pages 
172 and 173) and Temp50 (figures 4.I.10 A and 4.I.11 A, pages 178 and 179) by combined 
ranking approach.  TmFTIR (figure 4.I.7 A and 4.I.8 A, pages 175 and 176) and IsoSS 40°C 
(figure 4.I.14 A and 4.I.15 A, pages 181 and 182) physical stability prediction quality 
improved when one or more of TmµDSC, TmUv and Temp50 based rankings are included.   
 
3.2.2.2. Chemical stability: 
No significant improvement in chemical stability prediction of IsoSS40°C based ranking by 
combining with other predictive rankings (figures 4.I.12, 4.I.13 B and 4.I.14 B, pages 180 – 
182). On the other hand improvements were achieved in the predictive power of other 
methods when combined with IsoSS 40°C ranking. This can be seen on the higher correlation 
coefficients as well as the better prediction quality when rankings based on TmµDSC (figures 
4.6, 4.7 B and 4.8 B, pages 163 – 165), TmUV (figures 4.I.3, 4.I.4 B and 4.I.5 B, pages 171 – 
173), TmFTIR (figures 4.I.6, 4.I.7 B and 4.I.8 B, pages 174 – 176) or Temp50 (figures 4.I.9,  
4.I.10 B and 4.I.11 B, pages 177 – 179) is combined with IsoSS 40°C based ranking.  
 
3.2.2.3. Overall stability: 
No significant improvement in the overall stability prediction of TmµDSC (Figure 4.6) and 
TmUV (figure 4.I.3, page 171) by combining rankings from other techniques. TmFTIR (figure 
4.I.6, page 174), Temp50 (figure 4.I.9, page 177) and IsoSS 40°C (figure 4.I.12, page 180) 
based rankings showed significantly higher correlation coefficients when TmµDSC and/or TmUV 
are included. TmµDSC 50% prediction quality (figure 4.7 C) showed improvement by 
combining with either TmFTIR or IsoSS40°C. However, the best 20% selection quality was 
obtained by individual TmµDSC based ranking with no falsely predicted formulations (figure 
4.8 C). TmUv showed similar improvement in 50% and no improvement in 20 % prediction 
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quality by combining with other predictive rankings (figures 4.I.4 C and 4.I.5 C, pages 172 
and 173). Improvements in prediction quality of TmFTIR (figure 4.I.7 C and 4.I.8 C, pages 175 
and 176), Temp50 (figures 4.I.10 C and 4.I.11 C, pages 178 and 179) and IsoSS 40°C (figure 
4.I.14 C and 4.I.15 C, pages 181 and 182) by combining with either TmµDSC and/or TmUv 
based rankings were observed.  
 
 
4. Conclusion: 
Stability of a protein formulation is determined by both physical and chemical issues. 
Formulation conditions as well as stabilizing excipients affect both physical and chemical 
stabilities variably. However, to reach the right decision in a big formulation set in order to 
end up with a small group where the most stable candidates are included many issues should 
be considered. Whether chemical or physical stability would have the upper hand in the 
overall stability decision is very crucial to reach such a decision. This is dependant on protein 
structure, nature and action of the studied excipients, and effect of other formulation 
conditions. Being aware of such information this study would provide the formulator with a 
suitable guideline to choose the method that would be suitable for the studied protein and/or 
experimental design. The predictive powers of five analytical strategies towards both physical 
and chemical stabilities were tested. Furthermore, the predictive powers of these methods 
towards an overall stability ranking were also evaluated. Each method showed different 
behaviour in predicting the long term stability of 16 GCSF liquid formulations. µDSC and UV 
spectroscopy were able to equally predict both physical and chemical stabilities and therefore 
have an advantage in predicting the overall stability of the formulation set. However, µDSC 
based rankings were able to predict the best 3 stable formulations without false prediction. 
Temp50 which represent the temperature at which 50% of the monomer in the formulation is 
denatured, after non-isothermal stress from 20 to ca. 80°C, was more biased to physical 
stability. On the other hand IsoSS40 was extremely biased to chemical stability. FTIR showed 
unclear correlation behaviour due to reasons addressed in the discussion. However, including 
FTIR in combined rankings resulted in a significant improvement of the selection quality.  
Considering ranking based on FTIR, Temp50 or IsoSS40°C didn’t improve the predictive 
power of µDSC or UV.  
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6. Appendix 4.I: 
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Figure 4.I. 1: Comparison between correlation coefficients resulting from correlating different FTIR 
measured Tms based ranking with physical (Rp), chemical (Rc), or overall (Rs) stability based rankings of
the studied 16 GCSF formulations. 
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Figure 4.I. 2: Comparison between correlation coefficients resulting from correlating different UV 
determined Tms based ranking with physical (Rp), chemical (Rc), or overall (Rs) stability based rankings 
of the studied 16 GCSF formulations. 
 
 
 
 
170 
Other strategies for the prediction of long term stability of GCSF liquid formulations 
_________________________________________________________________________________________________________________ 
 
U
V
U
V
 +
 µ
D
S
C
U
V
 +
 F
TI
R
U
V
 +
 T
em
p5
0
U
V
 +
 Is
oS
S
40
U
V
 +
 µ
D
S
C
 +
 F
TI
R
U
V
 +
 µ
D
S
C
 +
 T
em
p5
0
U
V
 +
 µ
D
S
C
 +
 Is
oS
S
40
U
V
 +
 F
TI
R
+T
em
p5
0
U
V
 +
 F
TI
R
 +
 Is
oS
S
40
U
V
 +
 T
em
p 
50
 +
 Is
oS
S
 4
0
U
V
 +
 µ
D
S
C
 +
 F
TI
R
 +
 T
em
p 
50
U
V
 +
 µ
D
S
C
 +
 F
TI
R
 +
 Is
oS
S
40
U
V
 +
 µ
D
S
C
 +
 T
em
p 
50
 +
 Is
oS
S
40
U
V
 +
 F
TI
R
 +
 T
em
p 
50
 +
 Is
oS
S
40
A
LL
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1 Rp Rc Rs
 
Figure 4.I. 3: Effect of combining different predictive rankings with ranking based on TmUV on the 
correlation coefficients resulting from correlating each combined ranking with the real stability based 
ranking. Rp states for ranking based on physical stability, Rc for ranking based on chemical stability and 
Rs for ranking based on overall stability 
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(C) 
Figure 4.I. 4: Effect of combined rankings on the 50% prediction quality of TmUV in predicting physical 
stability (A), chemical stability (B) and the overall stability ranking (C) of 16 GCSF formulations after 20 
months storage at 4°C 
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(C) 
Figure 4.I. 5: Effect of combined rankings on the 20% prediction quality of TmUV in predicting physical 
stability (A), chemical stability (B) and the overall stability ranking (C) of 16 GCSF formulations after 20 
months storage at 4°C 
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Figure 4.I. 6: Effect of combining different predictive rankings with ranking based on TmFTIR on the 
correlation coefficients resulting from correlating each combined ranking with the real stability based 
ranking. Rp states for ranking based on physical stability, Rc for ranking based on chemical stability and 
Rs for ranking based on overall stability 
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(C) 
Figure 4.I. 7: Effect of combined rankings on the 50% prediction quality of TmFTIR in predicting physical 
stability (A), chemical stability (B) and the overall stability ranking (C) of 16 GCSF formulations after 20 
months storage at 4°C 
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Figure 4.I. 8: Effect of combined rankings on the 20% prediction quality of TmFTIR in predicting physical 
stability (A), chemical stability (B) and the overall stability ranking (C) of 16 GCSF formulations after 20 
months storage at 4°C 
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Figure 4.I. 9: Effect of combining different predictive rankings with ranking based on Temp50 on the 
correlation coefficients resulting from correlating each combined ranking with the real stability based 
ranking. Rp states for ranking based on physical stability, Rc for ranking based on chemical stability and 
Rs for ranking based on overall stability 
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(C) 
Figure 4.I. 10: Effect of combined rankings on the 50% prediction quality of Temp50 in predicting physical 
stability (A), chemical stability (B) and the overall stability ranking (C) of 16 GCSF formulations after 20 
months storage at 4°C 
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(C) 
Figure 4.I. 11: Effect of combined rankings on the 20% prediction quality of Temp50 in predicting physical 
stability (A), chemical stability (B) and the overall stability ranking (C) of 16 GCSF formulations after 20 
months storage at 4°C 
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Figure 4.I. 12: Effect of combining different predictive rankings with ranking based on IsoSS40°C on the 
correlation coefficients resulting from correlating each combined ranking with the real stability based 
ranking. Rp states for ranking based on physical stability, Rc for ranking based on chemical stability and 
Rs for ranking based on overall stability 
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(C) 
Figure 4.I. 13: Effect of combined rankings on the 50% prediction quality of IsoSS40°C in predicting 
physical stability (A), chemical stability (B) and the overall stability ranking (C) of 16 GCSF formulations 
after 20 months storage at 4°C 
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(C) 
Figure 4.I. 14: Effect of combined rankings on the 20% prediction quality of IsoSS40°C in predicting 
physical stability (A), chemical stability (B) and the overall stability ranking (C) of 16 GCSF formulations 
after 20 months storage at 4°C 
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Chapter 5 
 
Summary of the thesis 
 
The prediction of the overall protein stability is not trivial before the real time stability studies 
are conducted, which are very costly and time consuming. Due to the complex formation 
mechanisms and structure of protein degradation products it is quite hard to characterize and 
furthermore to quantify such species accurately with a single analytical method. In fact, many 
analytical techniques have to be involved to get reliable decisions. Moreover, predictive 
strategies are still not well evaluated with respect to real long term stability of proteins. For 
successful prediction of protein long term stability the selected analytical method(s) should be 
able to predict the rates of main protein degradation processes.  In chapter 1 some general 
aspects on protein stability are summarized including mechanisms and factors involved in 
protein stabilization and/or destabilization processes. Furthermore, an overview on analytical 
techniques used in protein formulation development is presented. 
 
µDSC represents a predictive tool which is believed to be successful depending on measured 
Unfolding temperatures (Tm) but till now comprehensive, systematic data from real time 
studies correlated with Tm determined by µDSC have not been published. 
Therefore, the main objective of this study is to find out how far a formulator can rely on Tm 
as a predictive marker for protein stability. Systematic studies to correlate µDSC data with 
long term stability as well as short term stress studies are performed and the quality of the 
obtained prediction is evaluated. 
 
 
1. Microcalorimetry as a predictive tool for physical stability of granulocyte colony 
stimulating factor (GCSF) in solution at different pH values (chapter2).  
Tm and degree of unfolding reversibility were determined using differential scanning 
microcalorimetry (µDSC) for 12 unbuffered GCSF formulations over a pH range from 2 – 7.  
Tm showed no significant difference in the range from pH 3.5 – 4, below and above these pH 
values Tm is significantly reduced. The degree of unfolding reversibility showed a clear 
reduction with increasing the pH values till pH 3.9. Further increasing the pH value, GCSF 
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showed no reversibility any more. Now the applicability of both Tm and degree of unfolding 
reversibility in predicting physical stability of GCSF was evaluated. Two accelerated stress 
stability studies applying either isothermal or mechanical stress were performed and the 
results were compared with the µDSC parameters. The results showed excellent predictive 
power of Tm for the isothermal stability study at elevated temperature which was further 
improved by considering the degree of unfolding reversibility. The degree of unfolding 
reversibility was even significantly better than Tm in predicting the outcome of the 
mechanical stress stability study. 
 
 
2. Critical evaluation of µDSC as a predictive tool for the long term stability of 
different protein classes (Chapter 3). 
A systematic stability study on up to 24 different Granulocyte colony stimulating factor 
(GCSF), 15 Monoclonal antibody (MAB) and 14 Pegylated Interferon α2a (PEG-INF) 
formulations was performed. The formulations were tested with respect to different factors. 
For all formulations Tm and unfolding reversibility, when applicable, were determined. The 
same formulations were used for isothermal stability studies (IsoSS) at ICH temperatures (4, 
25, and 40°C) for a period of up to 24 months in GCSF and 12 months for MAB and PEG-
INF. At different time intervals the formulations were analyzed using classical analytical 
methods (size exclusion chromatography, turbidimetry, light blockage, gel electrophoresis, 
and reversed phase chromatography). Finally, microcalorimetric data were correlated with 
IsoSS data 
 
In large groups of formulations Tm was not able to predict the exact rank order, but selecting 
the good formulations and excluding the bad ones was an excellent approach to reduce the 
work load in long term stability studies. Surprisingly, Tm showed stronger correlation and 
more reliability than routinely applied accelerated stability studies. Such conclusions should 
encourage many changes in routinely applied formulation development scenarios in 
biopharmaceutics. 
 
In 24 GCSF formulations, where Tm and unfolding reversibility could be determined, further 
optimization of Tm based ranking by considering the degree of unfolding reversibility did not 
show any significant benefit on predictions. Tm showed superior predictive power, in 
predicting the overall stability ranking especially at 4°C. Although ranking based on IsoSS at 
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25°C showed higher correlation coefficients and higher prediction quality toward real time 
stability at 4°C, 9 to 12 months are needed to reach predictive results. Predictive studies using 
µDSC for 24 formulations can be carried out in an experimental plan which needs less than 4 
weeks to be done and show approximately similar predictive power compared to IsoSS at 
25°C. Concerning chemical stability, IsoSS at elevated temperatures (e.g. 40°C) showed 
significantly higher correlation coefficients and high prediction quality.  
 
In a µDSC study for 15 MAB formulations three different transitions were determined. 
Selecting the good formulations and excluding the bad ones was very successful based on the 
earliest transition (Tm1) especially for long term stability at 4°C. Predictive studies based on 
Tm1 measurements had proved superiority in predicting physical stability ranking to the 
routinely performed accelerated isothermal stability studies at elevated temperatures.  
 
For PEG-INF formulations Tms were not able to predict the long term stability at 4°C but 
selecting the good formulations and excluding the bad still did work. Pegylation of a protein 
molecule seems to prevent accurate prediction of the long term stability at 4°C. 
 
 
3. Other strategies for the prediction of long term stability of GCSF liquid 
formulations (Chapter 4). 
In this study the long term stability data of 16 from the previously studied 24 GCSF liquid 
formulations were used to evaluate other predictive methods. Those include Fourier 
Transform Infrared Spectroscopy (FTIR), 2nd Derivative UV spectroscopy and non-isothermal 
stability studies. Improvement of the predictive power was also tested by a combined ranking 
approach. 
 
The predictive powers of five analytical strategies towards both physical and chemical 
stabilities were tested. Furthermore, the predictive powers of these methods towards an 
overall stability ranking were also evaluated. Each method showed different behaviour in 
predicting the long term stability of 16 GCSF liquid formulations. µDSC and UV 
spectroscopy were able to equally predict both physical and chemical stabilities and therefore 
have an advantage in predicting the overall stability of the formulation set. However, µDSC 
based rankings were able to predict the best 3 stable formulations without false prediction. 
Temp50 which represent the temperature at which 50% of the monomer in the formulation is 
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denatured, after non-isothermal stress from 20 to ca. 80°C, was more biased to physical 
stability. On the other hand IsoSS40 was extremely biased to chemical stability. FTIR showed 
unclear correlation behaviour due to reasons addressed in the discussion. However, including 
FTIR in combined rankings resulted in a significant improvement of the selection quality.  
Considering ranking based on FTIR, Temp50 or IsoSS40°C didn’t improve the predictive 
power of µDSC or UV.  
 
For a better quality of candidate selection during protein formulation development a 
formulation selection scheme was suggested and shown in figure 5.1 
 
 
 
TmµDSC OR TmUV
Tm based Rankings 50% or 20% selection
Prototype Formulations
Best 
Candidate
IsoSS at 40 °C (3 
months)
Protein formulation set 
containing different stabilizers 
and/or solution conditions
Chemical stability and fine Tuning
 
 
Figure 5. 1: Formulation selection scheme for better quality of candidate selection 
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